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Chapter 1
Chapter 1
Aim and outline thesis
Nanotechnology is an emerging and promising field o f  research, which  
focuses on the design and creation o f novel architectures on the nanometer scale. 
Only recently imaging techniques have come into existence that enable 
visualization o f  the nanometer domain. Nanotechnology covers a broad range of  
subjects, ranging from the development o f  more efficient solar cells to novel drug 
delivery systems; it therefore has the potential to have a dramatic impact on society. 
To create the large diversity o f  nano-structures currently available, a plethora o f  
different techniques are used, which can be divided into two main approaches: a 
bottom-up and top-down approach. The latter one creates small structures by 
starting from larger ones. Photo-lithography is an example o f  this approach, where 
parts o f  a thin film  which is patterned by light are selectively removed and partly 
replaced to generate for example a silicon chip. The bottom-up approach on the 
other hand does exactly the opposite by creating nano-structures starting from small 
components. The structuring o f  these components is directed by molecular self­
assembly, i.e. the components are designed such, that molecular recognition 
phenomena between the components causes them to organize into higher ordered 
architectures. While scientists have just started to comprehend and use self­
assembly to create structures, nature uses self-assembly to create architectures o f  a 
mind-boggling complexity. The multitude o f  examples presented by nature can be 
used to obtain information about the self-assembly process itself, while at the same 
time natures building blocks such as proteins and nucleic acids can be employed to 
create novel synthetic structures. The design and synthesis o f  these novel structures 
in turn might provide us with more insight in the way nature functions. Nature, for 
the major part, uses only four basic building blocks to create biomolecules, i.e. 
sugars, lipids, amino acids, and nucleotides. From these compounds, larger building 
blocks, such as proteins or D N A  are made, which become the construction
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materials for even more complex systems. Relatively simple materials like DNA  
and short peptides are already commonly employed in the creation o f  synthetic se lf  
assembled nano-structures.1,2 More recently, also complex structures like viruses 
have found application as nano-building blocks.3 Viruses and bacteriophages are 
arguably the most abundant biological entities on earth,4 and nature has presented 
us with a large variety o f  shapes and sizes to choose from (figure 1 ).
Figure 1 Cartoon impression o f the wide variety o f sizes and shapes o f viruses.
Most o f  these viruses are easily produced in either their natural host or in 
another host, i.e. a heterologeous expression system, such as yeast or bacteria. 
Although they are certainly more complex than a single stranded D N A  chain or a 
peptide, viruses have evolved to form relatively simple structures from rather 
uniform building blocks. Many viruses consist only o f  a protein shell surrounding a 
number o f  nucleic acids. The protein shell is typically composed o f  multiple copies 
o f  one or a small number o f  different proteins. Viruses usually adopt only one 
morphology, although some viruses can exist in different shapes depending on the 
circumstances. The monodispersity o f  viruses is unparalleled by any synthetic 
nano-sized structure. This allows for example the growth o f  very monodisperse 
nanoparticles on the inside o f  the virus.6 Furthermore, the highly symmetric 
organization o f  the virus allows precise positional modification o f  the virus shell 
which is called capsid. Since the capsid is composed o f  proteins, it can be 
functionalized through genetic means or by chemical modification. This property 
has been elegantly used to create e.g. a light powered water splitting nano-catalyst 
by Nam et al.7 They genetically modified the tobacco mosaic virus (TMV) such that 
it expressed peptides on the capsid exterior that bind to IrO2, a water oxidizing
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catalyst. Through additional chemical modification o f  the capsid proteins, a 
photosensitizer was then grafted onto the virus surface, to yield the water splitting 
system.
Not only the outer surface o f  a virus is accessible for modification, also by 
modifying the interface o f  the constituting proteins, the assembly properties and 
morphology o f  the virus can be changed. M odification o f  the interior presents some 
additional challenges, such as low accessibility and the presence o f  the viral genetic 
material. Often, however, viruses can be produced without their genetic material, 
resulting in empty capsids. Most viruses contain pores in their capsid shell, through 
which small molecules can reach the capsid interior. Using this property, a 
chemotherapeutic agent, taxol, was attached to the interior o f  the MS2 capsid .8 
While the majority o f  viral capsids can only be obtained as an intact protein cage, 
with or without the genetic material, the cowpea chlorotic mottle virus (CCM V) has 
the special property that after removal o f  the viral RNA, the capsid proteins dimers 
can still reversibly assemble, and disassemble, depending on the pH. This property 
greatly increases versatility o f  this virus particle.
It is this property o f  the CCMV that has inspired and enabled the research 
presented in this thesis. The potential o f  the w ell defined protein cage o f  the CCMV  
virus to aid the formation o f  new materials or act as a highly confined reaction 
space is investigated. In particular the latter is o f  interest to increase our 
understanding o f  (bio)chemical reactions in a spatially restricted environment such 
as a cell or cellular compartments. By decorating the interior o f  the CCMV capsid 
with polymers, micelles, metals or enzymes a function can be added to the capsid, 
leading to the development o f  new, responsive materials, delivery systems, and 
nano-reactors.
In order to place the use o f CCMV as a nanoreactor into perspective a 
literature survey o f  reactions in protein containers is given in chapter 2 , together 
with a short description o f  the properties o f  CCMV. In chapter 3 the encapsulation 
of a negatively charged redox active polyelectrolyte inside the CCMV capsid is 
described. Following up on this work, in chapter 4 it is shown that besides 
negatively charged polymers also D N A  based amphiphile assemblies can be 
encapsulated. N ot only the native capsid protein, but also a genetically modified 
capsid protein is able to encapsulate negatively charged polymers. This work is 
reported in chapter 5. The expression and purification o f  the genetically modified 
capsid protein produced in Escherichia coli (E.coli) bacteria is also extensively 
discussed in this chapter. This non-native capsid protein is further modified for the
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efficient and controlled encapsulation o f  enhanced green fluorescent protein 
(EGFP) (chapter 6), while a detailed analysis o f  the complex assembly mechanism  
o f this modified virus system is described in chapter 7. Without the presence o f  
RNA, the capsid is only stable at acidic pH, but in chapter 8 a method is described 
to stabilize the capsid at physiological pH, by using the non-native capsid proteins 
that are appended with a metal binding peptide sequence. Finally, in chapter 9 the 
encapsulation o f  multiple enzymes inside the CCMV capsid is described forming a 
working protein nanoreactor. In this chapter also the kinetic data obtained from 
biocatalytic conversions in the protein capsid are discussed in relation to effects o f  
confinement.
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Chapter 2
Literature overview: reactions inside protein cages
Introduction
Reactions in confined space are currently gaining much interest, because they are 
expected to lead to unique characteristics o f  the products and to have a drastic 
impact on reaction kinetics.1,2 By performing enzymatic reactions in a confined 
space, scientists are trying to mimic the way in which enzymes react in nature. 
Compartmentalization occurs inside cells to create small separate locations with a 
specialized function, in which high concentrations o f  specific enzymes can be 
realized, and to achieve control over the order in which the enzymes react. Often 
the product o f  one reaction functions as a catalyst or substrate for the following  
one.3 This might significantly decrease formation o f side-products and increase 
reaction rates. The study o f  enzymes in confined spaces is therefore o f  crucial 
importance to gain insight in the complex processes o f  the cell, and for the 
development o f  improved catalytic systems, for the synthesis o f  new products, etc. 
Many studies concerning the encapsulation o f  enzymes by using various spherical 
particles, such as liposomes, polymersomes, and other spherical aggregates, have 
been reported.4-7 However, due to their polydisperse nature, reaction conditions 
vary considerably from particle to particle. Protein cages are very monodisperse, 
and would therefore be o f great use for the study o f  enzymatic reactions in confined 
space. The use o f  protein cages for enzymatic reactions is relatively new and only 
recently a few  examples have been reported.8-11 The development o f  methods to 
achieve encapsulation o f  enzymes into the confined space o f  the CCMV capsid and 
the subsequent study o f  enzymatic reactions within it, is one o f  the main goals o f  
the research presented in this thesis.
Protein cages do not only have potential applications in the study o f  
enzymatic reactions. In the past 20 years, the field o f  biomineralization has
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demonstrated that protein cages can also be used for the formation o f  highly 
monodisperse nanoparticles. In these processes the protein cage has different 
functions; it provides a constrained environment providing the proper conditions for 
the formation o f  highly monodisperse nanoparticles, it prevents aggregation o f  the 
formed nanoparticles, and in many cases it induces the mineralization reaction. It 
does so by providing the molecular interactions between the organic and inorganic 
phases that are crucial for the biomineralization process.12 An example is the well- 
defined interior cavity o f protein cages like ferritin, which is used as a nanoreactor 
for the synthesis o f  inorganic nanoparticles.13 Also viral cages and even bacterial 
multi-enzyme complexes have been used for this purpose.12 These systems have a 
high charge density at certain regions in their inner cavity, which can act as 
nucleation sites for the mineralization. Using these strategies, monodisperse single 
crystal nanoparticles can be grown inside capsids and cages. In addition the protein 
shell itself can be modified to add extra functionality to the nanoparticles.
Protein Cages
In nature, several proteins exist that carry or store metal ions and minerals. These 
proteins can often be used as hosts for biomineralization reactions. A  well known 
and intensively studied example is the iron-storage protein ferritin, which is 
discussed below. Other proteins that are also being used for these purposes are 
Bacterial D N A  binding proteins from starved cells (Dps) ferritin and the small heat 
shock protein (sHsp).
Ferritin
Ferritins are a class o f  non-haem iron storage proteins that are produced by animals, 
plants, fungi, and bacteria.14 In nature, iron is stored within the multi-subunit 
protein shell as a hydrous ferric oxide nanoparticle.15 Ferritins can withstand high 
temperatures (85 °C) and high pH values (8.5-9.0) which makes them attractive for 
use in supramolecular and organic synthesis.16
Iron-free ferritin (apoferritin or holo-ferritin) is a protein complex o f  
approximately 450 kDa,17 It consists o f  24 polypeptide subunits which assemble 
into a hollow sphere with an outer and inner diameter o f  12 nm and 8 nm, 
respectively (figure 1) .18 Small channels located at the subunit junctions are 
required for the release o f  iron and transport o f  other metal ions and small organic 
m olecules.19 The protein shell o f  ferritin has several functions: it acquires Fen,
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catalyses its oxidation and induces mineralization within the cavity, which can store 
up to 4500 iron atoms. This high storage capacity is achieved by sequestering the 
iron as a compact mineral, which resembles the structure o f  the mineral ferrihydrite 
FeO(OH). To perform these functions, the protein shell contains two structurally 
similar, but mechanistically different protein subunits, the heavy (H) and light (L) 
chains. The H-type subunit catalyses the oxidation o f  Fen to Fem, while the L-type 
subunit promotes mineralization inside the protein cage.
*-------------- 12 n m ----------------►
Figure 1 Schematic representation o f horse spleen ferritin a) Complete structure o f the 24­
meric protein assembly b) Outer and inner diameter o f the protein cage 20
In 1991, Mann and co-workers pioneered the use o f  ferritin as a nanosized 
bioreactor. Their main goal was to produce monodisperse metal particles from other 
metals than iron inside the ferritin cavity.21 They applied horse spleen apoferritin 
(HSFn) to produce iron sulfide particles, as w ell as manganese oxide and uranyl 
oxohydroxide crystals. 21-23 The iron sulfide particles were formed by an in situ 
reaction o f  the native iron oxide cores. By reacting the ferritins with H2S or Na2S in 
an aqueous buffer, the ferrihydrite cores were transformed into iron sulfide 
nanoparticles. Soon thereafter, they also showed that manganese oxide could be 
formed by redox-driven reactions in the apoferritin cavity.22
Using similar biomineralization strategies, many different inorganic 
nanoparticles have since then been synthesized inside the core o f  apoferritin. These 
include cobalt oxide, cobalt oxohydroxide, chromium hydroxide, nickel hydroxide, 
indium oxide, cadmium sulfide, cadmium selenide, zinc selenice, magnetite, 
cobalt/platinum alloys, platinum and other particles.20,24-29 Some o f  the recent 
publications on inorganic nanomaterial synthesis inside the apoferritin cavity are 
describing in more detail below.
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Douglas and co-workers studied the use o f  the protein constrained iron oxide 
core o f  ferritin as a photoreduction catalyst.30 In this work, the authors showed that 
the native ferric oxyhydroxide ferrihydrite Fe(O)OH encapsulated within the 
protein cage o f  ferritin could act as a semiconductor photocatalyst for the reduction 
o f the highly toxic CrVI to the more benign Crm. With this strategy at hand, the 
same group used the ferritin system to catalyze the photoreduction o f  Cu11 to a 
colloidal dispersion o f  Cu0 with a narrow size distribution.31 It was also observed 
that a higher CuII/ferritin ratio led to larger Cu0 particle sizes.
A  few years later, the group o f  Watanabe used a similar approach for the 
development o f  a size-selective hydrogenation biocatalyst.20 They encapsulated a 
Pd nanocluster inside the apoferritin cavity by in situ  chemical reduction o f  encased 
Pdn ions using NaBH4 (figure 2). This hybrid metal catalyst was subsequently used 
for the hydrogenation o f  a series o f  olefins. Ferritin contains eight negatively 
charged pores which are located at the junctions o f  three subunits. Substrate charge 
might therefore influence the diffusion o f  substrate into the cavity. The effect o f  
substrate charge on catalytic hydrogenation efficiency o f  the Pd-apoferritin hybrid 
was therefore evaluated. When anionic or bulky substrates were used, only low  
turnover frequencies were obtained, but when small, cationic substrates were 
utilized, high turnover frequencies were observed. These results suggest that the 
system discriminates based on the size and charge o f  the substrates.
Q * 0
C<Y5 U  [pdclJ . NaBH,.
Pd - apo-ferriiln
Figure 2 Schematic representation o f the preparation o f Pd-apoferritin.20
After having successfully incorporated Pd-complexes in the apoferritin cavity, 
Watanabe and co-workers proceeded with the encapsulation o f  RhII-complexes for 
the polymerization o f  phenylacetylene inside the cavity (figure 3).32 Because o f  the 
constrained environment o f  the ferritin cage, polymers with a narrower weight 
distribution were obtained than when phenylacetylene was polymerized by the same
14
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Rh-catalyst in bulk. The resulting polymers also have a restricted molecular weight 
(~13 kg m ol-1), and just a few polymer chains can be prepared within one 
apoferritin cage. This suggests that the polymerization is limited by the available 
space in the ferritin cavity.
0 a
Monomer
Apo-Fr Rh(nbd)*apo-Fr
Figure 3 Schematic representation o f a o f Rh-catalyzed polymerization inside apoferritin. 32
Kramer et al., synthesized silver nanoparticles within the cavity o f  ferritin by 
using a similar encapsulation approach combined with genetical modification o f  the 
ferritin interior.33 The authors modified the C-terminus o f  the L-chain o f  ferritin 
with a dodecapeptide, AG4, which was previously identified from a phage display 
library to be able to reduce silver ions to metallic silver. This method yielded 
spherical particles with an average diameter o f  7 ± 1 nm.
Recently, Kasyutich et al., developed another strategy to synthesize 
homogeneous silver nanoparticles using ferritin protein cages.34 It was already 
suggested in the literature that two parameters are important for obtaining an 
efficient metal-ion incorporation and a narrow size distribution o f  the formed 
nanoparticles inside the protein cage. These are the ratio o f  external/internal charge 
distribution35,36 and the number o f  available metal binding/nucleation sites.37 On 
basis o f  the literature data the authors utilized ferritin from the hyperthermophilic 
archaeon Pyrococcus furiosus (PfFt), a protein with a distinctive charge distribution 
and fewer iron nucleation sites compared to other ferritins. By using the PfFt-cage, 
silver nanoparticles o f  2.1 ± 0.4 nm were obtained (figure 4), with a high stability in 
water solution and a high thermal stability (up to ~90°C). Other ferritins did not 
give the same results.
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Figure 4 Silver ions (spheres) access the cavity o f Purococcus furiosus and bind to the 
binding/nucleation centers at the internal surface.34
Aime et al. entrapped up to 10 GdIII-chelates in the cavity o f  apoferritin, 
which resulted in a complex that exhibited high relaxivity o f  water protons with 
potential applications in magnetic resonance imaging (MRI).38 Though this work is 
very promising, it does not describe chemical reactions within the cavity o f  protein 
cages and is therefore not further discussed here.
The group o f  Mann also created magnetic nanoparticles by synthesizing 
ferromagnetic nanocrystals o f  magnetite (Fe3O4) 39,40 and magnetite/maghemite 
(Fe3O4/y-Fe2O3)41 within the ferritin cavity to yield a magnetic protein, called 
‘magnetoferritin’. Apoferritin, loaded with various amounts o f  ironn ions, was 
oxidized by trimetylamino-N-oxide (figure 5). In this method, the authors used the 
unusual stability o f  the apoferritin cage at high temperature (60°C) and pH (8.5). 
This approach resulted in the formation o f  crystalline inorganic particles with 
diameters o f  approximately 6-7 nm. A  few years later, Klem et al., reported the 
preparation o f  metal oxide nanoparticles containing both Fe and Co oxides.42 By 
controlling the addition o f  Co to the reaction mixture, a two- to fourfold increase in 
the ferromagnetic blocking temperature (with respect to ‘Fe-pure’ magnetoferritin), 
was observed.
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Figure 5 Schematic representation o f the formation o f magnetoferritin from native ferritin. 
First, the native ferrihydrite cores from horse spleen ferritin are removed by dialysis at pH  
4.5. Then, apoferritin is reconstituted with a FeII-solution under slow oxidative conditions at 
60°C and pH  8.5.40
Dps ferritin
Dps are a member o f  the ferritin superfamily. They prevent DNA damage by 
condensing DNA, and by accumulating iron atoms within their central cavity that 
might otherwise have produced free hydroxyl radicals by reaction with hydrogen 
peroxide.43,44 Dps uses the hydrogen peroxide to oxidize iron, resulting in an iron 
oxide core similar to that o f  ferritins.45 Dps is structurally similar to ferritin. Its 12 
Dps subunits have a similar structure as the ferritin subunits and the overall 
architecture resembles that o f  the ferritin cage .46,47 As ferritin contains twice as 
many subunits than Dps, the Dps cage is smaller, i.e. it has an outer diameter o f  8.5 
nm and an inner diameter o f  5 nm. Structural analysis indicates that the 0.8 nm 
pores at the subunit interfaces should allow molecular access to the interior cavity 
o f  the protein cage .48 Dps can accumulate 500 iron atoms within its small cavity. It 
is suggested from X-ray crystal structural data that six clusters o f  on the interior 
surface could act as analogues o f  the mineral nucleation sites in ferritin.48
The Dps protein cage was also utilized as a size and shape constrained 
nanoreactor, as previously described for ferritin. Ferrimagnetic iron oxide,13 cobalt 
oxide,49 cadmium sulfide50 and platinum nanoparticles51 were synthesized within 
this cage. It is worth mentioning that for the first time, the formation o f  these 
particles was monitored by Kang et al. 51,52 using mass spectrometry
To enhance the formation o f  nanoparticles, Swift et al. replaced the 120 
surface accessible hydrophilic residues o f  Dps with hydrophobic amino acids.53 
Despite these mutations, the Dps proteins were still able to self-assemble and 
mineralize iron.
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Heat shock proteins
Heat shock proteins are produced in high levels in response to cellular stress, and 
assist in the correct folding o f  proteins. The sHsp cage from the hyperthermophilic 
archaeon M ethanococcus jannaschii consists o f  24 subunits o f  16.5 kDa which self- 
assemble into a cage with octahedral symmetry.54 The major difference between  
this cage structure and that o f  the ferritins are the large pores (3 nm in diameter) in 
the sHsp cage .55 The cage is stable in the pH range 5-11 and can withstand 
temperatures up to 70°C. It has en exterior diameter o f  12 nm.
Douglas and co-workers functionalized both the interior and exterior surfaces 
o f sHsp with organic and inorganic groups.56 By genetic manipulation o f  the protein, 
thiol groups and endogenous amine groups on both the exterior and interior surfaces 
were used to attach different molecules for the templating size-constrained 
synthesis o f  inorganic materials. Because o f  the large pores present in the sHsp cage, 
the functional groups on the interior can easily react with guest molecules. This 
property has also been used to achieve the chemical attachment o f  doxorubicin, a 
chemotherapeutic agent, in the cavity o f  sHsp.57
Like ferritin, sHsp was also used as a reaction vessel for biomimetic 
mineralization reactions.56,58 Transition metals, iron oxide and alloy nanoparticles 
were entrapped and synthesized within the sHsp protein cage.
Recently, the group o f  Douglas reported the synthesis o f  a cross-linked, 
branched polymer network inside the protein cage o f  sHsp .59 A  genetic sHsp 
construct with cysteine residues located on its interior surface was used to initiate 
polymer growth by reaction o f  the cysteines with a bromo alkyne. Click-chemistry 
was then applied to synthesize polymers within this cage, by the sequential 
coupling o f  multifunctional monomers. It was observed that the stability o f  cages 
increased dramatically upon encapsulation o f  the branched polymer. The cages 
were able to withstand heat treatment that would otherwise completely disrupt the 
native protein cage.
Another heat shock protein, Hsp60, which has a cage o f  17 nm in diameter, 
self-assembles into an octadecameric double ring cage structure, which stacks into 
patterned arrays. The subunits were genetically modified to display a histidine 
sequence on the interior o f  the cage, creating a region with high affinity for metal 
ions. The modified cage was used to template the synthesis o f  Ni-Pd alloy 
nanoparticles.60
18
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Barrel-shaped protein assem blies
Barrel-shaped protein assemblies, such as molecular chaperonins, have also been 
used to accommodate inorganic nanoparticles. For example, GroEL is a protein 
assembly o f  14 identical subunits, which stack into rings, yielding a barrel-shape 
structure o f  800 KDa with a diameter o f  4.5 nm .61 Its function is to bind denaturated 
proteins and assist in their folding which takes place in its cavity. Aida and co­
workers used GroEL for the encapsulation and triggered release o f  nanoparticles.62 
However, as far as we know, no examples o f  synthesis inside the cavity o f  
chaperonins has been reported.
Viruses
In nature, viruses infect host cells in which they replicate and then exit the cell. 
During these processes, viruses encounter a broad range o f chemical environments. 
To be able to survive the harsh conditions outside cells but release their cargo when 
inside, viruses have balanced assembly and disassembly characteristics. All viruses 
package viral nucleic acid, but many can assemble (naturally or manipulated) into 
viral capsids, devoid o f  genetic material, allowing scientists to replace the virus’ 
natural cargo with a non-viral cargo compound. This can be accomplished in two 
different ways: the cargo can be synthesized in a preassembled capsid, or the 
protein cage can assemble around an existing cargo. The first method, in which the 
capsid itself acts as a nanoreactor, is used for the biomineralization o f  inorganic 
materials inside the capsid. The latter process is being referred to as 
encapsidation.63
In contrast to protein cages, viruses exhibit a much larger variety in sizes and 
shapes (figure 6 ). When we look at their morphology, a distinction can be made 
between icosahedral capsids (quasi-spherical structures) and helical capsids (rod­
shaped structures). Icosahedral capsids range in size from 18 to 500 nm in diameter, 
but filamentous or rod shaped viruses like TMV can form rods up to 2 ^m in
length .63
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30 nm
Figure 6 Cryo-electron micrograph and image reconstructions o f a variety o f viral capsids. 
64 A) Paramecium bursaria Chlorella virus type I  (PCB-1), 170 nm diameter B) Murine 
polyoma virus (MPV), 51 nm diameter C) Cowpea mosaic virus (CMV), 31 nm diameter. D) 
CCMV 28 nm diameter. E) Satellite Tabacco Mosaic Virus (STMV), 18 nm diameter. F) 
Small section o f rod-shaped TMV, 18 by 300 nm. G) Sulfolobus turreted icosahedral virus 
(STIV) isolated from Yellowstone National Park.
Virus particles generally consist o f  several hundred protein molecules which 
can self assemble to form highly symmetrical structures that contain the viral 
nucleic acid. The subunits from which the viral capsid is built up can be 
manipulated both genetically and chemically, often without changing the overall 
architecture o f  the virus particles that they form. Like protein cages, the interior o f  
viruses can often be modified via the pores in the capsid. Some viruses can self- 
assemble in the absence o f  the endogenous nucleic acids.12
The variety in shape and size, and the self-assembly characteristics make viruses 
very suitable for the controlled synthesis o f  inorganic materials or the encapsulation 
o f other materials.
When w e regard viral capsids as molecular containers, three surfaces can be 
exploited: the interior, the exterior, and the interface between the protein subunits 
(Figure 7).65 In this chapter and in the rest o f  this thesis, we w ill focus on the 
modification o f  the inside o f  viral capsids.
20
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Figure 7 Schematic representation o f the three important interfaces available for chemical 
and genetic manipulation in a virus particle.64 Herein, we will focus on manipulations o f the 
interior cavity o f viral capsids.
CCM V properties
In this section CCMV and its properties w ill be briefly discussed. CCMV is the 
virus used for the studies presented in this thesis. A  more detailed description can 
be found in the thesis o f  Marta Comellas-Aragones.66
CCMV belongs to the Bromoviridae family o f  plant viruses. It consists o f  
exactly 180 identical capsid proteins, which self-assemble around a central RNA  
yielding highly defined icosahedral virus particles o f  28 nm in size. The virus can 
be dissociated into protein and RNA, the latter can be removed by precipitation, 
yielding capsid dimers. A ll research described in this thesis is conducted with the 
capsid proteins devoid o f  viral RNA. The capsid proteins can reassemble into 
various different structures depending on pH, ionic strength, and the presence o f  
divalent cations in the buffer solution .67 At pH 5.0 and appropriate ionic strength, 
the capsid proteins w ill reassemble into the native 28 nm icosahedral structure, 
which can be disassembled again into 90 dimers by increasing the pH to 7.5. This 
process is reversible and can be repeated many times.
21
Literature overview: reactions inside protein cages
T=1 1=2 T=3
Figure 8 Structures o f T=1, T=2 and T=3 CCMV capsids.
The 180 identical capsid proteins forming the native capsid are arranged in 12 
pentamers and 20 hexamers, forming an icosahedral shell with Caspar-Klug68 T=3 
quasi-symmetry (figure 8).69 When the N-terminus o f  the capsid proteins is 
truncated, the capsid proteins are also known to assemble into T=1 particles, which 
are 18 nm in size and consist o f  60 capsid proteins, or into pseudo T=2 particles o f  
~22 nm in size, and consisting o f  120 capsids.70 This structure is called pseudo T=2 
since geometrically, these particles are not icosahedrons, but dodecahedrons.
The N-termini o f  the capsid proteins are located at the centers o f  the hexamers 
and pentamers, and situated in the capsid interior. The N-termini are highly 
positively charged and involved in the binding o f  the negatively charged viral 
R N A .71 The C-terminus is highly involved in interdimeric and inter-protein contacts. 
Capsid proteins with truncated C-termini can not form dimers and fail to assemble 
into capsids.72 The C-terminus o f  one capsid protein o f  a dimer protrudes in the 
other capsid protein and is clamped by it.73 This results in a very stable 
conformation and therefore the capsid disassembles into dimers, and not into 
monomers.
Due to its special assembly properties, the CCMV capsid is an exceptionally 
versatile nano-building block, and its properties w ill be investigated and employed 
in the research described in this thesis.
Biom ineralization in viruses
Douglas and Young were the first to perform inorganic mineralization reactions 
inside the CCMV capsid. It was already known from literature73 that at a pH higher
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than 6.5 the capsid swells and 60 pores with a diameter o f  2 nm are formed. The 
swelling is reversed when the pH is lowered to 5.0. This property o f  CCMV was 
used for the oligomerization o f  tungstate (WO24-) and vanadate V i0O286" inside the 
capsid, which occurs when the pH is lowered. This approach yielded particles with 
an average diameter o f  15 nm .74
A  few years later, Douglas and Young showed that the charge on the protein 
cage interior o f  CCMV can be altered from cationic to anionic.12 This was carried 
out by replacing nine basic residues at the N-terminus o f  the CCMV coat protein by 
glutamic acid residues, but the assembly properties and stability o f  the formed 
particle remained similar to the wild-type capsids. The particles that are formed in 
this manner have a negatively charged interior, which favors interactions with 
positively charged ferrous and ferric ions. This makes the viral cage suitable for the 
hydrolysis o f  Fe11 to iron oxide, which leads to the size and shape constrained 
formation o f  nearly monodisperse iron oxide particles, with an average diameter o f  
24 nm .12
In a similar approach, the group o f  Douglas was able to use the CCMV capsid 
for the biomineralization o f  TiO2 nanoparticles.75 In this study, the authors made use 
o f  the wild-type capsid to attract negatively charged TiIV salts, which were 
subsequently converted to monodisperse TiO2 nanoparticles by changing the pH o f  
the solution.
De la Escosura et al., were able to synthesize Prussian Blue nanoparticles with 
an average diameter o f  18 ± 1.7 nm, within the cavity o f  CCMV .76 Prussian Blue 
nanoparticles were formed by a photo-initiated reaction. Negatively charged 
[Fe(C2O4)3]3- was accumulated in the capsid interior and produced Fe11 ions after 
photoreduction, which further reacted with encapsulated [FeCN6]3- to form the 
Prussian Blue clusters (figure 9). This is one o f  the first examples o f  the synthesis 
o f  magnetic nanoparticles inside viral capsids.
Figure 9 Schematic representation o f the synthesis o f Prussian Blue nanoparticles within the 
cavity o f CCMV.76
(NH4)3 [Fe(C20 4)3] 
(NH4)3 [Fe(CN)6] 
----------------------- ►
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Another viral capsid that is being used for the constrained synthesis o f  
magnetic nanoparticles is bacteriophage T7 .77 The interior o f  this virus can be very 
easily modified because the capsid is formed first, after which the nucleic acids are 
condensed within it. The empty capsid is therefore also stable without DNA. The 
T7 phage has an outer diameter o f  55  nm, and the interior diameter is around 40 nm. 
The growth o f  cobalt particles inside the T7 phage was achieved by incubating the 
empty capsids with a Co11 solution, after which the mixture was reduced by sodium  
borohydride to yield cobalt nanoparticles. By using this approach, uniform cobalt 
particles o f 42  ±  2  nm were obtained.
Bacteriophage MS2 is an icosahedral capsid consisting o f 180 identical 
subunits, which self-assemble to form particles with a diameter o f  27 nm. An 
important characteristic o f  this viral capsid is that it has 32 pores o f  about 1.8 nm, 
which enable the diffusion o f  small molecules into and out o f  the capsid interior. 
The group o f  Francis altered the interior o f  the MS2 capsid by functionalizing the 
tyrosine residues using diazo-transfer and hetero Diels-Alder reactions.78 This 
modification was used to confine Gd3+ binding ligands in the capsids, which could 
be used for MRI contrast imaging.79 Such chemical alterations o f  the interior o f the 
capsid may also facilitate chemical or enzymatic reactions in the confined space o f  
the nanoreactor, however, such reactions have not been carried out yet.
TM V is a helical, rod-shaped virus o f  which the interior has been used for the 
synthesis o f  nanowires, due to its anisotropic shape and stability. TMV is stable in a 
wide range o f  conditions; it can withstand pH ranges from 3.5 to 9.0, temperatures 
up to 900C and organic solvents.65 The TM V capsid is made up o f  2130 identical 
subunits, which are recruited by the RNA and assemble around it into a 300 x 18 
nm helical structure, with a core o f  4  nm in diameter (figure 10). The structure o f  
TMV can be seen as a series o f rings (comprising 14 subunits) stacked on top o f  
each other. This results in an overall chiral structure and inherent asymmetry which  
does not exist for icosahedral viruses. This property allows for chemical and 
physical differentiation on one end o f  the helical rod. TM V can easily be assembled 
in vitro and the TM V aspect ratio is determined by pH, ionic strength and protein 
concentration.16 TM V can also be produced in very high quantities (kilogram scale) 
from infected plant material and because o f  its high stability, it can serve as a 
template in a wide range o f  conditions.
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Side view T°P view
Figure 10 Cryo-electron imaging reconstructions o f tobacco mosaic virus (TMV). The virus 
is 300 nm in length, has a diameter o f 18 nm and a 4 nm channel.16
The channel o f  TMV was first used for the synthesis o f  N i and Co nanowires 
with lengths up to micrometer range,80,81 suggesting end-to-end assembly o f  
individual capsids. Later, the narrow channel was used to grow copper nanowires o f  
150 nm in length and 3 nm diameter82 and bimetallic alloys o f  CoPt, CoPt3 and 
FePt3 up to 100 nm length and 4 nm diameter.83
Furthermore, formation o f  small silver nanoparticles by photochemical 
reduction o f  A gI salts at pH 7 within the channel o f  TMV has also been reported.84 
In the same publication the authors describe the use o f  the exterior surface o f  TMV 
for the controlled formation o f  gold and platinum nanoparticles. The group o f  
Francis reported a method for site-selective modification o f  both the interior and 
exterior surfaces o f  TMV to expand the range o f  applications for which the capsid 
can be used .85
The exterior surface o f  TMV has been widely used as template for the 
synthesis o f  nanoparticles and nanotubes.81,84 These nanotubes are grown from 
deposited clusters o f  palladium, platinum, and gold on the exterior TMV surface.
The M13 bacteriophage is another helical virus, which has been extensively 
studied and has proven to be a valuable tool for the development o f  functional 
nano-materials. The M13 bacteriophage does not have an inner cavity in which 
reactions can be performed, but although this literature overview focuses on
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reactions on the interior o f  protein cages, the research in the group o f  Prof. Belcher 
is o f  such great interest that it is briefly discussed here.
The M13 bacteriophage consists o f  2700 copies o f  the p8 coat protein that 
assemble around circular single stranded DNA, and minor coat proteins which cap 
the ends o f  the structure. The coat proteins can be genetically modified to display 
peptides with metal-binding sequences. By modification o f  the minor coat proteins 
situated at the virus ends with ZnS binding sequences, and incubation with a ZnS 
liquid crystalline suspension, the viruses form highly ordered composite materials.86 
A  similar strategy was used to position the virus on single-walled carbon nanotubes 
(SWNT). Besides modification o f  the minor coat proteins with SWNT binding 
peptides, the major coat proteins o f  this virus were modified with peptides capable 
o f  nucleating amorphous iron phosphate (a-FePO4). A  crosslinked network o f  a- 
FePO4 coated viruses attached to SWNTs was thus created (figure 11). This 
network is highly conductive, and was used as the positive electrode o f  a lithium­
ion battery.87 This battery is very light-weight and can be produced and disposed o f  
in environmentally friendly manners, in contrast to conventional Li-ion batteries.
Figure 11 Schematic representation o f the formation o f a virus based battery. A) The minor 
coat proteins o f the M13 bacteriophage are modified with SWNT binding peptides, and the 
major coat proteins are modified with peptides capable o f nucleating a-FePO4. B) Addition 
o f the a-FePO4 templated virus nanowires to SWNTs results in a highly conductive network, 
which is used as the positive electrode o f a lithium ion battery. 87
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Enzym atic reactions inside viral capsids
In the past few years, there has been a growing interest in mimicking cellular 
compartments. As mentioned in the introduction, viruses could serve as useful 
model systems for the study o f  enzymatic reactions in confined spaces, due to their 
monodispersity and small internal volume. In addition many viruses contain pores 
through which substrates can enter the capsid. In order to construct a viral 
nanoreactor, their assembly and disassembly properties could be o f  use, as w ell as 
the accessibility o f  the capsid to genetic and chemical modification. Despite these 
promising applications, however, only very few o f  these viral nanoreactors have 
been produced.8,88,89 One o f  the main goals o f  the research presented in this thesis is 
therefore to construct a viral nanoreactor and measure the effect o f  confinement on 
enzymatic activity.
The CCMV capsid is very suitable for the encapsulation o f  enzymes, 
because under influence o f  the pH it can disassemble into its dimers, and 
reassemble again. When enzymes are added to the protein dimers and the pH is 
lowered to 5.0, enzymes are entrapped inside the capsid (figure 12).
Figure 12 Schematic representation o f enzyme encapsulation in the CCMV capsid. After 
disassembling into dimers at pH  7.5, the guest enzyme is added and upon decreasing the pH  
to 5.0 the capsid assembles with the enzyme entrapped in its cavity.8
Comellas-Aragones et. a l used this approach to incorporate horseradish 
peroxidase (HRP) enzymes in the inner cavity o f  CCMV .8 The goal o f  this project 
was to study the activity o f  one single-enzyme present in the capsid. Therefore, the 
concentration o f  the enzyme in buffer was lowered to make sure that only one 
enzyme or no enzyme was encapsulated in the capsid. The enzymatic activity o f  the 
encapsulated HRP was examined by confocal fluorescence microscopy. The non- 
fluorescent dihydrorhodamine 6G was used as a substrate. Under influence o f  HRP 
this substrate is oxidized to rhodamine 6G which is highly fluorescent and thus can 
easily be monitored. The experiment showed that the capsid acts as a nanoreactor 
and is permeable for both substrate and product (figure 13).
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Figure 13 Single enzyme study on HRP (E) encapsulated within CCMV. The substrate (S) 
diffuses into the capsid and is converted into a fluorescent product (P) which accumulates 
before it diffuses out o f the capsid.
Not only plantviruses, but also animal viruses, like the polyomavirus family 
have been engineered in order to obtain nanocapsules. Simian virus 40 (SV40) and 
murine polyomavirus (MPV) have been studied extensively for their potential use 
in delivering biologically active materials.90 These are icosahedral, non-envelopped 
DN A  viruses, with an outer diameter o f  about 45 nm. Their capsid consists o f  72 
pentamers o f  the major coat protein VP1 (figure 14).91,92 The minor coat proteins 
VP2 and VP3 are associated with the VP1 proteins and are located on the capsid 
interior. Recombinant VP1 pentamers can self-assemble into genome-free 
icosahedral virus-like particles (VLPs) both in vitro  and in vivo. 93-95
Figure 14 Architecture o f the SV40 capsid. Arrangement o f the pentamers on the T=7 
icosahedral lattice.92
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Recently, many VLPs have been exploited as delivery vehicles .90 For 
polyomaviruses this has been achieved by genetically fusing heterologous proteins 
to VP1 proteins.96,97 However, the particles formed in these studies were irregular 
and had showed poor solubility when expressed in E. Coli.
Inoue et a l . reported a novel strategy for the encapsulation o f  proteins and 
enzymes into SV40 VLPs.88 In this work, EGFP was fused to the C-terminus o f  the 
VP2 and VP3 minor coat proteins, using a flexible linker. When these constructs 
were co-expressed with VP1, VLPs with EGFP inside were obtained. The resulting 
capsids retained their ability to bind to, and enter cells, after which the EGFP was 
delivered. Next, yeast cytosine deaminase (yCD) was encapsulated via the same 
method. This enzyme converts cytosine to uracil and is used as a prodrug- 
converting enzyme in gene therapy. It was demonstrated that upon encapsulation 
the yCD enzymes retained most o f  their activity.
To the best o f  our knowledge, no enzymatic reactions inside other capsids 
have been described so far.
Helical viruses have not been used for the encapsulation o f  enzymes 
because their internal channel is too narrow for these purposes.1 However, Candida 
Antarctica Lipase B (CalB), more recently renamed Pseudozyma antarctica lipase B 
(PalB), has been linked to the surface o f  Potato Virus X  (PVX ).98 This virus particle 
has a flexible rod-shaped structure, which is 500 nm in length and has a diameter o f  
13 nm. It is build up from 1270 identical coat proteins. The authors linked the lipase 
to the N-terminus o f  the coat protein by constructing a PalB-coat protein fusion 
protein. In this way the PalB was positioned at the exterior o f  the virus particle 
(figure 15). The lipase remained catalytically active, and this work suggests that in 
the future multiple types o f  enzymes can be linked to the exterior o f  a viral capsid, 
in order to catalyze multi-step enzymatic synthesis. These types o f  reactions are not 
constrained by the dimensions o f  the virus, and w ill therefore not be discussed 
further in this thesis.
Figure 15 Schematic representation o f the PVX virus particle (grey) with the PalB enzyme 
molecules (darkgrey) on its surface.98
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Molecular microcompartments and bacterial enzymes
A family o f bacterial proteins that resemble virus capsids are the encapsulins (in 
literature also referred to as linocin-like proteins), which form assemblies with a 
diameter o f  20 nm and have icosahedral symmetry. Although the sequence 
similarity between encapsulins and viral proteins is weak, the proteins show great 
structural similarity to virus capsid proteins. These nanocompartments package 
enzymes, and are thus excellent examples o f  nanoreactors. The group o f  Ban 
studied this protein family99 and found two different proteins that can be packaged 
within the encapsulins; i.e. a peroxidase or a protein that has the same fold as 
ferritin monomers and contains the ferroxidase active site. Interestingly, the pores 
o f encapsulin resemble those o f  ferritin. The proteins are attached to the encapsulin 
shell using a C-terminal extension that interacts with a binding site o f  the 
encapsulin proteins.
Besides nanocompartments, many bacterial species produce 
microcompartments to confine enzymes that have toxic or volatile intermediates, or 
to increase the local enzyme concentration. These microcompartments are solely  
composed o f  proteins. The carboxysome for example is a bacterial 
microcompartment that packages the enzyme ribulose bis-phosphate carboxylase 
oxygenase (RuBisCO) by forming polyhedral bodies with a diameter o f  80-140  
nm .100-102 Other examples are the Eut and Pdu organelles, which also are likely to 
package enzymes from metabolic pathways.103,104 An eukaryotic microcompartment 
built o f  protein subunits is the vault particle.105
In contrast to protein microcompartments, where structural proteins form the 
walls o f  the compartment, multi-enzyme complexes exist, in  which the enzymes 
themselves form the walls o f  the complex. Substrates can enter these complexes but 
they are not permeable to other macromolecules. Examples are lumazine 
synthase,106 fungal fatty acid synthase107 and the pyruvate dehydrogenase 
com plex.108
Bacterial m icrocom partm ents
From diverse bacteria it is known that they produce proteinaceous intracellular 
compartments, to entrap enzymes to confine them and increase their local 
concentration.99 However, the mechanisms by which bacterial microcompartments 
like Ethanolamine utilization (Eut) and Propanediol utilization (Pdu) encapsulate 
their enzymes is not very w ell understood.
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The best studied bacterial microcompartment is the carboxysome, which  
confines CO2 in the vicinity o f  RuBisCO to enhance autotrophic CO2 fixation .11 
Although this microcompartment can be viewed as a potential nanoreactor for 
enzymatic reactions, since in nature its function is already to encapsulate enzymes, 
no such applications o f  the carboxysome have been published yet.
Another bacterial microcompartment that gains interest is the Pdu which is 
used for the B 12-dependent degradation o f  1,2-propanediol (1,2-PD). The first two 
steps o f  1,2-PD degradation occur in the lumen o f Pdu, the last two in the 
cytoplasm o f the cell.11 Pdu consists o f  14 different polypeptides, including seven  
different shell proteins and four enzymes.109 The encapsulated enzymes include 
CoA-dependent propionaldehyde dehydrogenase (PduP), which convert 1,2-PD to 
propionyl-CoA via a propionaldehyde intermediate. The function o f  Pdu is to 
sequester propionaldehyde to protect cells from D N A  damage and cytotoxicity.
Fan et al. showed that short N-terminal peptides o f  Pdu and other 
proteinaceous microcompartments (MCPs) play a major role in the encapsulation o f  
enzym es.11 In the same publication, the authors show that fusion o f  the 18-amino 
acid N-terminal sequence o f  PduP to green fluorescent protein (GFP), Glutathione 
S-transferase (GST) or a maltose-binding protein (MBP) resulted in their 
encapsulation in Pdu. Though the exact binding mechanism o f the N-terminal 
sequences to the microcompartments is not known, from these experiments it is 
clear that they are essential for the binding o f  certain enzymes to the interior o f  the 
microcompartments.
Since recombinant enzymes containing these N-terminal extensions are 
readily made, this discovery offers great potential for the utilization o f  
microcompartments as nanoreactors. As these compartmental structures have only 
recently been discovered and studied, this has not been accomplished yet, at least to 
the best o f our knowledge. It can be expected that these microcompartments w ill be 
used in the future as nanoreactors.
V ault nanoparticle
Vaults are large ribonucleoprotein capsules with dimensions o f 42x42x75 nm ,110 
with a thin protein shell o f  2 nm thick, surrounding an inner cavity large enough to 
encapsulate hundreds o f proteins (figure 16).9 Vaults consist o f  four components: 
96 copies o f  the major vault protein (MVP), vault poly(ADP ribose) polymerase 
(VPARP), telomerase-associated protein 1 (TEP1), and untranslated vault RNA.
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Recombinant MVPs expressed in insect cells can self-assemble into a vault-like 
particle, without the remaining components.
Figure 16 Vault reconstruction with imposed eight-fold symmetry9
The group o f  Rome has studied the properties o f  the vault capsules, mainly for 
their potential as a drug vehicle .111,112 Because vaults are abundant in most 
eukaryotes, including humans, they are less to elicit an immunogenic response than 
virus capsids or bacterial microcompartments.
First, the authors demonstrated that luciferase could be encapsulated in the 
cavity o f  vault, by fusing the luciferase encoding DN A  to the vault interaction 
domain and inserting it into the baculovirus expression vector.113 In a similar way, a 
variant o f  GFP (green lantern) was also sequestered within the vault cavity. 
Luciferase was still active after encapsulation but its activity seemed to be affected 
by a diffusion barrier for charged molecules.
A  few years later the same group showed that a semiconductor polymer could 
be encapsulated in recombinant vaults.114 This study provided important insight in 
the encapsulation process o f  nonbiological cargos which could be applied in the 
sequestration o f  drug molecules. Recently, gold nanoclusters and histidine-tagged 
proteins have been targeted to the inner wall o f  vault particles by using a carrier 
derived from a vault lumen-associated protein.111
Lum azine synthase
Lumazine synthase is a hollow 1MDa bacterial enzyme complex, consisting o f  60 
subunits. It is involved in the synthesis o f  lumazine, which is a precursor to 
riboflavin. X-ray structure analysis showed that lumazine synthase is a hollow
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sphere with T=1 icosahedral symmetry, with an outer and inner diameter o f  14.7 
nm and 7.8 nm respectively.115 The inner wall o f  the capsid is negatively charged, 
due to the presence o f  glutamic acid residues. The interior o f  the lumazine synthase 
capsid can be accessed via hydrophilic channels, which are lined with the glutamic 
acid residues and located at the ten threefold axes.106 Channels consisting o f  
symmetrically arranged a-helices are present along the six five-fold pentamer 
axes115 (figure 17). The pores formed by these channels at the interior surfaces are 
surrounded by polar residues and probably play an important role in substrate 
import and product export from the enzyme catalytic sites located at the interior o f  
the com plex.116 The capsid is highly stable at pH 7 in presence o f  phosphate buffer 
or substrate analogues. In absence o f  ligands, the structure can dynamically be 
rearranged to form larger particles, with an external diameter o f  30 nm .117
Figure 17 models o f the 60-subunit lumazine synthase capsid. Left: view from the 5-fold 
icosahedral axis; one o f the 12 channels is clearly visible. Right: view from the 3-fold 
icosahedral axis.115
Shenton et al. investigated the potential o f  the lumazine synthase capsid as 
bio-nanoreactor for the mineralization o f  iron oxide.118 In the environment which 
the authors used for this reaction (pH 6.5 and absence o f  ligands) the capsids had an 
internal diameter o f  20 nm and an external diameter o f  30 nm, as confirmed by 
transmission electron microscopy (TEM). Mineralization o f  iron oxide was induced 
by adding aliquots o f  Fen to the buffer solution. The formation o f  electron dense 
iron-containing nanoparticles was confirmed by TEM images and corresponding
33
Literature overview: reactions inside protein cages
energy dispersive X-ray analysis (EDX). The ratio Fen ions/subunits lumazine 
synthase was varied in the experiments. More FeII ions per subunit resulted in more 
electron dense and more crystalline iron-containing nanoparticles. The diameter o f  
these particles varied between 10 and 15 nm. TEM measurements on the iron- 
containing capsids revealed that the formed capsids were mostly 30 nm in diameter, 
but that a small percentage was in the native form o f 15 nm in diameter. This 
suggests that the native form is destabilized by the presence o f  FeIII ions and 
transforms into a higher ordered structure. The authors thus showed that it is 
possible to use a hollow bacterial enzyme complex for the mineralization o f  
inorganic nanoparticles. They also suggested that due to the presence o f  both 
positively and negatively charged channels in  the capsid, it should be possible to 
sequester cationic and anionic reactions for the synthesis o f  other nanoparticles (as 
previously demonstrated for ferritin). This has not been reported yet.
A  few  years later, Seebeck e t a l. reported an encapsulation method for 
lumazine synthase which utilizes a tagging system based on charge 
complementarity.10 The authors used lumazine synthase from Aquifex aeolicus 
which they genetically engineered in such a way that four residues per monomer, 
which project into the lumen, were mutated to glutamic acid residues, to create an 
additional negative charge on the interior surface o f  the capsid (figure 18). As the 
capsids contain either 60 or 180 subunits, these mutations, therefore, could yield  
240 or 720 extra negative charges, respectively. Furthermore, a histidine-tag was 
incorporated at the C-terminus o f  the protein to facilitate purification. The 
negatively charged lumazine synthase was brought to expression in E.coli and this 
yielded capsids which can withstand temperatures up to 95°C. Next, the authors 
showed that a positively charged stretch o f  amino acids added to a cargo protein led 
to encapsulation o f  the cargo protein. This was carried out by fusing a deca-arginine 
(R10) tag to the C-terminus o f  GFP. When co-produced with the lumazine 
synthetase, GFP-R10 was encapsulated in the negatively charged lumazine synthase 
capsid. Sedimentation equibrilium data and scanning force microscopy (SFM) 
revealed that both T=1 capsids consisting o f  60 subunits and T=3 capsids, 
consisting o f  180 subunits were formed.
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Figure 18 Left: sequestration o f GFP in the lumazine synthase capsid, based on the crystal 
structure o f the T=1 capsid formed by A. aeolicus. Right: lumazine synthase pentamer. In 
black the four mutated glutamic acid residues.10
Pyruvate dehydrogenase com plex
Pyruvate dehydrogenase (PDH) multienzyme complexes o f  icosahedral symmetry 
are found in the mitochondria o f  eukaryotes and gram-positive bacteria.119 These 
PDH-complexes contain a dihydrolipoyl acetyltransferase (E2), a pyruvate 
decarboxylase (E1), a dihydrolipoyl dehydrogenase (E3), and, in the case o f  the 
mammalian enzymes, an E3-binding protein and regulatory kinases and 
phosphatases. The E2 component o f  this complex consists o f  a 28 KDa catalytic 
domain, a 4-kDa peripheral subunit-binding domain (PSBD) and a 9-kDa lipoyl 
domain, which are connected by long stretches o f  polypeptide chain thought be 
largely flexible in conformation.120 In a native PDH-complex, 60 copies o f  E2 self- 
assemble through interactions o f  their catalytic domains to form an icosahedral 
structure, to which 42-48  copies o f  an a2p2-E1 (153 KDa) and 6 -12  copies o f  a 
homodimeric E3 (100 KDa) bind tightly around the outside (figure 19).119
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Figure 19 Schematic representations o f the PDH-complex. A) Surface representation o f a 
three-dimensional model o f a E2E3 complex, viewed along the 3-fold axis o f symmetry. B) 
Same representation with a portion o f the outer protein shell removed to visualize the inner 
E2-core119
The inner icosahedral shell formed by the E2 subunits is approximately 24 nm 
in diameter and has 12 openings o f  5 nm each. Since this enzyme complex is 
derived from a thermophilic organism, the association o f  the subunits into the 
multi-enzyme complex has been shown to be stable at high temperatures.121
Domingo et al. showed that it is possible to display antibody epitopes and 
EGFP on the outer surface o f  E2 .122,123 This was achieved by replacing the PSDB  
and lipoyl domains linked to the E2 catalytic domain with either antibody epitopes 
or EGFP. The resulting fusion protein was able to assemble, thus displaying the 
epitopes and EGFP on the exterior o f  the complex. A  few years later, Dalmau et al. 
investigated the potential o f  the E2 scaffold as a potential molecular carrier.124 In 
this work, the authors first synthesized a truncated gene encoding for E2 which was 
optimized for expression in E.coli. By mutation o f  the E2 encoding gene, selected 
aminoacids were changed to aminoacids with different physicochemical properties. 
Even after 120 mutations, the E2 complex still assembled into a dodecahedral 
structure with high thermal stability. The cysteine mutants o f  the scaffold were used 
to couple two fluorescent dyes, leading to its sequestration into the inner cavity o f  
the E2-complex. TEM images showed that even after covalent encapsulation o f  the 
molecules in the inner cavity, the dodecahedral structure remained intact.
In this work, the authors describe a clear method to encapsulate foreign cargos 
in the cavity o f  the E2-complex. Their work can be regarded as a tool for the 
encapsulation o f  enzymes in the future. However, no enzymatic or chemical 
reactions have been reported yet in the constrained environment o f  the E2-cage.
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Concluding remarks
In this chapter many different examples o f  protein-based nanoreactors have been  
described. These self-assembled structures all exist in nature and can be chemically 
or genetically modified for the creation o f  nanoparticles, or nano catalysts
Protein cages from ferritin and ferritin-like proteins were the first bio­
nanoreactors used for biomineralization reactions in a constrained environment. A  
very wide range o f  inorganic materials has been successfully synthesized within 
these cage-structures. A  few  years later, the use o f  viral cages for the same purposes 
became o f  great interest. Viral cages offer a similar constrained reaction 
environment but exist in a wider range o f  shapes and structures, for example the 
rod-shaped TM V and the icosahedral CCMV, which enables the formation o f  
nanoparticles o f  more diverse sizes and shapes. Also, some o f  the viruses are 
known to be able to change their morphology upon exposure to a changing 
environment, which increases the possibilities even further. CCMV and TMV are 
now commonly used to nucleate minerals in their cavities, but this field is still 
young and it is very probable that in the future more applications for viral capsids 
will be developed, like MRI contrast imaging agents.
As mentioned before, one o f  the main advantages o f using protein cages for 
the synthesis o f  nanoparticles, is the monodispersity o f  the resulting particles. This 
is a direct result o f the monodispersity o f  the protein cages themselves, as the 
nanoparticles grow until they fill the interior o f  the capsid. It would be expected  
therefore, that all nanoparticles formed in one type o f  protein cage would be o f  the 
same size. This is however not always the case, as is shown by the different sizes o f  
the nanoparticles formed within the CCMV capsid. Although all nanoparticles o f  
the same type are very monodisperse, there is a considerable size difference 
between different types o f  nanoparticles formed within the CCMV capsid, ranging 
from vanadate particles o f  15 nm in diameter,74 to iron particles o f 24 nm in 
diameter.12 This can be due to the presence o f  a ‘void  space’ between the capsid 
shell and the nanoparticle. It is probable that the size o f  this space is influenced by 
the encapsulated material and possibly by the reaction conditions.
The confined space o f  protein cages has thus far mainly been used for 
biomineralization reactions. The metal nucleation sites have also been used to 
immobilize small inorganic catalysist on the interior, which resulted in a 
nanoreactor that could initiate polymerization o f  monomers inside the cage.32 The 
application o f  protein cages for the immobilization o f enzymes and the study o f
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enzymatic reactions has great potential, especially since the discovery o f  bacterial 
microcompartments show that nature also uses protein cages for the encapsulation 
o f enzymes to create mini-organelles. Thus far only a few  groups have published 
methods to encapsulate proteins in protein cages10,11,88,113 and even fewer have 
reported on enzymatic reactions inside the cages,8 but the future for this field is very 
promising. A  large part o f the research described in this thesis is therefore devoted 
to this subject.
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Chapter 3
CCMV capsid formation induced by a functional 
negatively charged polymer*
Introduction
Materials composed o f  nanometer-sized compounds have gained much interest over 
the past decades with a growing number o f  practical utilizations.1 These structures 
are more and more often constructed from biomolecules like proteins and D N A .2-9 
Their major advantage with respect to non-biological nano-sized compounds is their 
exceptional ability to self-assemble into precisely well-defined structures. CCMV is 
an example o f  such a defined biological system10 (see chapter 2).
Sikkema e t al. have shown that the negatively charged polymer polystyrene 
sulfonate (PSS) together with capsid dimers at pH 7.5 forms VLPs o f  19 nm .11 
These VLPs likely consist o f  60 protein subunits instead o f  180 and can be 
described as a T=1 particle. In order to investigate whether the same principle 
would apply to other negatively charged polymers, and to add functionality to the 
system, we describe in this chapter the encapsulation in CCMV o f a functional 
negatively charged polyelectrolyte, polyferrocenylsilane (PFS) polyanions (figure 
1).12
PFS contains redox active ferrocene units in the main chain and can therefore 
be oxidized and reduced reversibly,13,14 either by chemical or electrochemical 
means.15 In the reduced state, the polyions have a net negative charge due to the 
negatively charged sulfonate polymer side groups. 1
* This work was carried out in collaboration with Yujie Ma, Mark Hempenius and Julius 
Vancso from the Department of Materials Science and Technology of Polymers, University 
of Twente and has been published in Org. Biomol. Chem., 2009, 7, 4685
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.S03-Na+
Figure 1 Structure o f the anionic PFS polymer
Complete oxidation o f  the polymer w ill introduce additional positive charges 
on the ferrocene units in the polymer main chain, which results in a net neutral 
charge. The formation o f  the capsid at neutral pH likely depends on the interaction 
o f  the protein dimers with a negatively charged species, so switching the polymer 
towards its neutral state could have an effect on the stability o f  the capsid. 
Conversely, the capsid proteins might also have an effect on the redox chemistry o f  
the polymer, since it is known from e.g. the cytochrome family, that proteins can 
have a significant impact on the redox potential and behavior o f  a metal center.16 
Here, w e report on studies o f  the interaction o f  the PFS polyanions with the capsid 
proteins at neutral pH (figure 2), the redox chemistry o f  the PFS capsid complex, 
and the stability o f  the PFS capsid complex under these circumstances.
pH 5.0 pH 7.5 pH 7.5
<■
Polyferrocenylsilane
(PFS)
28 nm sized 
empty capsid
Protein Dimers 18 nm sized capsid 
filled with PFS
Figure 2 Schematic representation o f PFS encapsulation.
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Results and Discussion
CCMV capsid proteins and PFS polyanions were obtained according to a literature 
procedure.14,17,18 The PFS polyanions (figure 1) were dissolved in a small volume o f  
milli-Q (MQ) and added to the capsid protein at pH 7.5 in a ratio o f  40 polymer 
monomeric units per capsid protein, since previous experience with the 
encapsulation o f  PSS polymer had indicated that 40 negative charges per capsid 
monomer was the optimal ratio.11 The particles were allowed to form for at least 15 
minutes at 4°C and were subsequently analyzed by Fast Performance Liquid 
Chromatography (FPLC) and TEM. The formed particles eluted at V= 1.20 mL as 
detected at both ^=280 and ^=450 nm (figure 3). The PFS polyanions have a 
specific absorption at ^=450 nm 19 when it is in the reduced state, whereas proteins 
do not absorb in this region. This showed that the PFS polyanions co-elute with the 
protein (figure 3), indicating that it is indeed encapsulated. Non-encapsulated PFS 
polyanions did not seem to elute from the column, possibly because the PFS 
polyanions stick to the column.
70
0.0 0.5 1.0 1.5 2.0 2.5 
Elution volume/mL
Figure 3 FPLC trace o f capsid proteins mixed with PFS polyanions. The FPLC was 
equipped with a superose 6 size exclusion column. The bed volume o f this column was 2.4 
mL. The thick line represents the UV absorption at 280 nm, at which both the protein and the 
polymer absorb. The thin line represents the UV absorption at 450 nm, which is specific for  
the PFS polyanions. The elution volume o f the peak is 1.20 mL. CCMV capsids o f 28 nm in 
size usually elute at V=1.1 mL, and the capsid dimers usually elute at V=1.8 mL.
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In order to visualize the capsids with TEM, these particles were stained with 
uranyl acetate, a negative staining agent, revealing capsids with a diameter o f  d=18 
nm in size (figure 4a). This result was confirmed by Dynamic Light Scattering 
(DLS). This negative staining procedure visualizes the protein material, because the 
staining agent (uranyl acetate) does not adhere to proteins. In that way the particle is 
visible as a bright spot, often with a sharp rim, in a darker background. Since the 
PFS contains iron atoms in the main chain, the PFS-containing particles should also 
be visible without this staining technique. Indeed, particles o f  a slightly smaller size 
than the stained PFS containing capsids were visible without applying staining 
(figure 4b), exhibiting dark PFS loaded capsules. This is further support o f  the 
encapsulation o f  PFS.
Figure 4 Size o f the PFS-protein nanoparticles as obtained from TEM imaging. A) PFS 
loaded capsids stained with uranyl acetate. B) Non-stained PFS loaded capsids, (the iron 
atoms o f the PFS polyanions provide the contrast in this case) C) PFS loaded capsids stained 
with uranyl acetate after dialysis with MQ. D) Size distribution o f PFS loaded capsids.
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The percentage o f  PFS that was encapsulated in the T=1 particles purified by 
FPLC was determined using the U V  absorbance ratio at 1= 280 and 450 nm. The 
capsid protein absorbs at 1=280 nm, while the PFS absorbs at both these 
wavelengths and has a 280/450 nm absorbance ratio o f  11.67. Since the 280/450 nm 
ratio o f  the T=1 particles was consistently 20, the percentage o f  PFS loading can be 
calculated, indicating that about 12% o f the added PFS is encapsulated. From this 
data, the concentration o f  PFS inside the capsids can be determined, yielding a 
value o f  1.9*10"2 M  PFS, whereas the concentration o f the same amount o f  PFS 
free in solution would be 5.8* 10-5 M  (see experimental section for calculation 
details). This means that the concentration o f  PFS inside the capsids is about 330 
times higher than one would expect from statistical encapsulation. This strongly 
indicates that the encapsulation o f  PFS is favored, probably because it is needed to 
stabilize the capsid structure in the absence o f  the natural RNA.
The PFS containing particles appeared to be quite stable; they survive at least 
two months o f  storage at 4°C, and even dialysis in MQ (figure 4c). This is in 
contrast to the empty T=3 capsids resembling the natural virus particle, which need 
large amounts o f  salt to stabilize their structure. This is a strong additional indicator 
that the PFS polyanions stabilize the T=1 particle, presumably through ionic 
interactions o f the negatively charged PFS polyanions with the positively charged 
interior o f  the capsid proteins. Taking these properties into account, it is o f  interest 
to study whether the PFS containing particles are still stable when these ionic 
interactions are altered. Since the PFS polyanion is redox responsive,14 the polymer 
can be switched from a negative to a net neutral state, which can potentially disrupt 
the ionic interactions.
PFS can be oxidized chemically by FeCl3. Unfortunately, this oxidant 
appeared to harm the capsid proteins. That is, when FeCl3 was added to the capsid 
protein dimers, the dimer peak in the FPLC disappeared. A  new peak at V=2.06 mL 
appeared, but this is probably due to the oxidized polymer, since a Western blot o f  
the material eluting at this volume revealed that it did not contain any capsid protein. 
The addition o f  other oxidizing agents (KI, KMnO4, Cl2 (g)) gave the same result. 
(NH4)3 [Fe(CN)6] did not appear to have such a detrimental effect on the protein, 
since the capsid protein dimer was still clearly visible by FPLC. Unfortunately, 
however, this compound did not oxidize PFS completely, as was visible by the 
absence o f  a change in optical appearance. This in contrast to the oxidation with 
FeCl3, where the optical appearance changed immediately from yellow  to dark 
green/blue, after addition o f  FeCl3. This finding was confirmed by U V -V is analysis
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o f the samples (figure 5). Oxidized PFS has a small absorption band at X=640 nm. 
When the PFS loaded capsids were oxidized with FeCl3, the absorption at X=640 
nm was larger than when the PFS loaded capsids were oxidized with (NH4)3 
[Fe(CN)6]. This indicates that (NH4)3 [Fe(CN)6]  is not as effective in oxidizing the 
PFS, as FeCl3. Therefore, it seemed that the balance between an oxidizing agent that 
was sufficiently strong to oxidize the PFS, but not so strong as to oxidize the 
protein, would be very delicate or even non-existent.
/i/nm
Figure 5 UV-Vis absorbance spectra o f  PFS loaded capsids (black line), FeCl3 (purple line), 
PFS loaded capsids oxidized with FeCl3 (blue line), (NH4) 3 [Fe(CN)6]  (green line) and PFS 
loaded capsids oxidized with (NH4) 3 [Fe(CN)6]  (red line). Inset: fu ll UV-Vis absorbance 
spectra.
For that reason electrochemical oxidation was carried out to oxidize the PFS 
polyanions. Experimentally, 3 platinum wires acting as the working, reference and 
counter electrodes respectively were submerged into the T=1 particle containing 
solution and attached to a potentiostat with a cyclic voltametry (CV) setup. The 
recorded cyclic voltammograms showed that the electrochemical behavior o f  the 
PFS inside the capsid deviated significantly from the behavior o f  PFS polyanions 
that are free in solution (figure 6). Normally, PFS can be oxidized and reduced
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reversibly, but once encapsulated this did not seem  to be the case. In the first cycle, 
the oxidation peak was about as strong as the oxidation peak o f  the PFS free in 
solution, but the reduction peak was much weaker. In the subsequent cycle, the 
oxidation peak was also weaker, and the reduction peak decreased even further, 
until in the third cycle the peaks had disappeared completely. This could point to an 
incomplete reduction o f  the PFS polyanion. With each successive cycle more PFS 
polyanions remain oxidized, until after only three cycles, no electrochemical 
response can be detected anymore. Also the positions o f  the redox peaks in the 
voltammograms were shifted upon encapsulation with regard to normal PFS. This 
could be related to an effect o f  the protein environment, as proteins are also known 
to have a profound influence on the redox potentials o f  for example iron in the 
cytochrome protein fam ily.16
Ef J
Figure 6 CV diagrams o f  PFS loaded capsids. Blue line: buffer, black line: free PFS in 
solution, red line: the first oxidation cycle o f  the PFS loaded capsids, orange line: the second 
oxidation cycle o f  the PFS loaded capsids, green line: the third oxidation cycle o f  the PFS 
loaded capsids. Inset top left corner: enlargement o f  oxidation peaks in the CV diagram.
Inset bottom right corner: enlargement o f reduction peaks in the CV diagram.
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In order to check whether the redox response is really caused by the PFS 
polyanions and not by the protein shell surrounding it, a redox unresponsive 
polyanion, PSS, was encapsulated and CV was measured in the same way. Indeed, 
no redox response was observed (figure 7), confirming that the redox response o f  
the PFS loaded capsids was caused by the ferrocene units, and not by the protein.
Figure 7 CV diagrams. Thick black line: buffer, grey line: free PSS in solution, thin black 
line: PSS loaded capsids.
To investigate whether the capsid stability was affected by the oxidation and 
reduction o f  the polymer, the particles were studied by TEM at three different time 
points: before oxidation, immediately after oxidation, and following reduction 
(figure 8). In order to obtain a representative view  o f  the electrochemical process 
the TEM samples were prepared by dipping the specimen grids in the solution at 
designed time points. Since the concentration o f  particles is much higher in these 
experiments, as compared to the concentration normally used to prepare TEM grids, 
the images are somewhat blurred. At each time point capsids were still visible, 
although directly after oxidation the capsids seemed less well-defined. In this case, 
however, the contours o f  the PFS containing particles were still clearly visible; 
therefore it is unlikely that the capsids are completely disassembled.
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Figure 8 TEM micrographs o f the uranyl acetate stained PFS loaded capsids during the CV 
experiment. Grids were prepared by quickly dipping the grid into the solution containing the 
PFS polyanions A) PFS-loaded capsids before the oxidation and reduction cycle B) PFS- 
loaded capsids after the first oxidation step. C) PFS loaded capsids after the first oxidation 
and reduction steps.
Conclusions
The experiments described above have shown that negatively charged PFS is also 
able to assemble capsid proteins to form T=1 particles; similar to e.g. PSS .11 As 
mentioned, this is probably due to the interaction o f  the negatively charged polymer 
with the positively charged capsid interior. The redox properties o f  the encapsulated 
PFS were quite different from those o f  the ‘free’ PFS. The initial shift o f  the 
oxidation and reduction potentials might be explained by the interaction o f  the 
polymer with the protein shell. In subsequent electrochemical cycles the peaks were 
found to shift and their intensity was decreased. Apparently, the complex formed 
between PFS and the capsid protein can be oxidized but not be reversibly reduced. 
The reduction therefore proceeds incompletely, so that the polymer/protein complex 
is likely still largely hydrophobic in nature and inaccessible for the subsequent 
oxidation, also because a substantial part o f  the polymer is still oxidized. The 
oxidation peak is thus decreased in height and shifted to a higher voltage because 
compared to the blank specimen, i.e. ‘free’ PFS, it is getting more difficult to 
oxidize the polymer. This cycle repeats itself until all polymer is oxidized and 
becomes inaccessible for further oxidation. This might explain the CV results, but it 
still does not explain why the capsids appear to stay intact during this process. It 
might be that although the PFS is crucial for the initial formation o f  the T = 1
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particle, it is no longer needed when the capsid is formed. Possibly the interactions 
between the capsid proteins in the formed spherical structure are sufficiently strong 
to maintain the capsid structure.
Future prospects
Knowledge o f  the role o f  negatively charged polyelectrolytes in the stabilization o f  
the capsid after induction o f  capsid formation might provide novel insight into the 
interactions between capsid proteins, and thus contribute to the understanding o f  
their assembly mechanisms.
PFS does not seem to be a suitable polyelectrolyte to conduct such studies as 
the electrochemical oxidation needed to diminish the interactions between PFS and 
the capsid proteins is experimentally challenging. Therefore a different polymer 
might be a better candidate for such investigations.
Figure 9 Self-immolative polymer with photocleavable linker. After UV-irradiation, the 
photocleavable head-group is cleaved, resulting in a cascade reaction which disassembled 
the polymer in monomers.
Sagi et al. 20 developed a self-immolative polymer, which already possesses 
many o f  the properties such a polymer should have and which can be modified to fit 
our requirements. These self-immolative polymers have the same basic features as 
PFS and PSS; they contain negatively charged carboxylic acids as side chains, 
which make the polymer water soluble, they could potentially interact with the 
interior o f  the capsid, and the polymer can also be synthesized with sulphonated 
side groups. But more importantly, after removal o f  the polymer head group, a
o
/ = \  > :C  
o 2n - ^ J > - n h
HO
HO
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chain reaction is set in motion, resulting in the total disassembly o f  the polymer into 
its monomers. This would in principle eliminate the stabilizing interactions with the 
capsid proteins. To make matters even better, the disassembly o f  the polymer can 
easily be monitored, as the monomers have a very strong fluorescence emission, 
and the polymers have not. Sagi et al. have also shown that it is possible to add a 
tail reporter group to the polymer, so that it is possible to visualize the degree o f  
disassembly. The head group triggering the disassembly can easily be varied, and 
for our purposes a photocleavable head group would be very suitable, since UV- 
irradiation would probably not be harmful to the capsid proteins (figure 9).
After encapsulation o f  the immolative polymer, UV-irradiation could release 
the head group, initiating the disassembly o f  the polymer. This would then either 
result in disassembly o f  the capsid or in an intact, but empty T=1 particle (figure 
10).
pH 7.5
/
Figure 10 Schematic representation o f the UV-initiated disassembly o f the self-immolative 
polymer shown in figure 9.
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Experimental section 
Methods and materials
For all experiments a buffer solution containing 0.4 M NaCl, 0.05 M Tris-HCl, 0.01 M 
MgCl2, and 0.001 M EDTA of pH 7.5 was used.
Protein concentrations were determined using a Cary 50 Conc (Varian, Middelburg) UV-VIS 
spectrophotometer. FPLC measurements were performed using a superose 6 PC 3.2/30 
analytical column from GE lifesciences, on an Amersham Ettan LC system, fitted with a 
fractionating device. Buffers for FPLC were filtered with a Millipore 0.2 ^M filter before use. 
TEM grids (Formvar-Carbon) were exposed to an electron discharge treatment using a 
Cressington Carbon coater and power unit. Unless stated otherwise, the sample was applied 
to the grids by adding a drop of 5 ^L solution (~ 0.2 mg/mL) to the grid and carefully 
removing it following 1 minute immersion using a filter paper. The grid was allowed to dry 
for at least 15 minutes before applying 5 ^L of a 2% (w/v) uranyl acetate aqueous solution, 
which was removed after 15 seconds. The grid was again allowed to dry for at least 15 
minutes. Samples were studied on a JEOL JEM-1010 TEM (Jeol, Japan). CV measurements 
were performed on a Autolab PGSTAT10 potentiostat from Echochemie. PFS loaded capsids 
were purified on FPLC and concentrated to a concentration of ~  1mg/mL protein with 
Millipore centrifugal devices (MWCO 100 kDa).
Calculation o f PFS encapsulation
The extinction coefficient, e, of the PFS anions at X=280 nm was calculated by measuring the 
UV-Vis absorbance of several samples of PFS polyanions of known concentrations dissolved 
in MQ. Since the law of lambert-beer states: A=ecd, where A stands for absorption, c for 
concentration and d for the pathlenght of the cuvet. The extinction coeffient could thus be 
calculated.
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1 1 . 6 7
1 4  A =  A1 280(CP) 280( PFS)
1. 4 s  C P cC P d s  PFScPF Sd
1 5  4 c  =  cCP PFS
There are 15.4 monomeric PFS units per capsid protein and 924 per T=1 particle. 7200 
monomeric units were initially added, hence 12.8% of the added PFS is encapsulated.
The concentration of PFS inside the T=1 capsids is approximately 330 times higher than the 
expected concentration when the PFS polyanions would randomly be distributed over the 
entire solution (CPFS). The concentration of PFS inside the T=1 particles (CPFS T=1) is the 
number of moles of PFS inside the T=1 particles (nPFS T=1) divided by the total interior 
volume of all T=1 particles (VPFS T=1). Here nPFS T=1 is the number of moles of PFS added 
times the percentage that is encapsulated (12.8%). The total interior volume can be calculated 
by multiplying the number of T=1 particles in solution (#T=1), with the approximated interior 
volume of one T=1 particle (VT=1). The interior volume is approximated by regarding the 
interior as a perfect sphere and assuming that the capsid wall thickness is the same as it is for 
the T=3 particles i.e. 10 nm, which leads to a capsid interior radius of 4 nm.
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VT =  4 n r-  =  2 . 6 8 . 1 0 -22 L
T=  3
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Chapter 4
Virus-like particles templated by DNA micelles *
Introduction
In the previous chapter it was shown that different kinds o f  negatively charged 
polyelectrolytes, i.e. PSS and PFS, can be loaded into the CCMV capsid via a facile 
route. The negative charges presumably interact with the positively charged capsid 
interior, which prevents the polyelectrolyte from diffusing out o f  the capsid through 
the pores. They possibly also provide stabilizing interactions to keep the capsid 
intact. Not all compounds possess these properties, which makes their encapsulation 
more challenging. Drugs are typical examples o f  compounds that possess none o f  
the above mentioned properties. The development o f  a method to encapsulate these 
small compounds could, however, be o f  great importance for the development o f  a 
capsid-based drug delivery system. The use o f plant viruses as drug-delivery 
vehicles has several advantages. Plant viruses are in the nano-meter size range, 
which enhances their cell-permeability.1-3 Furthermore they are very monodisperse, 
biodegradable and biocompatible. Their exterior can be modified to contain for 
instance cell-targeting ligands, or polyethylene glycol (PEG) chains to suppress the 
immune response4 and to prolong blood circulation times. The porous nature o f  
CCMV however, makes it hard to retain small drug-like molecules inside the capsid 
without for instance covalently attaching them to the capsid proteins. This is 
difficult because, drug molecules are often hydrophobic and therefore solvent 
incompatibilities severely complicate covalent attachment to the capsid interior.
* This work was carried out in collaboration with Minseok Kwak and Andreas Hermann from 
the University of Groningen and Melanie Brasch from the University of Twente, and has 
been published: JACS, 2010, 132, 7834
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It is however possible to entrap hydrophobic molecules in m icelles consisting o f  
DN A  amphiphiles. These amphiphiles consist o f  single stranded DNA coupled to 
either fatty chains or hydrophobic organic polymers. They aggregate into micellar 
structures with a hydrophobic interior and an anionic corona. The m icelles are 
approximately 10 nm in diameter, which roughly corresponds to the internal 
diameter o f  a CCMV capsid. It is therefore conceivable that the anionic corona can 
interact with the capsid proteins and induce assembly. While hydrophobic 
m olecules can be entrapped in the hydrophobic interior o f  the m icelles, small 
hydrophilic molecules can be attached to the m icelles by linking them to a single 
stranded DNA chain, which is subsequently hybridized with the micellar DNA.
In this chapter a strategy along this line, i.e. the facile self-assembly and loading o f  
CCMV capsids with small molecules using D N A  amphiphiles is reported. (figure 1)
Figure 1 DNA micelle-templated capsid formation. (A) Loading o f hydrophobic molecules 
into the micellar core followed by encapsulation. (B) Equipping functional DNA attached 
moieties to the micelle via hybridization followed by encapsulation.
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Results and Discussion
Two different classes o f  DNA amphiphiles were used for this research. The first 
class consists o f  low molecular weight hydrophobic molecules that are attached to 
small oligonucleotides (ODNs).5 A  lipid-DNA 11-mer (UU11) containing two 5- 
dodec-1-ynyluracil nucleobases at the 5 ’- end followed by 9 naturally occuring 
nucleobases was synthesized and used for this purpose (figure 2 ).
Figure 2 DNA amphiphiles used for encapsulation and structure o f DiI dye.
The second class consists o f  DN A  block copolymers (DBCs), in which a nucleic 
acid sequence is covalently attached to a hydrophobic organic polymer via its end 
group.6 Here two different DBCs were used; both containing polypropylene oxide 
(PPO) blocks with a molecular weight o f  6800 g/mol, but attached to D N A  o f  
different length, i.e. 11 nucleotides (P11) and 22 nucleotides (P22) (figure 2). A ll 
three amphiphiles form m icelles with a diameter o f  7-11 nm at room temperature.
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Figure 3 TEM micrographs o f DNA-micelle-capsid assemblies. The scale bars are 40 nm. A) 
P11-capsid protein B) P22-capsid protein C) Wild type empty capsid assembled at pH  5.0. 
Staining is by uranyl acetate.
To test whether the m icelles could induce capsid formation, a similar 
procedure was followed as for capsid formation using PFS or PSS. The capsid 
proteins were mixed with the DNA amphiphiles at pH 7.5 in various ratios, and the 
results were analyzed by FPLC or TEM (figure 3). A  ratio o f  ~2.3 amphiphiles to 
one capsid protein monomer was found to be the optimal ratio for induction o f  
capsid formation.
To distinguish between capsid protein and micelles on FPLC and to 
demonstrate that it was possible to incorporate small hydrophobic molecules inside 
the capsid, the micelles were loaded with a test compound, i.e. a hydrophobic dye, 
1,1’-dioctadecyl-3,3,3’,3 ’-tetramethylindocarbocyanine perchlorate (Dil) (figure 2), 
before mixing with the capsid proteins and inducing capsid formation. Non­
encapsulated m icelles eluted at 1.6 mL (figure 4), while the sample containing both 
capsid protein and Dil-loaded UU11 m icelles showed a peak at V=1.8 mL, which is 
the unassembled capsid protein, and an extra peak at V=1.4 mL. The latter peak 
also showed Dil-specific absorption at ^=549 nm, and an increased absorption at 
^=280 nm with respect to the absorption at ^=549 nm, indicating the presence o f  
protein, which absorbs strongly at ^=280 nm. As the capsid protein is not able to 
assemble at pH 7.5, the m icelle must have induced the assembly o f  the capsid. 
Together with the observed co-elution o f  capsid protein and Dil-loaded micelle, this 
strongly suggests that the m icelle is encapsulated inside the capsid. As the formed 
particles elute at V=1.4 mL, they are probably smaller than the native virus, which 
elutes at V=1.1 mL.
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Figure 4 FPLC traces o f micelles and micelle-capsid assemblies. The FPLC system was 
equipped with a Superose 6 column and equilibrated with a buffer o f pH  7.5. The thin line 
represents UV-Vis absorption at 1=260 nm, the thick black line UV-Vis absorption at 1=280 
and the thick grey line represents DiI specific absorption at 1=549nm. A) DiI-loaded UU11 
micelles. B) Capsidproteins incorporating DiI loaded UU11 micelles.
To further determine the size o f  the micelle-capsid assembly, the FPLC 
fractions were analyzed by TEM.
Figure 5 TEM micrographs stained by uranyl acetate o f UU11-capsid FPLC fractions. Scale 
bars are 40 nm. A) Capsid-UU11 micelle particles eluting at V=1.4 mL. The inset shows 
empty capsids for comparison. B) UU11 micelles eluting at V=1.6 mL.
This revealed that the fraction eluting at V=1.4 formed structures o f  19.9 ±3.1 
nm (figure 5), which is slightly larger than would be expected for a T=1 particle. It 
is possible, therefore, that the capsid proteins (partially) adopt a T=2 symmetry. The 
interior o f  the capsids appeared to be unstained, indicating they have a filled interior.
65
Virus-like particles templated by DNA micelles
The non-encapsulated m icelles eluting at V=1.6 were 8.1±1.6 nm in size, which 
corresponds with their known size.7 The diameter o f  the m icelles is 11 nm smaller 
than the diameter o f  the formed capsids. Together with the thickness o f  the capsid 
wall, which is approximately 5 nm, this leads to a good fit o f  the micelle inside the 
capsid particle.
To confirm the presence o f  capsid protein in the FPLC fraction eluting at V=1.4 mL, 
the fractions were analyzed by SDS-Page and visualized using silver staining 
(figure 6). This showed the presence o f  capsid protein in the V=1.4 mL fraction, 
(lane 3).
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Figure 6 Silver stained SDS-Page gel o f FPLC fractions. Lane 1: marker, lane 2: wt CP, 
lane 3: capsid-UU11 micelle particles eluting at V=1.4 mL, lane 4: DiI loaded UU11 
micelles eluting at V=1.6 mL.
To further explore the use o f  the capsid-micelle particles as vehicles that can 
load small compounds, UU11 m icelles were loaded with pyrene, a hydrophobic 
small fluorescent dye. Particles were generated using the same procedure as for the 
Dil-loaded capsids. FPLC analysis showed a clear pyrene absorption at V=1.3 mL 
(figure 7a). The fluorescent spectrum o f  this fraction showed characteristic pyrene 
emission bands (figure 7b).
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Figure 7 FPLC trace and fluorescence spectra o f pyrene-loaded capsid-UU11 micelle 
particles. A) FPLC trace. The thick black line represents protein absorption at X=280 nm, 
the grey line represents pyrene absorption at 1=342 nm, the thin black line represents 
absorption o f the DylightTM labeled wt CP at X=654 nm. B) Fluorescence spectra (Aex = 342 
nm) o f the FPLC fraction eluting at V=1.3 mL as depicted in figure 7A (thick black line), and 
wt CP (thin black line).
In order to investigate the loading o f  the micelle-capsid particles with small 
hydrophilic molecules, UU11 micelles were equipped with 6-carboxylic-X- 
rhodamine (ROX), a small hydrophilic dye. This was achieved by hybridizing a 
single DNA strand conjugated to ROX with the UU11 micelles (figure 1b). The 
capsid proteins were labeled with a Dylight™  647 dye prior to mixing with the 
labeled micelles. FPLC analysis confirmed the presence o f  ROX in the formed 
particles (figure 8).
elution volume/ mL
Figure 8 FPLC trace o f ROX loaded UU11 micelle-capsid particles. The FPLC system was 
equipped with a Superose 6 column and equilibrated with a buffer o f pH  7.5. The thick black 
line represents the absorption at X=280, the thin black line represents absorption o f the 
Dylight™  labeled wt CP at X=654 nm. and the grey line represents ROX specific absorption 
at X=575nm.
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Using the absorption values obtained by FPLC, the aggregation number o f  the 
UU11 micelle was calculated to be 25 ±2. Fifty percent o f  the D N A  was hybridized 
to the ROX containing complementary D N A  sequence, and thus has a double 
charge density, so the total amount o f  negative charges per capsid is approximately 
412. Assuming a T=2 conformation, there would be 3.4 negative charges per capsid 
protein. This is rather similar to the number o f  negative charges found for the PFS 
containing capsids, which is 5.1 (see experimental section for calculation details).
Conclusions
The incorporation o f negatively charged micelles inside CCMV-capsids 
demonstrates that not only linear negatively charged polyelectrolytes are capable o f  
inducing the assembly o f  the capsid proteins. The results presented in this chapter 
further demonstrate the possibilities to direct and control the assembly o f  the 
CCMV capsid proteins. It is rewarding that through the encapsulation o f  
amphiphilic micelles the co-encapsulation o f  small molecules can be achieved. The 
general loading strategy presented in this chapter might be o f  great value for the 
development o f  new capsid-based drug delivery systems.
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Experimental section 
Methods and materials
For all experiments a buffer of pH 7.5 containing 0.5 M NaCl, 0.05 M Tris-HCl, 0.01 M 
MgCl2, and 0.001 M EDTA at pH 7.5 was used.
Protein concentrations were determined using a Cary 50 Conc (Varian, Middelburg) UV-VIS 
spectrophotometer.
FPLC measurements were performed using a Superose 6 PC 3.2/30 analytical column from 
GE lifesciences, attached to an Amersham Ettan LC system, fitted with a fractionating device. 
Buffers for FPLC were filtered with a Millipore 0.2 ^M filter before use. TEM grids 
(Formvar-Carbon) were exposed to an electron discharge treatment using a Cressington 
Carbon coater and power unit. Unless stated otherwise, the samples were applied to the grids 
by adding a drop of 5 ^L solution (~ 0.2 mg/mL) to the grid and carefully removing it using a 
filter paper after 1 minute immersion. The grid was allowed to dry for at least 15 minutes 
before applying 5 ^L of a 2% (w/v) uranyl acetate aqueous solution, which was removed 
after 15 seconds. The grid was again allowed to dry for at least 15 minutes. Samples were 
studied on a JEOL JEM-1010 TEM (Jeol, Japan) instrument. Fluorescence measurements 
were performed on a Perkin Elmer LS-55 fluorescence spectrometer.
DNA amphiphiles
DNA amphiphiles were synthesized and analyzed by Minseok Kwak as described in the 
literature.7,8
Production and purification of wild type capsid protein (wt CP)
The purification of the CCMV virus and the removal of its RNA were carried out according 
to literature procedures.1
Wt CP labeling
A solution of capsid protein in 0.1 M phosphate buffer pH 7.5, 0.15 M NaCl, was added to a 
vial containing 50 ^g DyLight™ 647 NHS-ester and stirred for 1 h at room temperature (RT). 
The non-coupled dye was removed by dialysis to a buffer pH 7.5 or pH 5.0.
Preparation of micelle-loaded capsids
A DNA amphiphile and wt CP were mixed in a 1 : 2.3 molar ratio (Table 1) in pH 7.5 capsid 
buffer and the mixture was allowed to form capsids for 1 h at 4 °C.
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Table 1 Mixed volume and concentration o f  micelle loaded capsids
Amphiphile used for micelle loaded DNA amphiphile Wt CP
capsid formation
(molar ratio of the amphiphile : wt
CP)
Pyrene/UU11 (1 : 2.3) 19.6 (209 ^M) 100 ^L (94 ^ M)
DiI/UU11 (1 :3.6) 8.1 ^L (400 ^M) 100 ^L (148 ^M)
ROX-ODN/UU11 (1 : 2.3) 19.6 ^L (209^M) 90 ^L (83 ^M)
Preparation of Loaded Micelles
Dii or pyrene was dissolved in acetone. A drop of the dye solution (400 ^g/ml) was added to 
a tube and subsequently evaporated. A UU11 micellar solution was added to the tube and the 
mixture was agitated overnight at room temperature.
UU11 was hybridized with 50 mol percent of ROX-ODN in MgAc2 (10 mM) buffer at pH 
7.5.
Calculation of the aggregation number (Z) of the UU11 micelle inside the capsid
The molarity ratio of UU11 : wt CP was calculated using the Beer-Lambert law, A = ecl. 
From the absorbances of ROX on complementary DNA (4.30 mAU, 50% hybridized) and 
Dylight™ 647 on wt CP (85.5 mAU, 17% labeled), see elution peak at 1.28 ml in Figure 8, a 
molar ratio of 1 : 4.82 was calculated. In a capsid of T = 2 geometry, which consists of 120 
CPs, this corresponds to 120/4.82=24.9 single-stranded UU11 molecules in the capsid-cavity. 
The micelle in the cavity thus has an aggregation number of Z = 24.9.
Calculation of the number of negative charges per capsid protein for encapsulated PFS
As stated in the previous chapter, the concentration of PFS inside the capsid is 1.9*10"2 M. 
The number of molecules of PFS molecules per capsid can be obtained from this number, by 
multiplying with the internal volume of a T=1 capsid (assuming a perfect sphere with a 
diameter of 8 nm), and with the number of Avogadro. This leads to 3.08 molecules of 
PFS/capsid. Since PFS has an average charge density of 100 negative charges per molecule, 
the number of charges per 60 capsid proteins (T=1 particle) is 308, and thus the number of 
charges per capsid protein is 5.1.
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Bacterial capsid protein*
Purification and assembly of the His-tag capsid protein
The CCMV capsid protein dimers can form a plethora o f  different structures when  
the ionic strength, the concentration o f  divalent cations and the pH o f the buffer 
solution are varied.1 This demonstrates the enormous versatility o f  the CCMV 
capsid protein to self-assemble. To further explore and expand the (assembly) 
properties o f  the capsid protein, it was heterologeously expressed in E.coli to be 
able to genetically modify the capsid protein. The procedure involved the extraction 
o f RNA from the CCMV virus particles after which a reverse transcriptase reaction 
was used to obtain the copy D N A  (cDNA). The cD N A  was amplified using PCR 
and cloned into a pET-15b E.coli expression vector. The obtained plasmid was 
transformed into E.coli BL21(DE3)pLysS cells. This work w ill be described in 
detail in the forthcoming thesis o f  L.J.A. Hendriks.2
Importantly, the expression vector contained a histidine-tag (His-tag) 
sequence which allows for easy purification o f  the protein, followed by a thrombin 
cleavage sequence, which facilitates removal o f  the His-tag. The D N A  encoding for 
the coat protein was inserted directly after the thrombin cleavage site, and thus the 
resulting coat protein contained an N-terminal His-tag followed by a thrombin 
cleavage site.
A  His-tag is an amino acid m otif which consists o f  several histidines in a row, 
in the present case 6. It is widely used for affinity purification o f  proteins. 
Histidines are good ligands to nickel, and in this way the engineered proteins can be 
selectively bound to a solid support functionalized with nickel chelating 
nitrilotriacetic acid (NTA) groups, i.e. N i-NTA resins.
* Part of this work is submitted for publication
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Protein expression and purification
For capsid protein with His-tag (His-CP) expression, E.coli cells suitable for high- 
level protein expression (BL21 cells) containing the coat protein plasmid were 
grown overnight in lysogeny broth (LB) medium, a standard bacterial growth 
medium, provided with the appropriate antibiotics. The next day the culture was 
diluted 10 times with LB medium and antibiotics. Expression o f  the protein was 
induced by adding isopropyl p-D-1-thiogalactopyranoside (IPTG) at the logarithmic 
growth phase o f  the cells and after approximately 7 hrs the cells were pelleted by 
centrifugation and stored at -20oC awaiting purification. The production o f  His-CP 
increased more than six fold when cells were grown at 30oC instead o f  37oC, 
resulting in final yields o f  approximately 20 mg o f His-CP from a 1 L bacterial 
culture.
For His-CP purification, the pelleted cells were defrosted on ice, and 
resuspended in a lysis buffer containing a small amount o f imidazole. Imidazole has 
the same structure as histidine side groups, and is therefore able to coordinate to the 
Ni-NTA resin. The addition o f  imidazole to the lysis buffer prevents some a- 
specific binding o f proteins to the Ni-NTA resin, while the concentration is still 
sufficiently low not to interfere with the binding o f  the engineered protein to the 
resin. To disrupt the bacterial cell walls, lysozyme was added, followed by 
sonication. The resulting homogeneous mixture was subjected to centrifugation, to 
pellet the bacterial debris. The supernatant containing soluble proteins was added to 
the Ni-NTA column and the proteins were allowed to bind for at least an hour at 
4oC. The flow  through was then collected, and the column was washed with a wash  
buffer containing a larger concentration o f  imidazole than the lysis buffer, to 
remove all non-specifically bound proteins from the resin. To elute His-CP from the 
column, small amounts o f  elution buffer containing a large excess o f imidazole 
were added. The imidazole competes with the His-tagged proteins for binding to the 
column, and since a large excess is used, the proteins are eluted this way. The 
elution fractions were then dialyzed to buffer pH 7.5, to remove excess o f  imidazole 
in the buffer. This step should take place as soon as possible, but at least within a 
day after the purification, since high concentrations o f  imidazole are harmful to 
proteins.
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Figure 1 SDS-PAGE analysis o f purified His-CP samples. M=Marker. Lane 1-7 are 
consequtive elution fractions o f a His-CP containing protein mixture, after His-CP elution 
from a Ni-NTA column. Lane 8 is the same sample as 1-7, after 46 days. A small band which 
is degraded His-CP protein, has appeared underneath the main His-CP band.
After purification a portion o f  the His-CP protein appeared to precipitate within a 
few days. This seemed to be somewhat concentration dependent. The soluble part 
o f  the solution did not appear to contain much degraded protein as was shown by 
SDS-PAGE analysis (figure 1). It was tried therefore to assemble the soluble part o f  
the His-CP solution into capsid particles. Unfortunately, the His-CP proteins rarely 
assembled into capsids, as was evident from the absence o f  capsid particles on the 
TEM pictures and the absence o f  a capsid peak at V=1.1 mL in the FPLC traces. 
Incidentally FPLC traces showed traces o f  assembly, but the peak height at V=1.1 
mL was much smaller than the peak height o f  a sample o f  wild-type (wt) CP with a 
similar concentration. The inability to assemble was not caused by degradation o f  
the proteins, since SDS-PAGE analysis showed no degradation and only proteins o f  
the correct molecular weight were observed (figure 1). Comparison o f  the UV-Vis 
spectra o f  the wild-type capsid protein (wt CP) and His-CP showed that His-CP had 
a much stronger absorption at X = 260 nm compared to the wt CP. Nucleic acids 
absorb mainly at X = 260 nm and proteins at X = 280 nm, and therefore the ratio o f  
these absorption values (the 260/280 ratio) is indicative o f  the purity o f  the protein. 
The wt CP has a 260/280 ratio o f  0.7, but the ratio for His-CP was usually between 
1.1  and 1 .6.
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It is very likely, therefore, that the His-CP samples contained more nucleic 
acid material* than the wt CP samples. Probably, the nucleic acid material 
originated from E.coli, and co-eluted from the Ni-NTA column, due to electrostatic 
interactions between the positively charged N-terminus o f  His-CP and the 
negatively charged nucleic acid backbone. To examine if  this was the reason for the 
poor assembly o f  His-CP, purification conditions had to be found that would avoid 
this co-isolation o f  nucleic acid material with His-CP. Conditions that would  
destroy the nucleic acid material, i.e. shearing and the addition o f  nucleases, were 
complemented with a range o f  conditions that had the purpose o f  separating the 
remains o f  the nucleic acids from the proteins (table 1). Some o f  these separating 
conditions aimed at disrupting the presumed electrostatic interactions between the 
nucleic acid material and His-CP, either by increasing the ionic strength o f  the 
buffer solutions used, or by increasing the pH to deprotonate the positively charged 
residues o f  His-CP. Others intended to disturb hydrophobic interactions that might 
exist between the nucleic acids and His-CP, and also methods to precipitate the 
nucleic acid material were studied.
Table 1 Different purification conditions used fo r  the optimization o f  His-CP purification.
# Condition Purpose
1
Normal, but with extensive resuspending o f  pelleted 
cells
Destroying nucleic acid material by 
shear force
2
As 1 + addition o f RNAse and DNAse to the pelleted 
cells after sonication Cleaving nucleic acid material
3
As 2 + addition o f  0.8% (v/v) Triton X-100 to all 
buffers
Disrupting hydrophobic interactions
4
As 2 + addition o f  2 M NaCl to all buffers instead o f 
0.3 M  normally present
Disrupting ionic interactions
5 As 2 + addition o f 10% EtOH (v/v) to all buffers Disrupting hydrophobic interactions
6 As 2 + addition o f  30% Glycerol (v/v) to all buffers Disrupting hydrophobic interactions
7
As 1 + addition o f  0.04% poly(ethyleneimine) at pH 
8.0 to pelleted cells for 15’ on ice before sonication
Precipitating nucleic acid material 
with poly(ethyleneimine)
8 As 2 + addition o f  2 M M gCb to all buffers Disrupting ionic interactions
9 As 1 + addition o f NaOH to increase the pH to 12
Disrupting ionic interactions by 
deprotonating arginines and lysines
It should be noted that the co-isolated impurity to the CP might be more complex than just nucleic acid. 
Throughout this chapter we will refer to this impurity as nucleic acid material
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Table 2 Concentrations and 260/280 ratio o f the purified His-CP proteins using the 
purification conditions mentioned in table 1.
# Condition
260/280
Ratio
Concentration 
sample (mg/mL)
Concentration  
applied to TEM  grid 
(mg/mL)
1 Extensive resuspending 1.14 1.09 0.03
2 RNAse and DNAse 0.96 0.66 0.02
3 0.8% (v/v) Triton X-100 0.61 a 2.26 0.45
4 2 M NaCl 0.72 2.16 0.05
5 10% EtOH (v/v) 1.41 1.31 0.26
6 30% Glycerol (v/v) 1.54 1.72 0.34
7 0.04% PEI 1.56 1.20 0.24
8 2 M MgCl2 0.84 1.12 0.03
9 pH to 12 1.32
a Unreliable UV-Vis values, Triton X-100 was not completely removed from the sample.
To measure which purification conditions were best suited for the removal o f  
nucleic acid material from His-CP, the 260/280 ratio was determined for all 
samples. As expected, the purification conditions aimed at disturbing the 
electrostatic interactions were most successful (table 2, entries 4 and 8). The 
260/280 ratios o f  these samples were approximately the same as for the wt CP. On 
the other hand, the purification conditions that disturbed hydrophobic interactions 
even seemed to have a disadvantageous effect on the 260/280 ratio (table 2 , entries 
5 and 6).
To test if  the modified purification conditions still resulted in pure and intact 
protein, the samples were analyzed by SDS-PAGE. This showed that only the last 
purification condition resulted in degraded protein (figure 2). This was most likely 
caused by degradation o f  the protein due to the high pH o f the buffer solutions used 
for these samples. This pH was raised to 12, in order to deprotonate the positively 
charged residues o f  His-CP in that way disrupting interactions with the negatively 
charged nucleic acids.
A ll the other samples on the gel seemed to consist o f intact and pure proteins 
o f the correct molecular weight. The proteins were not dialyzed to a capsid buffer 
pH 7.5 prior to their application on the gel resulting in some smearing o f  the lanes, 
which could be prevented by dialysis to a buffer with lower ionic strength (not 
shown).
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Figure 2 SDS-PAGE gel o f His-CP purified with different purification conditions. 
M=Marker. Lane 1-9 correspond to purification conditions 1-9 (table 1).
To test whether the 260/280 ratio indeed had an effect on the capsid assembly, the 
different samples were dialyzed to pH 5.0 and all samples were analyzed by TEM 
(figure 3). Samples with a 260/280 ratio < 0.9 not only contained far more capsids 
than the samples with a 260/280 ratio > 0.9, but the interior o f  the capsid was also 
empty, instead o f  filled.
An empty capsid interior is visible in the TEM analysis as a dark spot inside 
the bright capsid shell. This effect is caused by the procedure used to provide 
contrast to the materials in the EM, i.e. negative staining using uranyl acetate. 
Proteins, in general, are hardly stained, and therefore appear as bright spots on a 
dark background. When the interior o f  the capsid is filled, for example with nucleic 
acids (as is the case for the CCMV virus), the uranyl acetate can not freely enter the 
capsid interior and the virus is therefore visible as a filled white circle (figure 
3a).The staining agent can, however, enter the interior o f  the empty capsid, which is 
therefore visible as a dark spot surrounded by a white rim (figure 3 b). It seems that 
the nucleic acid material can accumulate inside the capsids, since samples with a 
high 260/280 ratio appear to have a filled interior (figure 3 e, g-i). In contrast to the 
native RNA, this does not seem to drive the assembly o f  the capsid, since less 
capsids are formed in samples which have a 260/280 ratio > 0.9 compared to the 
samples which have a 260/280 ratio < 0.9. Although the amount o f  capsids formed 
is difficult to determine using TEM, the concentration o f  sample that is needed to 
get TEM images with a well-distributed capsid density does give an indication.
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Figure 3 TEM pictures o f assembled His-CP purified following different purification 
conditions (see table 1). A) CCMV virus. B) wt CP. C) His-CP purified by extensive 
resuspending. D) His-CP purified by adding nucleases. E) His-CP purified with additional 
Triton X-100. F) His-CP purified with buffers containing 2 M  NaCl. G) His-CP purified with 
buffers containing 10% EtOH. H) His-CP purified with buffers containing 30% glycerol. I) 
His-CP purified by addition o f poly(ethyleneimine) to pelleted cells. J) His-CP purified with 
buffers containing 2M MgCl2. Scale bar = 100 nm.
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In order to quantify the amount o f  capsids that were formed more precisely, 
some samples were also analyzed by FPLC (figure 4). This analysis was not 
possible for all samples; since His-CP substantially precipitated from the samples 
with a 260/280 ratio > 0.9. The FPLC trace o f  sample 2, which was only treated 
with nucleases, showed a minor capsid peak at V=1.1 mL and hardly any capsid 
dimers. Although this might suggest that no protein was present in the sample, UV- 
Vis measurements showed that the sample concentration was approximately 1 
mg/mL. When the assembly efficiency o f  proteins obtained by purification 
procedures 2 and 4 (table 1) are compared by FPLC (figure 4) it is clear that 
procedure 4 gives a much higher yield o f  capsids than the other procedures. It 
seems therefore that the purification conditions applied to sample 4 greatly increase 
the ability o f  the His-CP proteins to self-assemble. In the experiments so far 2 M o f  
NaCl was used in all buffers. In order to further optimize this procedure, different 
concentrations o f  NaCl were tried. A ll NaCl concentrations between 1 M and 2 M  
gave the same result. For the remaining His-CP purifications described in this thesis, 
buffers with 1.5 M NaCl were therefore used.
The increase in ionic strength o f  the buffers used in the purification procedure 
seems to be an efficient and simple way to avoid co-purification o f  nucleic acid 
material with His-CP. Moreover, it seems that the presence o f  the non-native 
nucleic acid material prevented the proper assembly o f  the capsid, and might also 
have caused the rapid precipitation o f  His-CP over time.
elution volume/ mL elution volume/ mL elution volume/ mL
Figure 4 FPLC graphs o f assembled wt CP and His-CP at pH  5.0. Samples were measured 
using an FPLC equipped with a superose 6 column. Black lines represent absorption at 
1=280 nm, grey lines represent absorption at 1=260 nm. A) wt CP. B) His-CP purified with 
nucleases (table 1, entry 2). C) His-CP purified using buffers with 2 M  NaCl added (table 1, 
entry 4).
80
Chapter 5
Degradation o f capsid proteins
Like almost all proteins, the capsid protein is sensitive to degradation. Especially 
the N-terminus o f  the capsid protein is sensitive to this process. At pH 5.0 the 
degradation is very slow- the capsid is stable for months, while at pH 7.5, the 
degradation is quite rapid -after 2 days substantial degradation product is observed. 
The ‘protecting’ effect o f the pH might be due to inactivation o f  proteases by the 
low  pH. This is unlikely, however, as many proteases are naturally located in the 
lysosome and therefore have a low pH optimum. Another explanation might be that 
at pH 5.0, the capsid is assembled, and since the N-terminus is localized on the 
interior o f the capsid, it is protected from cleavage by proteases or other degradative 
processes. It is known from literature3 that the N-terminal part o f  the capsid protein 
is cleaved predominantly at residue 34, resulting in an N-terminally truncated 
capsid protein (wt CP N A 34*). Tang et al. 3 have shown that this truncated protein 
is still able to assemble into the native T=3 structure when assembly is induced by 
lowering the pH to 5.0. Besides T=3 particles, the capsid proteins can also assemble 
into pseudo T=2 and T=1 particles. These forms are seldomly observed with the full 
length wt CP.
It has been suggested that the full length wt CP is not able to assemble into 
T=1 particles, because the formation o f  a T=1 particle requires a sharper angle 
between the two capsid proteins o f  a dimer, which supposedly can only be made by 
the truncated wt CP. It is clear that by using pH induced assembly conditions 
formation o f  the T=1 particle only occurs with the truncated wt CP, but this does 
not prove that it is essentially impossible to form a T=1 particle from full length wt 
CP. It could be that formation o f  a T=1 particle from full length wt CP is possible, 
but energetically unfavorable at pH 5.0.
Sikkema e t a l.4 have shown that particles o f  the same size as T=1 particles can 
be formed when PSS is added to the wt CP at pH 7.5. The interaction between the 
negatively charged PSS and the positively charged capsid protein interior probably 
provides the driving force for this assembly. The capsid proteins (CP) in these 
experiments consisted mostly o f  full length wt CP, so it seems likely that the 
particles were composed predominantly o f  this type o f  CP, which are deemed
* The N in this notation indicates that the amino acids are missing from the N-terminus, A 
indicates missing amino acids, 34 states the number of missing amino acids.
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unable to form the sharper angle. Unfortunately, wt CP degrades during the 
experiments at pH 7.5, and thus it was not possible to form the particles from capsid 
protein samples that were 100% intact. His-CP seems to degrade at a slower rate 
than the wt CP (see below), so by using this CP instead o f  wt CP it might be 
possible to use a 100% non-degraded capsid protein sample for these assembly 
experiments.
Figure S Degradation o f capsid proteins over time. A) SDS-PAGE analysis o f degradation 
over time. tcHis-CP = thrombin cleaved His-CP. B) Percentage o f full-length capsid protein 
at pH  7.5 as function o f the time. Filled diamonds represent His-CP, open squares represent 
wt CP.
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To investigate the difference in degradation rate between wt CP and His-CP, 
and the effect o f  pH on the degradation process, both proteins were stored at 4oC at 
pH 5.0 and pH 7.5 for two months, and were sampled in the course o f  time. To 
prevent further degradation o f  the samples obtained in this way, they were mixed  
with sample buffer for SDS-PAGE, boiled, and stored at -20oC. This process 
completely denatures all proteins in the sample, but does not degrade the proteins 
any further. After two months all collected samples were analyzed by SDS-PAGE 
(figure 5).
This experiment showed that at pH 5.0 both wt CP and His-CP do not visibly 
degrade within two months. At pH 7.5, however, both capsid proteins degrade 
substantially, although the wt CP degrades more rapidly. The degradation rate o f  wt 
CP seems to be very fast in the first week and then slows down, whereas His-CP 
seems to degrade at a more constant rate (figure 5b). It might be that the His-tag 
provides some degree o f  protection from degradation. Mass-analysis o f  the His-CP 
sample (figure 6) and data from literature3 revealed that His-CP and wt CP and are 
not cleaved at the same position.
The main degradation product o f  wt CP is the truncated protein lacking the 
first 34 amino acids, while the main degradation product for His-CP is the truncated 
protein missing the first 21  amino acids, which are exactly the additional amino 
acids o f  the His-tag and the thrombin cleavage site. The main degradation product 
o f  the His-CP therefore seems to be the wt CP (table 3).
A 20211.8
D 19924.3 B 22505.3
20500 21000 21500 2200020000 22500 23000
Mass
Figure 6 ESI-TOF mass spectrum o f partially degraded His-CP
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Table 3 Amino acid sequences o f the N-termini o f His-CP and its main degradation products. 
The first amino acid o f  wt CP NA34 is highlighted in grey. The first amino-acid o f the 
thrombin cleaved His-CP is printed in bold.
calculated
mass
measured
mass
partial amino acid sequence
2250 6 .6 22505.3 GSSHHHHHHSSGLVPRGSHMMSTVGTGKLTRAQRRAAARKNKRNTRVVQPVIVEPIAS
20212.1 20211.8 STVGTGKLTRAQRRAAARKNKRNTRVVQPVIVEPIAS
19924.8 19924.3 GTGKLTRAQRRAAARKNKRNTRVVQPVIVEPIAS
This could be very convenient for the study o f  the assembly o f  full-length CP 
into T=1 particles, since even the degraded form o f the His-CP is not shorter than 
the wt CP. Unfortunately, preliminary studies showed that His-CP was not able to 
form T=1 like particles. Upon incubation with PSS, slightly larger particles were 
formed, as determined by FPLC analysis. The 21 amino acids longer N-terminus o f  
the His-CP might be the cause o f  this. The N-terminus o f  the His-CP can be cleaved  
at the thrombin cleavage site, resulting in a protein that contains only four amino- 
acids more than the wt CP. Since it is possible that the His-tag retards the 
degradation, the degradation rate o f  the thrombin cleaved His-CP (tcHis-CP) might 
be different. Therefore, the degradation o f  the tcHis-CP was studied following the 
same procedure as outlined for the His-CP and wt CP (figure 5). This protein seems 
to rapidly degrade first to the w t CP, and then to a truncated version o f  wt CP, 
which further degrades to a still more truncated species. The exact size o f  these 
truncated versions was not determined. Since it seemed that the His-CP degrades 
more quickly after addition o f thrombin, PSS was added at different time-points 
after the addition o f  thrombin. Just before addition o f  PSS a sample was taken for 
SDS-PAGE analysis (figure 7a).
In addition to the tcHis-CP samples also full-length His-CP, wt CP and 
degraded w t CP were tested. The resulting particles were studied on DLS, TEM and 
FPLC (figure 7b-e). To determine if  the protein composition o f  the formed particles 
was identical to the initial protein composition, purified FPLC fractions were 
analyzed on SDS-PAGE, (figure 7a), showing only a slight difference in  
composition before and after addition o f PSS. Full length His-CP was incorporated 
into the particles to a slightly lesser extent than wt CP in the largest particles (figure 
7b). The degraded wt CP almost completely lacked the positively charged N- 
terminus, which supposedly interacts with the PSS, but still particle formation was 
observed at pH 7.5.
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Aniagyei e t al.5 observed assembly o f  a genetically truncated NA34 CP, which  
thus lacks the positively charged N-terminus, around an anionic gold nano-particle 
core. They postulate that the lack o f  electrostatic interaction between the negatively 
charged core and the positively charged N-terminus might be compensated by the 
reduced intersubunit electrostatic repulsion. This might also apply to our PSS 
containing system. The observed particles formed from the degraded wt CP seemed 
to be much smaller than all other observed particles, and with an average diameter 
o f about 14 nm, do not seem to fit to any known icosahedral symmetry. The size 
difference between the particles formed from wt CP and tcHis-CP and His-CP 
seemed to be much smaller. On TEM almost no difference in  size could be detected, 
while FPLC analysis seemed to indicate a gradual increase in  particle size, 
corresponding to an increased average protein size. DLS also showed the same 
trend, with the exception o f  the full length His-CP, which seemed to form smaller 
particles on DLS. Detailed analysis o f  the TEM pictures revealed that no 28 nm 
sized particles were formed. M ost particles were in the range o f  17-23 nm, which  
comprises both T=1 and pseudo T=2 particles. Since the difference in size between  
T=1 and T=2 particles is quite small, it is difficult to distinguish between them. The 
gradual shift in size might be explained by a shift o f  the T=1/ T=2 ratio. It is 
possible that the full-length His-CP is not able to form the curvature needed to form  
T=1 particles and is therefore kinetically trapped into T=2 particles.
It is striking that on FPLC at least there seems to be a large difference in size 
between wt CP and non-degraded tcHis-CP (samples 2 and 3). DLS and TEM do 
not indicate the same size difference, so it is difficult to conclude much from this. In 
order to really determine the size and structure o f  the formed particles cryo-TEM  
measurements and analysis is needed. Therefore, w e cannot conclude here that it is 
possible to form T=1 particles from non-degraded capsid protein, but it seems likely. 
Especially, since the amount o f  degradation in the wt CP mostly used for the 
formation o f  the PSS particles is usually very low. In order to form a T=1 particle, 
all dimers need to have a sharper dihedral angle.2 So if  the full-length wt CP would 
indeed be unable to form this sharper angle, it seems unlikely that a small amount 
o f degradation would suffice for the formation o f  T=1 particles. The seemingly 
inability o f  the larger His-CP to form such a particle does, however, suggest that at 
least for an elongated N-terminus, it is plausible to assume that the protein dimers 
are conformationally restricted to assembly in a structure with exclusive T=1 
symmetry.
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Figure 7 Addition o f PSS to capsid protein o f various lengths. A) SDS-PAGE analysis o f the 
samples before addition o f PSS and from FPLC purified PSS capsid protein samples. B) 
Percentage o f protein in the samples before addition o f PSS (light colors), and in the formed 
particles after addition o f PSS (dark colors) as determined by analysis o f the SDS-PAGE gel 
shown in A. Yellow bars represent degraded wt CP, blue bars represent wt CP, red bars 
represent His-CP. C) DLS analysis o f the formed particles, D) average size o f formed 
particles as determined by TEM, error bars indicate standard deviation. E) Elution volumes 
o f the particles as determined by FPLC analysis, FPLC was equipped with a superose 6 
column. F) TEM pictures o f the particles (the scale bar applies to all images). 1: degraded 
wt CP, 2: wt CP, 3: tcHis-CP 210 minutes after thrombin addition, 4: tcHis-CP 90 minutes 
after thrombin addition, 5: tcHis-CP 30 minutes after thrombin addition, 6: His-CP.
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Experimental section 
Methods and Materials
Protein concentrations were determined using a Cary 50 Conc (Varian, Middelburg) UV-VIS 
spectrophotometer using a quartz cuvette with a path length of 3 mm. FPLC measurements 
were performed using a Superose 6 PC 3.2/30 analytical column from GE lifesciences, on an 
Amersham Ettan LC system, fitted with a fractionating device. Buffers for FPLC were 
filtered with a Millipore 0.2 iM  filter before use. TEM grids (Formvar-Carbon) were 
exposed to an electron discharge treatment using a Cressington Carbon coater and power unit. 
The sample was applied to the grids by adding a 5 iL  drop of sample solution (~ 0.2 mg/mL) 
to the grid and carefully removing it after 1 min. immersion using a filter paper. The grid was 
allowed to dry for at least 15 min. before applying 5 ¡iL of a 2% (w/v) uranyl acetate aqueous 
solution, which was removed after 15 s. The grid was again allowed to dry for at least 15 min. 
Samples were studied on a JEOL JEM-1010 TEM (Jeol, Japan) instrument. DLS 
measurements were performed on a Zetasizer Nano S (Malvern Instruments Ltd, England). 
After purification of the proteins two buffers were used; a buffer of pH 7.5 (50 mM 
phosphate, 0.5 M NaCl) and a buffer of pH 5.0 (50 mM acetate, 0.5 M NaCl, 10 mM CaCl2), 
the pH of the buffers was set with HCl.
Creation o f a heterologous expression system for the capsid protein in E. coli cells.2,6
Detailed procedures for the heterologous expression of CP in E.coli will be published in the 
forthcoming thesis of L.J.H. Hendriks.2 CCMV virus particles were purified from cowpea 
plants and RNA was extracted as described in the literature.7 An amount of 3 ig  of RNA was 
used in a reverse transcriptase reaction using the primer 
A G TA GGATCCCTAATACACCGGAGTGAAG (BamHI restriction site underlined, 
complementary part italic). The primer is complementary to the cDNA encoding the C- 
terminus of CP. The obtained cDNA was directly used in a PCR reaction, using the primer 
described above and a primer complementary to the cDNA encoding the N-terminus of CP: 
AG TACATATGATGTCTACAGTCGGAACAGGG (NdeI restriction site underlined, 
complementary part italic). A 581 bp fragment was obtained, which was digested with NdeI 
and BamHI before it was ligated into a pET-15b E. coli expression vector digested with the 
same restriction enzymes. The obtained plasmid was transformed to E. coli and its sequence 
was confirmed by sequence analysis.
Expression of His-CP
One colony of BL21(DE3)pLysS cells expressing His-CP was used to inoculate 100 mL of 
LB medium containing ampicillin (0.050 g/L) and chloramphenicol (0.025 g/L). After 
growth overnight at 30°C this culture was used to inoculate 900 mL of LB medium 
containing ampicillin (0.05 g/L) and chloramphenicol (0.025 g/L) and grown at 30°C. Protein 
expression was induced during logarithmic growth (OD600 =0.4-0.6) by addition of IPTG to a 
final concentration of 1 mmol/L.
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Purification of His-CP
Cells were harvested after 7 hrs of expression by centrifugation at 4000 rpm for 15 min. at 
4oC. The supernatant was discarded and the pelleted cells were stored at -20oC. After thawing, 
the pelleted cells were resuspended in approximately 10 mL of lysis buffer (50 mM 
NaH2PO4, 10 mM imidazole and 1.5 M NaCl pH 8.0). Approximately 10 mg of lysozyme 
(EC 3.2.1.17 from Fluka) was added and the solution was incubated at 4oC for 30 min. The 
solution was sonicated for 5 times 10 seconds with duty cycle 40 and output control 6 
(Branson Sonifier 250, marius instruments Nieuwegein, the Netherlands). RNase (10 ug/mL) 
and DNase (5ug/mL) were added to the solution and the mixture was incubated at 4oC for 15 
min. The solution was centrifuged at 10,000 rpm for 20-30 min. to pellet the cellular debris. 
The supernatant was incubated with 1 mL of Ni-NTA agarose beads for 1 h at 4oC. The flow 
through was collected and the column was washed with 40 mL of wash buffer (50 mM 
NaH2PO4, 25 mM imidazole and 1.5 M NaCl pH 8.0)). The capsid protein was then eluted 
from the column using approximately 10 mL of elution buffer (50 mM NaH2PO4, 250 mM 
imidazole and 1.5 M NaCl pH 8.0) and the protein was collected in small fractions. The 
fractions were dialyzed overnight to buffer pH 7.5, to remove the excess of imidazole. The 
protein purity was checked with SDS-PAGE gel electrophoresis. Details about the 
experiments to optimize the protein purification can be found in the text.
Degradation of capsid proteins
Directly after purification of wt CP and His-CP the proteins were divided in two fractions, 
which were dialyzed to two different buffers: capsid storage buffer pH 5.0 (50 mM NaAc, 1 
mM NaN3, 1 M NaCl), and capsid buffer pH 7.5 (50 mM Tris, 500 mM NaCl, 1 mM EDTA, 
10 mM MgCl2). The four samples were diluted to a concentration of 1 mg/mL and stored at 
4oC for 2 months. At selected time points, samples were taken from these stock solutions for 
analysis by SDS-PAGE. Sample loading buffer and a capsid buffer pH 7.5 containing 0.2 M 
NaCl was added to the samples. The capsid buffer was added to dilute the samples to a final 
concentration of 0.16 mg/mL, to increase the pH and to decrease the salt concentration of the 
samples, in order to obtain nicely defined bands on SDS-PAGE. After addition of sample 
buffer and capsid buffer the samples were boiled for 5 min., and stored at -20oC to prevent 
further degradation of the proteins. After two months all collected samples were defrosted 
and analyzed on SDS-PAGE (figure 5).
Formation of PSS stabilized capsids
An amount of 0.44 ^L thrombin (Novagen 1.7 U/^L) was added to 1 mg of His-CP (1.85 
mg/mL) in capsid buffer pH 7.5. At selected time points samples were isolated from this 
stock solution. The isolated samples were all treated according to the following procedure; 2 
^L of the selected samples were diluted with sample buffer and MQ water to a final 
concentration of 0.18 mg/mL. The diluted samples were immediately boiled for 5 min. and 
stored at -20oC. 1 ^L PSS dissolved in MQ water (0.32 M) was added to 100 ^L sample and
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capsids were allowed to form for 15 min. at 4oC. The formed capsids were analyzed on DLS, 
after which the sample was analyzed by FPLC equipped with a superose 6 column. The 
capsid fraction eluting from the FPLC at V = ~1.3 mL was analyzed on TEM, and 16 iL  of 
the fractions were mixed with 4 iL  sample buffer, boiled for 5 min. and stored at -20oC. All 
collected samples were analyzed on SDS-PAGE and detected using silverstaining.
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Chapter 6
Controlled encapsulation o f multiple proteins in virus 
capsids*
Introduction
Viruses are masters in encapsulating nucleic acids; they are typically composed o f  a 
shell o f  highly organized protein molecules, which surround densely packed DNA  
or RNA chains. Recently, these protein shells (also called capsids) have also been 
used to package other guest compounds.1-4 CCMV is particularly suited for this 
purpose, due to its special assembly properties, which makes it possible to 
encapsulate compounds by mixing them with CCMV dimers at pH 7.5 and 
subsequently lowering the pH to entrap material inside the capsid.1,5
Since the CCMV capsid interior is positively charged, encapsulation works 
especially well with negatively charged guest molecules like inorganic salts and 
negatively charged polymers as described in chapter 3 .1,6 However, potentially 
useful cargos like enzymes are usually not negatively charged at acidic pH, 
resulting in a low encapsulation efficiency o f  these enzymes. Low encapsulation 
efficiency is not always a disadvantage, as has been shown in our study o f  a virus- 
based enzyme nanoreactor5 which has provided new insight in the behavior o f  
single enzyme molecules.
Following up on this work, it is o f  great interest, to study the behavior o f  multiple 
enzymes in the confined space o f  a virus nanoreactor. For example, cascade 
reactions catalyzed by a series o f  enzymes might take place more efficiently. In 
addition, such systems may provide new insights into the way living cells work, 
since viral nanoreactors could serve as a model system for simple cell organelles.
* This work was published: JACS, 2009, 131, 17771
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In order to achieve this goal, we need to improve and control the encapsulation 
efficiency o f  enzymes in the CCMV capsid, compared to the statistical 
encapsulation strategy previously reported by us.5
In this chapter we describe a novel encapsulation method, which makes use o f  
a non-covalent anchoring moiety to attach the target protein to the capsid protein 
prior to assembly o f  the latter. In this way the guest encapsulation efficiency is 
significantly improved, while to a large extent control over the amount o f  encased 
proteins is obtained.
Results and Discussion
Non-covalent anchoring was chosen over covalent anchoring methods, 
because it eliminates the need for chemical reactions, which are often not bio­
orthogonal, to bind the two proteins together. As a non-covalent anchor, we used a 
heterodimeric coiled-coil protein7. Coiled-coil motifs are oligomerization domains 
frequently found in nature8,9 and are also used by man, for example in affinity 
chromatography,10 biosensors,11 hydrogels12, and in the study o f  liposome fusion .13 
Coiled-coil motifs consist o f  a seven-amino acid-residue repeat, denoted as 
(abcdefg)n , in which residues a  and d  are usually hydrophobic amino acids, which  
align when the peptide sequence folds into a helical conformation. A  hydrophobic 
strip is subsequently formed at one side o f  the coiled-coil, which is the primary 
driving force for the self-assembly o f  two o f  such species.14 While nature 
commonly uses homodimeric coiled-coils, w e chose a heterodimeric coiled-coil to 
avoid the problem o f self-dimerization o f  either the capsid protein or the guest 
protein. To minimize the risk that the the introduction o f a coiled-coil would alter 
the structure and assembly properties o f  the capsid protein, a short coiled-coil was 
chosen, which nonetheless still has a small dissociation constant (Kd= 7*10 -8 M) 
(figure 1).7
Heterodimerization can be achieved by the placement o f  charged residues 
(glutamic acid or lysine) at the e  and g  positions o f  the coiled-coil motif. The 
resulting coiled-coil with glutamic acid at these positions is called the E-coil and 
the one with lysine at these positions, is called the K-coil. The complete amino acid 
sequences o f  these peptides are (EIAALEK)3 for the E-coil, and (KIAALKE)3 for 
K-coil.
Since the capsid interior is positively charged, we chose to attach the 
positively charged K-coil to the capsid protein ensuring that the coiled-coil does not
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stick to the capsid protein surface, which presumably would make it less available 
for binding with the E-coil. In order to attach the K-coil to the capsid protein, we 
cloned the gene encoding for the coiled-coil sequence in an expression plasmid 
containing the capsid protein gene, introducing the K-coil at the N-terminus o f  this 
protein. From this point on this protein w ill be referred to as CK.
Figure 1 Schematic representations o f the E/K coil heterodimer. A) Helical wheel 
representation o f the E/K coil heterodimer. The helix propagates into the page from the N  to 
the C-terminus. Hydrophobic interactions are depicted with open arrows, ionic interactions 
with closed two sided arrows. The left wheel represents the E-coil with amino acid sequence 
(EIAALEK)3 and the right wheel represents the K-coil with amino acid sequence 
(KIAALKE)3.. B) Cartoon o f the E/K coil heterodimer. The E-coil is represented in dark grey, 
and the K-coil is represented in grey. Negatively charged amino-acids are depicted in dark 
grey, positively charged amino acids are depicted in grey and hydrophobic amino acids are 
depicted in light grey.
The N-terminus was chosen for modification since the C-terminal part o f  the 
capsid protein is involved in the dimerization and assembly o f  the capsid proteins. 
Since the E-coil and K-coil bind in a parallel fashion, the E-coil was introduced at 
the C-terminus o f  EGFP by introducing it in an expression plasmid containing the 
gene sequence for EGFP and an N-terminal His-tag sequence. From this point on 
this protein w ill be referred to as GE. The modified proteins were brought to 
expression in E.coli cells. In order to assemble and purify the EGFP-capsid protein 
complex (GE-CK complex), w e used the N-terminal His-tag sequence o f  GE to 
immobilize it on a nickel-NTA column. The E-coil is attached to the C-terminus o f  
GE, and therefore available for binding to the modified capsid protein, which was 
added in excess to the column containing bound GE (figure 2).
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The modified capsid protein was allowed to bind for at least an hour before 
washing away all non-bound protein and eluting the complex from the column with 
an excess o f  imidazole. To remove the imidazole the complex was immediately 
dialyzed to a pH 7.5 buffer. In principle only the complete GE-CK complex will 
elute from the column, however, small impurities and any GE protein that did not 
bind to a capsid protein could have co-eluted as w ell from the column.
Figure 2 Purification o f the GE-CK complex. Bacterial lysate containing GE is added to a 
nickel-NTA column. Only GE will bind to the nickel-NTA with its N-terminal His-tag. A wash 
step removes all other proteins that lack the His-tag. The lysate containing the capsid protein 
is then added. CK binds to the C-terminal coiled-coil o f GE with its N-terminal coiled-coil. 
After another wash step, the entire complex is eluted from the column, using an excess o f 
imidazole.
The eluate was therefore further purified on a FPLC system equipped with a 
Superdex 200 column, and the identity and purity o f  the proteins was assessed by 
SDS-PAGE analysis and immunoblotting (figure 3).
A 1 2 3 4 5 B a-EGFP a-capsid
250
150
Figure 3 Analysis o f identity and purity o f proteins used for EGFP encapsulation A) SDS- 
PAGE gel, lane 1: elution fraction o f GE-CK complex from Ni-NTA column. Lane 2: protein 
marker, numbers represent molecular weights in kDa. Lane 3: GE-CK complex after 
purification by FPLC. Lane 4: wt CP. Lane 5: elution fraction o f GE from Ni-NTA column.
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B) Immuno blots. Lane 1 and 2: 1.1 mL peak fractions from the FPLC o f capsids with EGFP 
encapsulated at pH  5.0. Lane 3: GE-CK complex at pH  7.5. Lane 4: wt CP. Left blot was 
probed with anti-EGFP antibody, right blot was probed with anti-capsid antibody.
The ratio with which GE is bound to CK could be determined by comparing 
the UV-Vis spectra of pure GE with the spectra o f the GE-CK complex (figure 4).
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Figure 4 UV-Vis spectra o f GE (thick line) and GE-CK complex (thin line) at pH  7.5. Both 
absorption spectra are normalized to an absorbance o f 1.0 at X=280 nm.
Besides the normal protein absorption at X=280 nm, EGFP also has a specific 
absorption at X=490 nm at pH 7.5, which is approximately twice as intense as the 
X=280 nm absorption. However, when GE was bound to CK, which does not absorb 
at X=490 nm, the X=490 nm absorption intensity was about equal to the X=280 nm 
absorption. This suggests that GE and CK are approximately bound in a 1:1 ratio. 
(For a detailed calculation of this ratio see experimental section). Because the 
capsid protein always exists as a dimer, it is probable that a complex of a capsid 
protein dimer bound to two EGFP proteins is formed. This was further confirmed 
by FPLC analysis of the complex. At low concentrations the GE-CK complex 
eluted from the FPLC column at V=1.4 mL, which is the expected elution volume 
for a complex o f this molecular weight (figure 5).
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Figure 5 Calibration curves for the FPLC system. Diamonds represent measured proteins. 
Line represents fitted calibration curve. A) Calibration curve o f FPLC equipped with a 
superose 200 column. B) Calibration curve o f FPLC equipped with a superose 6 column.
In order to encapsulate GE, the GE-CK complex was mixed with wild-type 
capsid protein, isolated from the CCMV virus grown in plants. This was done in 
various ratios, to allow control over the amount of encapsulated GE and to prevent 
overcrowding o f capsid. After a short incubation period this mixture was dialyzed 
to pH 5.0 (figure 6) and analyzed by FPLC (figure 7). The amount o f GE 
encapsulated per capsid can be calculated using the 280 nm/395 nm absorbance 
ratio o f the capsid peak at V=1.1 mL.
Figure 6 Schematic representation o f EGFP encapsulation. The GE-CK complex is mixed 
with wild-type capsid at pH  7.5 and subsequently dialyzed to pH  5.0 to induce capsid 
formation.
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Figure 7 FPLC trace o f a mixture o f GE-CK complex with wild-type capsid at pH  5.0. The 
FPLC system is equipped with a Superose 6 column. The thick line represents the protein 
absorption at 1=280 nm, and the thin line the EGFP specific absorption at 1=395 nm. The 
capsid with encapsulated GE elutes at V=1.1 mL, and the unassembled capsid dimers and 
GE-CK complex elute at ~1.8 mL.
Since GE absorbs at both X=280 and X=395 nm, at pH 5.0, and CK only at 
X=280 nm, the CK/GE ratio was determined from these absorption ratios using the 
respective extinction coefficients (for determination o f  the extinction coefficients 
and calculation o f  the number o f  encapsulated GE molecules see experimental 
section).
ratio EGFP-capsid complex/total protein present
Figure 8 Number o f encapsulated EGFP proteins per capsid as a function o f the GE-CK 
complex to total protein ratio. Diamonds and triangles represent data points o f duplicate 
experiments. Crosses represent negative control experiments in which unbound GE was used 
instead o f the GE-CK complex. The thick line represents the polynomial trend line through 
the data points depicted with a triangular shape; the thin line represents the polynomial 
trend line through the diamond-shaped data points.
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The data show that it is possible to encapsulate up to 15 EGFP proteins per 
capsid (figure 8), and that the amount o f encapsulated EGFP to a certain extent can 
be controlled by varying the ratio between the wt CP and the GE-CK complex. The 
experiments proved to be highly reproducible.
Throughout this chapter the assumption is made that EGFP is located on the 
capsid interior, this is based on the following reasoning; In the crystal structure of 
the CCMV virus, the N-termini o f the capsid proteins are situated on the inside of 
the capsid. Since EGFP is attached to the N-terminus o f the capsid protein, it would 
seem likely that upon assembly o f the capsid, EGFP will be situated on the inside of 
the capsid. This a priori assumption is further supported by TEM micrographs 
(figure 9).
Figure 9 TEM micrographs o f uranyl acetate stained samples. A) CCMV virus. B) Wild-type 
capsids without EGFP. C) Capsids filled with 2 EGFP per capsid D) Capsids filled with 7 
EGFP per capsid. E) Capsids filled with 12 EGFP per capsid. F) Capsids filled with 15 
EGFP per capsid.
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In order to visualize capsids by TEM, a negative staining agent, uranyl acetate 
was used. The protein is not stained and thus will appear lighter than the 
background. In this way, the CCMV virus looks like a white filled circle, whereas 
the empty capsid has a black spot in the center o f the circle. This is caused by the 
accumulation o f uranyl acetate inside the empty cavity of the capsid. TEM pictures 
of capsid filled with different amounts o f EGFP show that the staining o f the capsid 
interior decreases as the amount o f encapsulated EGFP increases. This indicates 
that the capsid is no longer empty, and thus that the EGFP is encapsulated on the 
inside o f the capsid.
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Figure 10 DLS plot o f capsids with and without EGFP. Black line: CCMV, Blue line: 
capsids filled with 2 EGFP per capsid (negative control, statistical encapsulation o f GE). 
Purple line: capsids filled with 12 EGFP per capsid. Green line: capsids filled with 13 
EGFP per capsid. Red line: capsids filled with 14 GE per capsid.
Furthermore, DLS data showed that the particle size did not increase when 
EGFP proteins were encapsulated (figure 10). If  the proteins would be attached to 
the outside o f the capsid instead o f the inside, an increase in capsid size would be 
expected. Finally, anti-EGFP antibodies did not appear to bind to the capsids with 
encapsulated GE. This indicates that no EGFP is present on the outside of the 
capsids. Experimentally this was tested by incubating both empty capsids and 
capsids loaded with 7 EGFP per capsid with anti-EGFP antibody labeled with 
rhodamine. These mixtures were analyzed by FPLC equipped with a Superose 6 
column and compared with samples to which no anti-EGFP was added. This 
experiment showed that the anti-EGFP specific absorption from the rhodamine at 
X=516 was the same for all samples, indicating that no antibody was bound to the 
EGFP filled capsids (figure 11).
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elution volume/mL elution volume/mL
elution volume/mL elution volume/mL
elution volume/mL elution volume/mL
elution volume/mL elution volume/mL
Figure 11 FPLC graphs o f empty capsid and capsid with encapsulated GE, with and without 
anti-EGFP antibodies. Thick black lines represent protein absorption at 1=280 nm, thin 
black lines represent EGFP specific absorption at A=395 nm and thick grey lines represent 
the absorption o f the rhodamine labeled anti-EGFP antibody at 1=516 nm. All graphs have 
been normalized to an absorbance o f 1.0 at the capsid peak (1.1 mL) at 1=280 nm. Graphs 
E-H are enlargements o f graphs A-D, for clarity the 1=280 nm absorption is not depicted in 
graphs E-H. The capsids elute at 1.1 mL, the unbound anti-EGFP antibody elutes at 1.8 mL. 
Graph A and E show FPLC traces o f the empty capsid. Graphs B and F  show FPLC traces o f 
capsid with encapsulated EGFP. Graphs C and G show FPLC traces o f empty capsids 
incubated with anti-EGFP antibody. Graphs D and H  show FPLC traces o f capsid with 
encapsulated EGFP incubated with anti-EGFP antibody.
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To check if the antibodies were able to bind to GE in buffer pH 5.0, it was 
also tried to incubate GE with the antibodies and analyze the sample by FPLC. 
Unfortunately, it appeared very difficult to get a good separation between the 
unbound GE proteins and the GE-antibody complex with the help o f FPLC, even 
when using a Superdex 200 column instead o f the Superose 6 column. This was 
largely due to the fact that the GE proteins seemed to dimerize at very low 
concentrations at pH 5.0, thus making the difference in size between unbound GE 
and anti-EGFP antibody too small to result in well separated peaks on FPLC. 
Therefore, the binding of the anti-EGFP antibodies to the GE proteins was tested by 
immunoblotting. In order to mimic the conditions used for the GE filled capsids, the 
immunoblotting experiment was performed at pH 5.0 (for exact procedure see the 
experimental section). This revealed that the antibody was indeed able to bind to 
GE at pH 5.0 (figure 12). The above experiments all indicate that GE is situated on 
the inside o f the capsids and not on the outside.
GE wt CP
Figure 12 Immunoblot experiment o f GE and wild-type capsid protein probed with anti- 
EGFP antibody in buffer pH  5.0. Circles indicate the positions o f the spots.
Conclusion
From the data presented in this chapter we may conclude that it is possible to bind 
proteins inside the CCMV capsid in an efficient and controlled fashion, opening the 
way to the encapsulation of different types o f enzymes in one capsid. Our study 
furthermore shows that viral capsid assembly is a powerful tool for the controlled 
formation o f bio- nano-structures with diverse functions.
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Experimental section 
Methods and materials
Protein concentrations were determined using a Cary 50 Conc (Varian, Middelburg) UV-VIS 
spectrophotometer using a quartz cuvet with a path length of 3 mm.
FPLC measurements were performed using either a Superose 6 PC 3.2/30 analytical column 
or a Superdex 200 PC 3.2/30 analytical column from GE lifesciences, on an Amersham Ettan 
LC system, fitted with a fractionating device. Buffers for FPLC were filtered with a 
Millipore 0.2 ^M filter before use. TEM grids (Formvar-Carbon) were exposed to an electron 
discharge treatment using a Cressington Carbon coater and power unit. The sample was 
applied to the grids by adding a 5 ^L drop of sample solution (~ 0.2 mg/mL) to the grid and 
carefully removing it after 1 min. immersion using a filter paper. The grid was allowed to dry 
for at least 15 min. before applying 5 ^L of a 2% (w/v) uranyl acetate aqueous solution, 
which was removed after 15 s. The grid was again allowed to dry for at least 15 min.. 
Samples were studied on a JEOL JEM-1010 TEM (Jeol, Japan).
DLS measurements were performed on a Zetasizer Nano S (Malvern Instruments Ltd, 
England), Samples were first purified by FPLC and subsequently measured.
Restriction enzymes and Antartic Phosphatase were obtained from New England Biolabs. 
DNA containing the coiled-coil sequences was obtained from Biolegio (Nijmegen, The 
Netherlands).
Two buffers were used, a buffer pH 7.5 (0.5 M NaCl, 0.05 M Tris-HCl, 0.01 M MgCl2 and 
0.001 M EDTA) and buffer pH 5.0 (0.5 M NaCl, 0.05 M NaCH3COO, 0.01 M MgCl2 and
0.001 M EDTA), the pH of the buffers was set with HCl.
Creation of a heterologous expression system for the capsid protein in E. coli cells
CCMV virus particles were purified from cowpea plants and RNA was extracted15. An 
amount of 3 ^g of RNA was used in a reverse transcriptase reaction using the primer 
AG TAGGATCCCTAATACACCGGAGTGAAG (BamHI restriction site underlined, 
complementary part italic). The primer is complementary to the cDNA encoding the C- 
terminus of CP. The obtained cDNA was directly used in a PCR reaction, using the primer 
described above and a primer complementary to the cDNA encoding the N-terminus of CP: 
AG TACATATGATGTCTACAGTCGGAACAGGG (NdeI restriction site underlined, 
complementary part italic). A 581 bp fragment was obtained, which was digested with NdeI 
and BamHI before it was ligated into a pET-15b E. coli expression vector digested with the 
same restriction enzymes. The obtained plasmid was transformed to E. coli and its sequence 
was confirmed by sequence analysis.
Capsid protein with K-coil construction in vector pET-15b
The insert containing the K-coil DNA sequence was designed to have a 5’ NcoI and a 3’ 
NdeI restriction site overhang after annealing of the strands (table 1). The pET-15b vector
102
Chapter 6
containing the capsid protein sequence was digested sequentially with NcoI and NdeI, 
dephosphorylated with Antartic Phosphatase, and purified by agarose gel elecrophoresis. The 
vector was mixed with the annealed insert and ligated with T4 DNA ligase. The resulting 
plasmids were transformed into E. coli XL 1-Blue cells, the DNA was extracted and the 
sequence of the capsid protein with K-coil was confirmed by DNA sequencing. The plasmids 
were then transformed into E. coli BL21(DE3)pLysS cells, which were used for production 
of CK.
GE construction in vector pET-15b
The insert containing the E-coil DNA sequence was designed to have a 5’ BsrGI and a 3’ 
BamHI restriction site overhang after annealing of the strands (table 1).
The pET-15b vector containing the EGFP protein sequence was digested sequentially with 
BsrGI and BamHI, dephosphorylated with Antartic Phosphatase, and purified by agarose gel 
elecrophoresis. The vector was mixed with the annealed insert and ligated with T4 DNA 
ligase.
The resulting plasmids were transformed into E. coli XL1-Blue cells, the DNA was extracted 
and the sequence of the EGFP with E-coil was confirmed by DNA sequencing. The plasmids 
were then transformed into E. coli BLR (DE3 pLysS) cells, which were used for production 
of GE.
Expression of CK
One colony of BL21(DE3)pLysS cells expressing CK was used to inoculate 100 mL of LB 
medium containing ampicilin (0.050 g/L) and chloramphenicol (0.025 g/L). After growth 
overnight at 30°C this culture was used to inoculate 900 mL of LB medium containing 
ampicilin (0.05 g/L) and chloramphenicol (0.025 g/L) and grown at 30°C. Protein expression 
was induced during logarithmic growth (OD600 =0.4-0.6) by addition of IPTG to a final 
concentration of 1 mmol/L.
Expression of GE
One colony of BLR (DE3) pLysS cells expressing GE was used to inoculate 60 mL of LB 
medium containing ampicilin (0.05 g/L) and tetracycline (0.0125 g/L). After growth 
overnight at 30°C this culture was used to inoculate 540 mL of LB medium containing 
ampicilin (0.05 g/L) and tetracycline (0.0125 g/L) and grown at 30°C. Protein expression 
was induced during logarithmic growth (OD600 =0.4-0.6) by addition of IPTG to a final 
concentration of 1 mmol/L.
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Table 1 DNA and amino acid sequences. DNA sequences fo r  the inserts used fo r  the creation 
o f the CK and GE proteins. Overhangs are complementary with the overhangs in the vector 
sequences, created with restriction enzymes. Amino acid sequences fo r  wt CP, CK and GE 
protein. K-coil and E-coil amino acid sequences are printed in bold lettering.
First line: K-coil forward (5’^ 3 ’). second line: K-coil reverse (3’^ 5 ’)
CATGAAGATCGCCGCCCTGAAGGAGAAGATCGCCGCCCTGAAGGAGAAGATCGCCGCCCTGAAGGAGGG
TTCTAGCGGCGGGACTTCCTCTTCTAGCGGCGGGACTTCCTCTTCTAGCGGCGGGACTTCCTCCCAT
First line: E-coil forward (5 ’^ 3 ’). second line: E-coil reverse (3 ’^ 5 ’)
GTACACGCTAGCTGAAATTGCTGCTCTTGAAAAAGAAATTGCTGCTCTTGAAAAAGAAATTGCTGCTCTTGAAAAATAAGC
TGCGATCGACTTTAACGACGAGAACTTTTTCTTTAACGACGAGAACTTTTTCTTTAACGACGAGAACTTTTTATTCGCTAG
Wt CP amino acid sequence
MSTVGTGKLTRAQRRAAARKNKRNTRVVQPVIVEPIASGQGKAIKAWTGYSVSKWTASCAAAEAKVTSAITISLPNELSSERNKQ
LKVGRVLLWLGLLPSVSGTVKSCVTETQTTAAASFQVALAVADNSKDVVAAMYPEAFKGITLEQLAADLTIYLYSSAALTEGDVI
VHLEVEHVRPTFDDSFTPVY
CK amino acid sequence
MKIAALKEKIAALKEKIAALKEGMMSTVGTGKLTRAQRRAAARKNKRNTRVVQPVIVEPIASGQGKAIKAWTGYSVSKWTASCAA
AEAKVTSAITISLPNELSSERNKQLKVGRVLLWLGLLPSVSGTVKSCVTETQTTAAASFQVALAVADNSKDVVAAMYPEAFKGIT
LEQLTADLTIYLYSSAALTEGDVIVHLEVEHVRPTFDDSFTPVY
GE amino acid sequence
MGSSHHHHHHSSGLVPRGSHMLEKREAEAGRLGAGGPVATMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTL
KFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGID
FKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEK
RDHMVLLEFVTAAGITLGMDELYTLAEIAALEKEIAALEKEIAALEK
Purification of GE and CK
E. coli cells containing the GE proteins, and E. coli cells containing the CK protein, were 
separately harvested after 5 h of expression by centrifugation at 4000 g for 15 min. at 4°C. 
The supernatant was discarded and the pelletted cells were stored at -20°C. After thawing, 
the pelletted cells were resuspended in approximately 10 mL lysis buffer (50 mM NaH2PO4, 
10 mM imidazole and 300 mM NaCl pH 8.0 for GE, and 50 mM NaH2PO4, 10 mM 
imidazole and 1500 mM NaCl pH 8.0 for CK). Approximately 10 mg of lysozyme (EC 
3.2.1.17 from Fluka) was added and the solutions were incubated at 4°C for 30 min.. The 
solutions were sonicated for 5 times 10 s with duty cycle 40 and output control 6 (Branson 
Sonifier 250, marius instruments Nieuwegein, the Netherlands). RNase (10 ^g/mL) and 
DNase (5 ^g/mL) were added only to the solution containing CK and the mixture was 
incubated at 4°C for 15 min. The solutions were centrifuged at 10,000 rpm for 20-30 min. to 
pellet the cellular debris. The supernatant of the GE containing cells were incubated with 1 
mL of Ni-NTA agarose beads for 1 h at 4°C. The flow-through was collected and the column
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was washed with 20 mL of wash buffer (50 mM NaH2PO4, 12.5 mM imidazole and 300 mM 
NaCl pH 8.0). The supernatant of the CK containing cells was then added to the Ni-NTA 
beads containing the bound GE protein and incubated for 1 h at 4°C, to allow binding of the 
E- and K-coil of the GE and CK proteins respectively. The flow-through was again collected 
and the column was washed with 20 mL of wash buffer (50 mM NaH2PO4, 12.5 mM 
imidazole and 1500 mM NaCl pH 8.0). The GE-CK complex was then eluted from the 
column using approximately 10 mL of elution buffer (50 mM NaH2PO4, 250 mM imidazole 
and 1500 mM NaCl pH 8.0) and the protein complex was collected. The protein complex 
was dialyzed overnight to buffer pH 7.5, to remove the excess of imidazole. The protein 
purity was checked with SDS-PAGE analysis (figure 3)
Production and purification of wt CP
The purification of the CCMV virus and the removal of its RNA were carried out according 
to literature procedures16,17.
FPLC purification of GE-CK complex
The GE-CK complex was further purified by FPLC equipped with a Superdex 200 column to 
remove any non-complexed GE, CK or other proteins. Pure GE eluted at V=1.6 mL as 
detected at X=280 and 490 nm, whereas the CK-GE complex eluted at V=1.2-1.4 mL 
depending on the concentration of the complex.
EGFP encapsulation experiments
CK-GE complex in buffer pH 7.5 (50 mM Tris-HCl, 500 mM NaCl, 10 mM MgCl2, 1 mM 
EDTA pH 7.5) was added in different ratios to wild type capsid protein in the same buffer 
(table 2). The proteins were allowed to mix for 5 min., before dialyzing the mixture overnight 
to buffer pH 5.0. The mixtures were then analyzed on an FPLC system equipped with a 
Superose 6 column (figure 6). Peak fractions from the FPLC of the capsid with EGFP 
encapsulated were analyzed by immuno blotting (figure 3), showing intact EGFP-with E-coil, 
as well as wt CP and capsid protein with K-coil. Anti-capsid antibody was kindly donated by 
BJM Verduin, Wageningen University.
Calibration curves of FPLC columns
Calibration curves were made for the superdex 200 and superose 6 column using a protein 
based low molecular weight and high molecular weight gel filtration calibration kit from 
Amersham biosciences.
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Table 2 Data o f  the encapsulation experiments
Exp. M wt CP in M GE-CK aRatio Number of
# samples complex in [GE-CK EGFP
samples complex]/
[total
protein]
proteins 
encapsulated 
per capsid
1 7.71 x10'5 2.50x10-6 0.03 2.0
7.39x10-5 4.99x10-6 0.06 2.4
6.83x10-5 9.36x10-6 0.12 11.8
6.02x10-5 1.56x10-5 0.21 14.8
4.02x10-5 3.12x10-5 0.44 12.5
2 .0 1x10-5 4.68x10-5 0.70 7.3
8.03x10-6 5.62x10-5 0.87 1.1
0 6.24 x10'5 1.00 0.0
2 7.84x10-5 2.52x10-6 0.03 5.6
6.86x10-5 1 .0 1x10'5 0.13 10.3
6.37x10-5 1 .39x1 0-5 0.18 12.3
5.47x10-5 2.08x10-5 0.28 13.7
4.25x10-5 3.03x10-5 0.42 14.4
2.45x10-5 4.41x10-5 0.64 7.7
a Ratio was calculated by dividing molarity o f  the GE-CK complex by the molarity o f  the GE­
CK complex+M wt CP
Determination of EGFP extinction coefficients
EGFP was expressed and purified using the same procedure as for the GE protein, but 
without the addition of CK protein to the bound EGFP. The obtained EGFP was 
subsequently purified using an FPLC system equipped with a Superdex 200 column. The 
pure EGFP was concentrated in a 0.5 M NaCl solution and diluted to six different dilutions in 
a 0.5 M NaCl solution. These stock solutions were then diluted ten times with either buffer 
pH 7.5 or buffer pH 5.0. From each different combination three samples were made. Each 
sample was then measured twice with the help of a UV-Vis spectrophotometer. The 
absorption values (X=280 and 490 nm in buffer pH 7.5 and 280 and 395 nm in buffer pH 5.0) 
of the duplicate measurement were averaged. A calibration curve could be determined from 
the resulting graph (figure 13). Using the calibration curve several extinction coefficients of 
EGFP were calculated, using the extinction coefficient value of 5500018 at X=490 nm at pH
7.5 as a reference value (table 3).
106
Chapter 6
1.5 n 1.0
0.0 -I-------------------,-------------------,-------------------,-------------------,-------------------1 0.0 -I----------------- ,------------------1------------------1------------------,----------------- ,
0 20 40 60 80 100 0 20 40 60 80 100
concentration / concentration / |iM
Figure 13 Calibration curves for the determination o f the extinction coefficients o f EGFP in 
buffer pH  7.5 and buffer pH  5.0. A) Calibration curve o f EGFP in buffer pH  7.5, open 
squares represent absorption o f the EGFP samples measured at 1=490 nm, filled diamonds 
represent absorption o f the EGFP samples measured at 1=280 nm. B) Calibration curve o f 
EGFP in buffer pH  5.0, open triangles represent absorption o f the EGFP samples measured 
at 1=395 nm, filled diamonds represent absorption o f the EGFP samples measured at 1=280 
nm.
Table S3 Extinction coefficients o f EGFP at different pH  and wavelengths, determined using 
the calibration curves o f figure 13.
Buffer pH 5.0 pH 7.5
280 nm 26348 31807
395 nm 28506
490 nm 55000[a]
[aa literature value[7
Detection of GE using anti-EGFP antibodies
A sample containing capsids loaded with 7 EGFP proteins, was divided into two identical 
samples. To one of these samples anti-EGFP antibody conjugated with rhodamine (Santa 
Cruz biotechnology) dissolved in buffer pH 5.0 was added in an approximate 1:1 molar ratio 
with the encapsulated GE proteins, and to the other sample the same volume of buffer was 
added. The antibodies were allowed to bind for 1 h at room temperature, before analysis on 
an FPLC system equipped with a Superose 6 column. The same was done for sample 
containing empty capsid.
To test the binding of the anti-EGFP antibody to GE in buffer pH 5.0 a small drop of GE and 
empty capsid (as a negative control) in pH 5.0 buffer was added to a nitrocellulose membrane.
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minutes. The solution was removed and anti-EGFP antibody in 1% (w/v) non-fat dry milk in 
buffer pH 5.0 was added to the membrane and allowed to bind for 1 h. Non-bound antibody 
was then washed away with buffer pH 5.0 and a secondary antibody (Rabbit anti-mouse 
HRP) in 1% (w/v) non-fat dry milk in TBST (0.01 M Tris-HCl, 0.15 M NaCl, 0.05% Tween- 
20, pH 8.0) was allowed to bind overnight at 4°C. Non-bound secondary antibody was 
washed away with TBST and the membrane was incubated with an enhanced 
chemiluminescence (ECLTM) solution (GE healthcare life sciences) for 2 min. and 
subsequently exposed to film (Kodak medical X-ray film) for two min. before development.
Calculation of GE:CK ratio in GE-CK complex
The capsid protein has a peak absorption at X=280 nm, and at pH 7.5 EGFP has two peak 
absorptions, a standard protein absorption at X=280 nm and an EGFP specific absorption at 
X=490 nm. The ratio of the absorbance at X=280 nm and X=490 nm of the GE-CK complex at 
pH 7.5 was determined by UV-Vis spectrophotometry (figure 4) and was found to be 1.07. 
According to the law of Lambert-Beer, absorption (A) is equal to the extinction coefficient 
(s) times the concentration (c) times the path length of the cuvet (d). Since the path length is 
the same in all cases, we can omit this parameter from the equation, and substitute the 
absorption by the extinction coefficient times the concentration (the extinction coefficients of 
EGFP has been previously calculated, and the extinction coefficient of CK was assumed to 
be the same as that of the wild-type capsid. i.e. s =24075). After rearrangement of the 
resulting formula, this results in a ratio of GE:CK of 0.89. Hence, approximately 0.9 GE 
proteins are bound to 1 capsid protein monomer.
,4280 _  A280CK + A280GE
A 4 9 0  A 4 9 0 ge
A  _  s c
A280 _  s2 8 0 CKcCK + s2 8 0 GEcGE
4490  s4 9 0 GE CGE
A4^0 S490GE CGE _  s 2 8 0 CK CCK +  s 2 8 0 GE CGE
A280 s 2 8 0 CKc CK 
--------s4 9 0 GE _ --------C^ - C^  + s2 8 0 GE
A490 GE c GE GE
s2 8 0 CK CGE
s4 9 0 GE -  s2 8 0 GE Cc A490 GE GE
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Calculation of the GE-CK complex concentration
The GE-CK complex concentration was determined by UV-Vis spectrophotometry. The 
extinction coefficient of the complex was assumed to be the extinction coefficient of CK plus 
the extinction coefficient of GE times the ratio of GE:CK (sCK+ sGE*0.9).
Calculations of EGFP encapsulation
The number of EGFP proteins in a capsid can be calculated similarly to the number of GE 
molecules bound per capsid protein, by using the absorption ratios of the capsid peak (V=1.1 
mL) from the FPLC data.
The capsid protein has a peak absorption at X=280 nm, and at pH 5.0 EGFP has two peak 
absorptions, a standard protein absorption at X=280 nm and an EGFP specific absorption at 
X=395 nm. Therefore, the ratios of these absorptions can be used to determine the ratio of 
CK: GE in a mixture. The GE-CK complex was purified by FPLC, and the filled capsid 
eluted at V=1.1 mL. The ratios of the areas under the peak at V=1.1 mL for X=280 nm and 
X=395 nm were determined. All proteins, wt CP, CK and GE, contribute to the absorption at 
X=280 nm, but only GE contributes to the absorption at X=395 nm. Hence, after substituting 
the absorption with the extinction coefficient times the concentration, and rearranging the 
formula, this results in the ratio of the concentration of all capsid proteins to EGFP proteins. 
Since there are 180 capsid proteins per capsid, the number of EGFP molecules per capsid can 
easily be derived from this ratio.
A280 _ A280cp+ck + A280ge 
A395 _ A395ge 
A  _ sc
A280 _ s280CP+CKCCP+CK + s 280ge CGE 
A395 S395GE CGE
A280
------- s395 c _ s280 c + s280 cA395 ^ ge'-ge ^^^CP+CK^CP+CK ^  “^ W gE^ GE 
â ™ .  s395 _ s 280CP+CKcCP+CK + s280GE
A395 ge cGE GE
A280
------- s395GE - s 2 8 0 GE
A395 ge g^  ccp+ck
s 280Cp+ck cGE
number of EGFP proteins per capsid _ C<cp+ck /¡80
cGE
The number of EGFP proteins encapsulated per capsid however does not indicate which 
percentage of the added EGFP is encapsulated into the capsids. To calculate this, the amount 
of EGFP proteins per capsid is divided by the maximum number of EGFP proteins per capsid 
(ie. the number of EGFP proteins that could theoretically have been encapsulated if all EGFP
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proteins would have been incorporated into a capsid, and all capsid proteins would have 
formed a capsid). When plotted against the EGFP-capsid complex to total protein ratio (i.e. 
the percentage of EGFP added to the sample), the resulting graph shows an exponential 
decay in the percentage of EGFP which is incorporated into the capsids (figure 14).
Figure 14 Graph o f the percentage o f EGFP proteins encapsulated as a function o f the GE­
CK complex to total protein ratio. Diamonds and triangles represent data points o f duplicate 
experiments. The line represents the exponential trend line though the data points.
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Chapter 7
Complex assembly behavior during the encapsulation o f  
enhanced green fluorescent protein in the cowpea 
chlorotic mottle virus capsid*
Introduction
In the previous chapter we have presented a method for the efficient and controlled 
encapsulation of EGFP proteins into the CCMV virus capsid.1 In short, this was 
accomplished via the non-covalent attachment of EGFP to the capsid proteins via a 
short heterodimeric coiled-coil sequence. EGFP was provided with the E-coil (GE) 
via molecular biology techniques, and the capsid protein was likewise provided 
with the K-coil (CK). Mixing of the two proteins resulted in an EGFP-capsid 
protein complex (GE-CK complex). In order to encapsulate the EGFP, this complex 
was mixed with wt CP in various ratios, to allow control over the amount of 
encapsulated EGFP and to prevent overcrowding of the capsid, which forms upon 
lowering the pH.
The formed capsids contained different amounts of EGFP depending on the 
initial [GE-CK complex]/[total protein] ratio. When this ratio increases the number 
of encapsulated EGFP proteins per capsid first increases and then decreases again. 
Clearly, there must be a maximum to the number of proteins that can be 
encapsulated, due to limited space inside the capsid. But there does not seem to be 
an obvious reason why the number of encapsulated EGFP proteins per capsid 
should decrease with increasing amounts of EGFP present. In this chapter we 
provide an explanation of this seeming discrepancy between theory and practice.
* This work was published: MacromolBiosci, 2010, 10, 539
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Results and Discussion
Capsids containing multiple encapsulated EGFP molecules per capsid were 
analyzed by FPLC (figure 7, chapter 6) EGFP has a specific absorption at X=395 
nm at pH 5.0. By monitoring both this EGFP specific absorption and the protein 
absorption at X=280 nm during the run, EGFP can be distinguished from the capsid 
protein. Formed capsids typically elute at V=1.1 mL and since the EGFP specific 
absorption is present at V=1.1 mL, this indicates that EGFP is encapsulated. Free 
proteins like EGFP, and the capsid dimers elute between V=1.6-1.9 mL. A careful 
look at the FPLC graphs of the encapsulation experiments, shows that the peak 
around V = 1.6 -  1.9 shifts to lower elution volumes with increasing [GE-CK 
complex]/[total protein] ratios, which is indicative of the formation of a larger 
complex (figure 1 ).
It is hypothesized that this unknown complex (UC) consists of several GE-CK 
components. If this is true, the GE-CK contained in this UC would presumably be 
unavailable for incorporation into the capsid structure. This might explain the 
decrease in EGFP encapsulation efficiency with increasing [GE-CK complex]/[total 
protein] ratios.
To investigate this hypothesis, we first examined whether the UC was solely 
composed of the GE-CK complex, or o f the GE-CK complex and the w t CP. This 
was done by labeling wt CP with a fluorescent dye (DyLight™ 649) and repeating 
an encapsulation experiment with a [GE-CK complex]/[total protein] ratio that was 
known to cause the formation of the UC. The sample was analyzed by FPLC 
equipped with a Superose 6 column, and the resulting graph again showed a peak 
associated with the UC at V=1.65 mL, but the labeled wt CP eluted at V=1.73 mL 
(Figure 2). Hence, the UC seems to be composed of the GE-CK complex.
In the encapsulation experiments, the concentration of GE-CK complex was 
increased, while keeping the total concentration of capsid proteins (wt CP and CK) 
approximately at an equal level, to obtain increasing [GE-CK complex]/[total 
protein] ratios. As a result the effect of the concentration of the GE-CK complex on 
the UC formation is studied. During the GE-CK complex purification on FPLC it 
was already observed that at pH 7.5 the UC was formed, so the GE-CK complex 
was studied in more detail at this pH using a Superdex 200 FPLC column. This 
column is better suited for the mass range of the complex and the UC than the 
Superose 6 column used for the encapsulation experiments.
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Figure 1 Part o f the FPLC graphs o f the various encapsulation experiments. The FPLC was 
equipped with a superose 6 column. Thick lines represent the protein absorption at X=280 
nm and thin lines the EGFP absorption at A=395 nm. A) Graphs o f the encapsulation 
experiments with increasing amounts o f GE-CK complex. [GE-CK complex]/[total protein] 
ratios increase in the following order from top to bottom: 0.03, 0.14, 0.29, 0.43 and 0.66. B) 
Graphs from encapsulation experiments in which uncomplexed GE was used. [GE]/[total 
protein] ratios increase in the following order from top to bottom: 0.03, 0.12, 0.20, 0.43 and 
0.69.
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elution volume/mL
Figure 2 FPLC graph o f GE-CK complex mixed with labeled wt CP in a [GE-CK 
complex]/[total protein] ratio o f 0.7 and dialyzed to pH  5.0. The FPLC was equipped with a 
Superose 6 column. The thick black line represents protein absorption at X=280 nm, the thin 
black line represents EGFP absorption at X=395 nm, and the grey line represents labeled wt 
CP absorption at X=647nm.
The complexes were studied at several concentrations spanning the range of 
the concentrations used for the encapsulation experiments. The elution volumes 
increased with increasing GE-CK complex concentrations, this is indicative of the 
formation of a larger complex, presumably the UC. In order to estimate the 
molecular weights corresponding to the elution volumes of these complexes, a 
calibration curve was made for this column (see chapter 6).
This calibration curve was then used to calculate the molecular weights of the 
formed complexes. The resulting graph o f GE-CK complex concentration versus 
molecular weight (figure 3), shows a gradual increase in molecular weight with 
increasing GE-CK concentrations. Since the proteins of which the complex consists, 
have a discrete mass, a gradual increase can best be explained by a shifting 
equilibrium between two, or more distinct forms of the GE-CK complex. According 
to the calibration curve, the molecular weights corresponding to the smallest elution 
volume, V=1.3 mL and the largest elution volume, V=1.4 mL are 239 kDa and 127 
kDa, respectively. The theoretical molecular weight for the GE-CK complex is 113 
kDa, which corresponds to the V=1.4 mL peak. The molecular weight 
corresponding to the 1.3 mL peak (239 kDa) could correspond to two times the 
molecular weight of the GE-CK complex i.e. 226 kDa. Thus, the two distinct forms
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that are in equilibrium could be the GE-CK complex and a complex o f twice that 
molecular weight. Since the graph o f GE-CK complex concentration versus MW 
does not level off completely at the highest concentration used for EGFP 
encapsulation, it is possible that at higher concentrations even bigger complexes are 
formed. This was not studied in further detail.
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Figure 3 Graph o f GE-CK complex concentration versus the molecular weight o f the 
resulting complex. Closed squares represent data points. The elution volumes corresponding 
to the calculated molecular weights o f the data points are: 1.40 mL for 127 kDa, 1.35 mL for  
169 kDa, 1.34 mL for 179 kDa, 1.30 mL for 225 kDa and 1.29 mL for 239 kDa.
Since the capsid formation is induced by lowering the pH from 7.5 to 5.0, it 
was also investigated whether the same effect would be seen at pH 5.0. This indeed 
seemed to be the case. At low concentrations o f the GE-CK complex (6.3 ^M), the 
complex had an elution volume of V=1.4 mL, which corresponds to the molecular 
weight of the GE-CK complex. At high concentrations (37.9 ^M), the elution 
volume had shifted to V=1.3 mL, corresponding to the molecular weight o f two 
times the GE-CK complex.
To determine whether the elution volume o f the UC on a Superose 6 FPLC 
column (V~1.6 mL) also corresponded to twice the molecular weight o f the GE-CK 
complex, a calibration curve was also made for the Superose 6 column (see figure 
5b, chapter 6). This indicated that the elution volumes o f the GE-CK complex and 
that o f a complex o f twice that weight should have an elution volume o f V=1.73 mL
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and V=1.64 mL, respectively. This in turn suggests that the peak o f the UC at 
V=1.6 mL on the Superose 6 column indeed originates from a complex that has 
twice the weight o f the GE-CK complex.
Since it seems that the UC is twice the molecular weight o f the GE-CK 
complex, the UC might be a dimeric form of the GE-CK complex. A possible 
explanation is that the EGFP proteins o f the two GE-CK complexes dimerize. The 
crystal structure of GFP shows two GFP molecules dimerized in an antiparallel 
fashion,2,3 and EGFP also has a weak tendency to dimerize.4 GE also seems to have 
a tendency to dimerize at high concentrations, as was suggested by FPLC data, 
measured on an FPLC equipped with a Superdex 200 column. At low 
concentrations (16 ^M) GE had an elution volume o f V=1.64 mL on this column, 
which corresponds to a molecular weight o f 32 kDa. The theoretical molecular 
weight for monomeric GE is 33 kDa. High concentrations o f GE (390 ^M) however, 
resulted in an elution volume of V=1.51 mL, which corresponds to a molecular 
weight of 68 kDa. This is about twice the mass of the monomeric GE, thus 
indicating dimerization o f GE proteins and making it conceivable that this 
phenomenon is the cause of the apparent dimerization o f the GE-CK complex. The 
GE proteins bound to the capsid protein are positioned parallel with respect to each 
other (figure 4), whereas the GFP dimers in the crystal structure are dimerized in an 
antiparallel fashion. It is possible that this parallel orientation prevents the internal 
dimerization of the GE proteins in the GE-CK complex. GE proteins of two 
different GE-CK complexes, however, might be able to align in an antiparallel 
fashion in that way enabling the formation o f a dimeric complex. Hence, it is 
possible that the UC is a dimeric form of the GE-CK complex.
Figure 4 Schematic representation o f the structure o f the CK-GE complex and the possible 
structure o f the CK-GE complex dimer.
\
I
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Besides the concentration o f the GE-CK complex, other factors might also 
have an influence on the formation o f the dimeric GE-CK complex. Since in the 
encapsulation experiments not only the concentration of the GE-CK complex is 
changed, but also the [GE-CK complex]/[total protein] ratio, the effect o f this ratio 
was also investigated. The proteins were mixed in a ratio that was known to cause 
the formation of the dimeric GE-CK complex, i.e. a ratio o f 0.7 (figure 1), and 
dialyzed to buffer pH 5.0. This mixture was measured on an FPLC equipped with a 
Superose 6 column, and as expected, the majority o f the GE-CK complex was in the 
dimerized form (figure 5a). A very concentrated solution o f the wt CP at pH 7.5 
was then added to the mixture, thereby shifting the ratio from 0.7 to 0.4. Due to the 
small volume of the wt CP solution this did not significantly affect the pH, or the 
total concentration o f GE-CK complex in the sample. The mixture was equilibrated 
for one night and was then again measured using FPLC. The resulting FPLC graph 
(figure 5b) showed a decrease in the amount o f the dimeric GE-CK complex formed, 
and also an increase in the number o f encapsulated EGFP proteins per capsid. This 
experiment shows that the [GE-CK complex]/[total protein] ratio also affects the 
formation o f the dimeric GE-CK complex, and that it is a dynamic equilibrium.
elution volume/ mL elution volume/ ml_
Figure 5 FPLC graphs o f experiments to investigate the effect o f the [GE-CK 
complex]/[total protein] ratio on the ability o f the complex to form capsids. The FPLC 
system was equipped with a Superose 6 column and the samples were measured at pH  5.0. 
Thick lines represent protein absorption at X=280 nm and thin lines represent EGFP 
absorption at X=395 nm. A) [GE-CK complex]/[total protein] ratio o f the sample is 0.7. B) 
[GE-CK complex]/[total protein] ratio o f the sample was changed from 0.7 to 0.4
Since it appears that both the concentration of the GE-CK complex and the 
[GE-CK complex]/[total protein] ratio have an effect on the formation of the 
dimeric GE-CK complex, and both these variables were changed in the
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encapsulation experiments, new encapsulation experiments were performed, in 
which the concentration o f the GE-CK complex was kept constant (experiment #3 
and #4, see experimental section). That is, only the [GE-CK complex]/[total 
protein] ratio was varied. This resulted in a more or less constant encapsulation of 
about 9 EGFP proteins per capsid (figure 6).
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Figure 6 Number o f EGFP proteins encapsulated per capsid as function o f the GE-CK 
complex/ total protein ratio. To obtain different ratios only the concentration o f the wt CP 
was varied, the concentration o f GE-CK was kept constant. Open squares depict data points 
o f experiment #3 and open circles depict data points o f experiment #4. Experiment #3 and #4 
are duplicate experiments (see experimental section).
The form of this graph is significantly different from that o f the previous 
encapsulation experiments, in which the concentration of capsid proteins (wt CP 
and CK) instead of the concentration of the GE-CK complex was kept constant. 
This indicates that not only [GE-CK complex]/[total protein] ratio is o f importance 
for the encapsulation efficiency of EGFP into the capsids, but that the absolute 
concentrations of the individual proteins are also critical.
It is likely that the dimeric GE-CK complex can not be incorporated into the 
capsid. This would explain the decrease in encapsulation efficiency with increasing 
[GE-CK complex]/[total protein] ratios. However, this does not appear to be the 
only cause, since the FPLC peaks around 1.7 mL that are probably caused by the 
dimeric GE-CK complex are also observed when negative control encapsulation 
experiments are performed in which only GE is added to the wt CP instead of the 
GE-CK complex. The peaks around V = 1.6 -  1.9 mL of the resulting FPLC graphs 
(figure 1b) showed a remarkable similarity to the peaks around V = 1.6 -  1.9 mL of
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the normal encapsulation experiments (figure 1a). So these peaks could also be 
caused by the GE proteins without CK. To check if  this was also the case for the 
normal encapsulation experiments with the GE-CK complex, FPLC fractions of 
both the capsid peak at V=1.1 mL and the peaks around V = 1.6 -  1.9 mL were 
analyzed by SDS-PAGE analysis and visualized by silver staining (figure 7).
Figure 7 Silver stained SDS-PAGE gel o f EGFP encapsulation experiments with increasing 
amounts o f GE-CK complex to increase the [GE-CK complex]/[total protein] ratio. Numbers 
above the lanes indicate this ratio. FPLC was equipped with a superose 6 column.
This showed that the GE and CK proteins were not present in a 1:1 ratio in 
either the capsid peak at V=1.1 mL or the peaks between V=1.6 and 1.9 mL. This 
indicates that the GE-CK complex dissociates to certain extend, since otherwise the 
amount o f GE and CK in the FPLC fractions would be equal. It is known from 
literature5 that the E/K coil interaction is pH sensitive. At pH 7.5 the coiled-coil 
complex is stable, but at pH 5.0 the coiled-coils partially disassemble. Three 
disassembled E-coils can then form a trimeric coiled-coil structure. This would 
indicate that at pH 5.0 the (dimeric) GE-CK complex could partially disassemble 
and reassemble into free CK proteins and trimeric GE proteins. If  this disassembly 
would take place faster than the capsid formation, this could influence the 
efficiency with which EGFP is encapsulated as it would result in a decrease of the 
amount of GE-CK complex in solution.
peak fractions from FPLC, 
V=1.1 mL, pH 5.0
. A  .
V *  A<? V=1.6-1.9 mL, pH 5.0
!' jk ______ A ______.
peak fractions from FPLC,
<-GE
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<- WtCP
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Conclusion
Inclusion of Enhanced Green Fluorescent Protein in the capsid of the Cowpea 
Chlorotic Mottle Virus can be controlled to a certain extent by introducing non- 
covalent interactions between the guest and the capsid proteins, resulting in the 
formation of a stable GE-CK complex at pH 7.5. The subsequent encapsulation 
process in the presence of wild type capsid displays an unexpected optimum when 
the [GE-CK complex]/[total protein] ratio is increased. It was expected that the GE­
CK complex concentration in solution would be equal to the amount GE-CK 
complex added. This does not seem to be the case however. We have shown that at 
pH 7.5, part of the GE-CK complex tends to dimerize as a result o f both increasing 
concentration of the complex as well as the increasing [GE-CK complex]/[total 
protein] ratio. This dimeric complex also seems to be present at pH 5.0. Presumably 
the dimeric complex cannot be incorporated into the capsid, so the actual GE-CK 
complex concentration in the mixture is lower than expected. Another factor 
contributing to the decrease in GE-CK complex concentration in the mixture, is the 
pH dependent dissociation of the GE-CK complex. At pH 5.0, the (dimeric) GE-CK 
complex partially dissociates into CK proteins and GE proteins. The latter will then 
probably re-associate to form a trimeric GE complex as is reported in  detail for 
these coiled coil systems by Klok et al.5
So the mechanism of EGFP encapsulation as initially proposed by us (see 
chapter 6) and outlined in figure 6 of chapter 6 is more complex. Presumably part of 
the GE-CK complex dimerizes at pH 7.5 with increasing concentration and [GE-CK 
complex]/[total protein] ratio. At pH 5.0 this dimerized complex is not incorporated 
into the capsid. Due to the dissociation of the coiled-coils at this pH, both the 
dimerized GE-CK complex and the non-dimerized GE-CK complex probably 
partially disassemble, forming trimerized GE complexes and free CK. This leads to 
a mixture of five different species: the wt CP, free CK and GE-CK complex, which 
will assemble to a EGFP filled capsid, and the trimerized GE and dimerized GE-CK 
complex, which will not be incorporated into the capsid and elute from the FPLC 
column around V=1.7 mL (figure 8).
In summary, both the concentration and ratio dependent dimerization of the 
GE-CK complex as well as the pH dependent dissociation of the GE-CK complex 
result in a decrease of the available amount of GE-CK complex in solution, which 
in turn leads to a decrease in encapsulation efficiency.
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Since formation o f the dimeric GE-CK complex might be due to specific 
properties of the EGFP, it is possible that this effect will not occur with other 
proteins. This might mean that the current maximum of 15 EGFP proteins 
encapsulated per capsid is not necessarily the maximum for all proteins. Further 
studies are needed to answer this question.
1.1 mL FPLC peak 1.7 mL FPLC peak
Figure 8 Proposed EGFP encapsulation mechanism. The top row represents (from left to 
right): the wt CP, the GE-CK complex and the dimeric GE-CK complex at pH  7.5. Upon 
lowering the pH  to 5.0 the GE-CK complex is thought to partially dissociate, resulting in a 
mixture o f CK, trimeric GE and intact GE-CK complex. The dimeric GE-CK complex 
probably also partially dissociates, resulting in a mixture o f CK, trimeric GE and dimeric 
GE-CK complex. The wt CP, together with GE-CK complex, and dissociated CK then 
presumably form a capsid with EGFP encapsulated, giving rise to a V=1.1 mL peak on the 
FPLC, while the trimeric GE and dimeric GE-CK complex probably give rise to the peaks 
between V=1.6 and 1.9 mL.
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Experimental section 
Methods and materials
Protein concentrations were determined using a Cary 50 Conc (Varian, Middelburg) UV-VIS 
spectrophotometer using a quartz cuvette with a path length of 3 mm.
FPLC measurements were performed using either a Superose 6 PC 3.2/30 analytical column 
or a Superdex 200 PC 3.2/30 analytical column from GE lifesciences, on an Amersham Ettan 
LC system, fitted with a fractionating device. Buffers for FPLC were filtered with a 
Millipore 0.2 ^M filter before use.
Two buffers were used: a buffer pH 7.5 (0.5 M NaCl, 0.05 M Tris-HCl, 0.01 M MgCl2 and 
0.001 M EDTA) and a buffer pH 5.0 (0.5 M NaCl, 0.05 M NaCH3COO, 0.01 M MgCl2 and 
0.001 M EDTA). The pH of the buffers was set with HCl.
Expression and purification of wt CP, GE and CK
Expression and purification of wt CP, GE and CK, as well as the assembly of the GE-CK 
complex were carried out according to the procedures described in chapter 6.
EGFP encapsulation experiments
CK-GE complex or GE (negative control) in buffer pH 7.5 (50 mM Tris-HCl, 500 mM NaCl, 
10 mM MgCl2, 1 mM EDTA pH 7.5) were added in different ratios to wild type capsid 
protein in the same buffer (table 1 and table 2). The proteins were allowed to mix for 5 min., 
before dialyzing the mixture overnight to buffer pH 5.0. The mixtures were then analyzed on 
an FPLC system equipped with a Superose 6 column.
Encapsulation experiment with labeled wt CP
DyLight™ 649 NHS ester (Thermo Scientific) was added to wt CP in a 50 mM phosphate 
buffer pH 7.5 with 0.5 M NaCl, The unreacted dye was removed by extensive dialysis 
against buffer pH 7.5 and the labeling efficiency was determined according to the procedure 
described in the DyLight™ manual, which resulted in a labeling efficiency of 0.14 mol of the 
dye per mol wt CP. The labeled wt CP was mixed with GE-CK complex in a [GE-CK 
complex]/[total protein] ratio of 0.7. The concentration of wt CP in the sample was 2.01*10'5 
M and that of GE-CK complex was 4.69*10'5 M. The mixture was then dialyzed to buffer 
pH 5.0 and analyzed by FPLC equipped with a Superose 6 column.
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Table 1 Data o f the encapsulation experiments.
Exp. # M wt CP in 
samples
M GE-CK 
complex in 
samples
aRatio
[GE-CK complex]/ 
[total protein]
Number of EGFP 
proteins encapsulated 
per capsid
1 7.71 x10-5 2.50x10‘6 0.03 2.0
7.39x10-5 4.99x1 O’6 0.06 2.4
6.83x10-5 9.36x10-6 0.12 11.8
6.02x10-5 1.56x10-5 0.21 14.8
4.02x10-5 3.12x10-5 0.44 12.5
2 .0 1x10-5 4.68x10-5 0.70 7.3
8.03x10-6 5.62x10-5 0.87 1.1
0 6.24 x10‘5 1.00 0.0
2 7.84x10-5 2.52x10-6 0.03 5.6
6.86x10-5 1 .0 1x10‘5 0.13 10.3
6.37x10-5 1.39x10-5 0.18 12.3
5.47x10-5 2.08x10-5 0.28 13.7
4.25x10-5 3.03x10‘5 0.42 14.4
2.45x10-5 4.41 x10‘5 0.64 7.7
3 4.72x10-5 2 .02x10-5 0.30 8.0
3.04x1 O'5 2 .02x10-5 0.40 9.3
2 .02x10-5 2 .02x10-5 0.50 8.1
1.35x10-5 2 .02x10‘5 0.60 6.3
8.68x10-6 2 .02x10-5 0.70 7.7
5.06x10-6 2 .02x10-5 0.80 7.8
2.25x10-6 2 .02x10-5 0.90 9.8
4 2.69x10-4 2 .02x10‘5 0.07 9.2
1.24x10-4 2 .02x10‘5 0.14 11.2
8.10 x10-5 2 .02x10-5 0.20 11.3
5.47x10-5 2 .02x10-5 0.27 10.9
3.04x10-5 2 .02x10-5 0.40 6.9
1.80x10-5 2 .02x10-5 0.53 8.2
9.53x10-6 2 .02x10-5 0.68 9.4
5.06x10-6 2 .02x10‘5 0.80 7.1
2.25x10-6 2 .02x10-5 0.90 17.1
a)Ratio was calculated by dividing molarity of the GE-CK complex by the molarity of the
GE-CK complex+M wt CP.
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Table 2 Data o f  the negative controls fo r  the encapsulation experiments. In these 
experiments uncomplexed GE was used instead o f the GE-CK complex.
Exp. # M wt CP in 
samples
M GE in 
samples
aRatio
[GE]/
[total protein]
Number of EGFP 
proteins encapsulated 
per capsid
5 8.03x10'5 0 0.00 1.00
7.71 x10'5 2.38x10-6 0.03 1.93
6.83x10'5 8.91x10-6 0.12 1.84
6.02x10'5 1.48x10-5 0.20 2.19
4.02x10-5 2.97x10-5 0.43 2.20
2 .0 1x10-5 4.45x10-5 0.69 2.42
8.03x10-6 5.35x10-5 0.87 2.75
Investigation of the [GE-CK complex]/[total protein] ratio on the aggregation behavior of 
GE-CK
GE-CK (8.28x10'5 M) was mixed with wt CP (9.55x10-5M) in a GE-CK/total protein ratio of
0.7. The mixture was divided in two equal portions which were each dialyzed to buffer pH 
5.0. After 2 hrs, a concentrated solution of wt CP (6.92x10-4M, pH 7.5) was added to one of 
the mixtures resulting in a GE-CK/total protein ratio o f 0.4. The two mixtures were further 
dialyzed to buffer pH 5.0 for approximately 10 h before analysis on an FPLC equipped with 
a Superose 6 column.
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Chapter 8
Metal ion induced formation and stabilization o f the 
cowpea chlorotic mottle virus capsid*
Introduction
The well-defined assemblies formed by virus capsid proteins turn out to be suitable 
construction materials for the formation of (functional) nanostructures.1 The 
number of examples in which spherical viral cages are used as reaction vessels is 
steadily increasing,2-4 Rod-like virus systems, on the other hand, are used as a 
scaffold for enzymes5 or chromophores,6 and as templates for the crystallization of 
solid state materials.7 One of the next key steps in the further development of the 
emerging field of what is called “chemical virology”, i.e. the use of virus based 
materials to direct or study chemical processes, is to further control the size, shape 
and stability of the well-organized architectures formed by virus capsid proteins. 
We are employing the CCMV capsid as such a well-defined scaffold, because of its 
pH dependent assembly behavior. From previous results (e.g. chapters 3 and 4 of 
this thesis) we know that subtle interactions with guest (macro)molecules can direct 
the assembly of the CCMV coat protein and that the charged N-terminus of the 
protein chain can play a role in this. As mentioned in chapter 5, the capsid protein 
was genetically modified with an N-terminal histidine tag to aid its purification. 
The N-termini o f the capsid proteins are located at the quasi six-fold and five-fold 
axis o f the capsid. Residues 29 to 33 of the N-termini of a protein hexamer located 
at the quasi-six fold axis form a hexameric tubular structure8 (figure 1 ).
* This work is submitted for publication.
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Figure 1 Ribbon diagram showing the hexameric tubular structure formed by the N-termini 
(residues 26-39) o f a CCMV hexamer located at the quasi-six fo ld  axis.
Like the N-termini o f the coat proteins forming the hexamers, the five N- 
termini o f the coat proteins forming the pentamers are protruding into the capsid at 
the center o f the pentamers. The secondary structure o f these N-termini appears to 
be unordered.
Histidines can coordinate certain metal ions, e.g. cobalt and nickel, and by 
immobilizing the metal ions on a resin functionalized with metal chelating groups 
like NTA, His-tag modified proteins can be selectively bound to the resin. Since the 
modified capsid protein is purified using Ni-NTA affinity chromatography, all 
purified capsid proteins are capable of coordinating to nickel atoms.
In this chapter we report that upon addition o f nickel or other metal ions to the 
purified His-CPs, these ions appear to be able to induce and stabilize capsid 
assembly at neutral pH. Since the metal ions are positively charged and much 
smaller than negatively charged polyelectrolytes, the induction and stabilization of 
capsid assembly by metal ions is probably based on a different mechanism. The 
unprecedented stabilization o f the T=3 capsid structure at pH 7.5 as described in 
this chapter makes the capsid more compatible with physiological conditions and 
hence a more applicable nano building block or nanoreactor. In this chapter we will 
describe in detail the induction o f capsid-like structures by adding metal ions to the 
His-CP’s dimers, as well as the stabilization o f already assembled capsids from His- 
CP’s by metal ions at neutral pH.
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Results and Discussion
Induction of capsid like structures a t pH  7.5 by nickel ions
The interaction o f the His-tag sequence with metal salts is frequently used to 
immobilize proteins on a Ni-NTA colomn. The His-tag metal ion interaction can 
also be used to bind two or more His-tags together.9 Since the modified CCMV coat 
proteins contain an N-terminal His-tag, it would be interesting to see if  addition of 
nickel salts to the proteins would merely result in the connection between the two 
His-tags o f a dimer, or that more complex structures are formed. Experimentally 
this was tested by the addition of 10  equivalents o f NiCl2 (i.e. 10  nickel ions per 
capsid protein monomer) to purified His-CP dimers in a phosphate buffer pH 7.5. 
The mixture was gently stirred at room temperature for one hour and analyzed using 
FPLC. A small fraction of the sample eluted at V=1.20 mL (figure 2), which 
indicates a particle which is significantly larger than a capsid protein dimer, and 
even larger than a T=1 particle (elution volume V=1.3 mL) but smaller than a T=3 
particle (elution volume V=1.1 mL).
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Figure 2 FPLC trace o f His-CP incubated with NiCl2 for 1 hour at pH  7.5 The FPLC system 
is equipped with a Superose 6 column. The black line represents the protein absorption at 
X=280 nm. The formed 22-24 nm particles elute at V=1.2 mL, and the unassembled His-CP 
dimers elute at ~1.8 mL.
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However, the majority of the proteins eluted at V=1.80 mL, which is the elution 
volume o f the capsid protein dimer. To exclude that this could be caused by 
incorrect folding or other structural defect o f the His-CP which might hinder the 
assembly of the capsid, the His-CP was assembled by lowering the pH to 5.0. The 
formed capsid eluted at V=1.1 mL, which is consistent with the elution volume of 
the wild-type capsid, and only a small portion o f the His-CP’s eluted at V=1.8 mL, 
confirming the ability o f the His-CP’s to form capsids. To investigate whether the 
formed particles were in a dynamic equilibrium with the capsid protein dimers, the 
fraction eluting at V=1.2 mL containing the formed particles was isolated and 
reinjected after 1 hour. The resulting FPLC graphs (figure 3) showed that almost all 
particles were still intact, indicating that the formed particles are stable. Based on 
the available data it was unclear if  the material eluting at V = 1.8 mL contained 
bound nickel ions.
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Figure 3 A) FPLC trace o f His-CP incubated with NiCl2 for 1 hour at pH  7.5 The FPLC 
system is equipped with a Superose 6 column. The thick line represents the protein 
absorption at X=280 nm, and the thin line the absorption at X=260 nm. The formed 22-24 nm 
particles elute at V=1.2 mL, and the unassembled His-CP dimers elute at ~1.8 mL. B) 
Reinjection o f collected fractions at 1.2 mL from graph A.
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Figure 4 TEM micrographs o f uranyl acetate stained capsids. A) CCMV pH  5.0 B) Empty 
wild-type capsids pH  5.0 C) Empty His-CP capsids pH  5.0 D) Nickel induced His-CP 
particle formation pH  7.5
To determine the size of the formed structures eluting at V=1.2 mL with 
greater precision, this fraction was analyzed by TEM which revealed the formation 
of capsid-like structures with an average diameter o f D = 22 nm (figure 4). Unlike 
empty T=3 capsids, these capsids do not appear to have a stained interior. A stained 
interior o f empty capsids is generally caused by the accumulation o f the negative 
staining agent, uranyl acetate in this case, into the empty cavity. The importance of 
nickel atoms for the induction o f the His-CP assembly was investigated by 
removing the nickel ions from the formed particles by adding two equivalents of 
EDTA with respect to nickel to the solution. No particles could be detected on TEM 
hereafter, indicating that the nickel ions are indeed essential for the formation and 
structural integrity of the particles. The necessity of the His-tag was studied 
separately, as other sites on the capsids are also known to have a strong affinity for 
metal ions. In particularly negatively charged residues located at the three-fold axis 
are known to have an affinity for calcium and other metal ions.10 Binding of
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calcium to these putative calcium binding sites is thought to be important in the 
stabilization of the virus at pH 5.0.11 Given the affinity o f these residues for 
positively charged ions, it is not unlikely that they will also coordinate to nickel 
ions. To investigate if  coordination o f nickel ions to the putative calcium binding 
sites might be responsible for the induction o f particle formation, NiCl2 was added 
to wt CP using the same procedure as described for the His-CP. Wt CP and His-CP 
both contain the putative calcium binding sites, but the wt CP lacks the His-tags, 
therefore any particle under these circumstances could not be attributed to nickel 
His-tag interaction. The results o f these experiments revealed that no particles were 
formed from wt CP in the presence of nickel ions at pH 7.5, as was shown by TEM 
and FPLC analysis (figure 5). Hence both the His-tag and the nickel ions seem to be 
necessary for the assembly of the capsid-like structures.
elution volume/ ml_
Figure 5 FPLC trace o f wt CP incubated with NiCl2 for 1 hour at pH  7.5 The FPLC system 
is equipped with a Superose 6 column. The thick black line represents the protein absorption 
at X=280 nm, and the thin black line the absorption at X=260 nm. The protein dimers elute at 
V= 1.8 mL.
Induction of capsid like structures a t pH  7.5 by o ther m etal ions
Nickel is a widely used metal-ion for the affinity purification o f His-tagged proteins, 
but it is not the only metal ion that is capable of binding to histidines. Therefore, a 
range o f other metal ions were tested for their ability to induce formation o f the 
capsid-like structures. The procedure followed for the formation o f these particles 
was identical to the procedure described for the NiCl2 induced assembly, only the 
type of metal ion was varied. The results were analyzed by TEM (figure 4d and 6) 
and the following metals-salts were shown to induce particle formation: RhCl3, 
CoCl2, PdCl2, and AuCl3. Addition of IrCl3, PtCl2, CuCl2, ZnCl2, AlCl3 and AgNO3
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to the His-CPs resulted in some capsid-like structure formation, but notably less 
compared to the previously mentioned metal ions and NiCl2. No capsid-like 
structures were observed upon addition o f FeCl2 to the His-CPs. At this point the 
exact structure and the mechanism of formation o f the His-tag containing proteins 
architectures in the presence o f a variety of metal is still unclear. Since the absence 
of staining agent in the interior suggests either a solid particle or limited diffusion 
across the protein shell, the formed architectures are unlikely candidates for 
nanoreactors12 and we, therefore, focused on a slightly different strategy for the use 
of metal ions in the capsid protein assembly process (see below).
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Figure 6 Size distribution o f His-CP particle formation induced at pH  7.5, based on TEM 
micrographs. A) Particle formation induced with NiCl2. B) Particle formation induced with 
RhCl2. C) Particle formation induced with CoCl2.
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Stabilization of T=3 capsid structu re  a t pH  7.5 by nickel ions
Although it was demonstrated that addition o f Ni ions stabilized capsid-like 
structures at physiological pH it was clear from figure 3 that only a small part o f the 
His-CPs was involved in this. This is in contrast with the pH induced assembly of 
His-CP into the native T=3 capsid structure, which does proceed with very high 
efficiency and yield. In this case, the formed capsids are only stable at acidic pH, 
which is often a drawback. Therefore we tried to induce the assembly o f the capsid 
at pH 5.0, and to subsequently stabilize the formed assembly by the addition of 
NiCl2 (10 eq.), after which the pH was increased to 7.5. The formed particles were 
analyzed after three days using FPLC, TEM and DLS. TEM analysis (figure 7a), 
showed particles o f approximately 28 nm in size in line with FPLC results (figure 
7b), where V = 1.15 mL points to the same size.
Figure 7 TEM and FPLC results o f nickel stabilized capsids after three days at pH  7.5, A) 
TEM micrographs o f uranyl acetate stained nickel stabilized capsids. B) FPLC trace o f 
nickel stabilized capsids at pH  7.5. The thick line represents the protein absorption at X=280 
nm, and the thin line the absorption at X=260 nm. The formed capsids elute at V=1.15 mL. 
The FPLC system is equipped with a Superose 6 column.
The capsids seem to be very mono-disperse and show a darkly stained interior, 
which is also observed with the wild-type capsids. The DLS volume distribution 
showed particles with a hydrodynamic radius o f 30.4 nm (figure 8). This points to 
T=3 particles, which are assembled with high efficiency and these are stable at pH
7.5 for at least three days. To investigate the importance o f nickel ions for the 
stabilization of the capsids at pH 7.5, EDTA was added. FPLC analysis o f these 
samples now revealed an elution volume o f V=1.8 mL, indicating that all capsids 
had disassembled into dimers (figure 9).
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Figure 8 DLS traces o f nickel stabilized capsids at pH  7.5. Different lines indicate repeated 
measurements. A) DLS traces plotted against intensity. B) DLS traces plotted against volume.
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Figure 9 FPLC traces showing the effect o f addition o f EDTA to the stabilized capsids. The 
thick lines represent the protein absorption at 1=280 nm, and the thin lines the absorption at 
1=260 nm. The formed capsids elute at V=1.15 mL. Capsidprotein dimers elute at V=1.8 mL. 
The FPLC system is equipped with a Superose 6 column. A) FPLC trace o f nickel stabilized 
capsids at pH  7.5. B) FPLC trace o f the same sample after addition o f EDTA.
No capsids could be observed by TEM analysis either, indicating that the nickel 
ions are indeed essential for the stabilization o f the capsid at pH 7.5. To 
demonstrate that the stabilization of the capsid is caused specifically by the 
interaction of the His-tag with the nickel ions and not by interactions o f other 
nickel-coordinating amino-acids, like the negatively charged residues at the putative 
calcium binding site, wt CP’s, and His-CP capsids were separately labeled with 
chromophores and assembled by lowering the pH to 5.0. The formed capsids were 
then mixed and NiCl2 was added before increasing the pH to 7.5 (figure 10a). The 
mixture was analyzed by FPLC; the His-CPs eluted at V=1.1 mL, and the wild-type 
capsid proteins eluted at V=1.8 mL. This clearly shows that the His-CP’s did not 
disassemble upon increasing the pH, whereas the capsids of the wt CP did (figure
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10b), confirming the need o f the His-tag for the stabilization of the T=3 particle at 
pH 7.5. Since the two dyes used to label the capsid proteins have a small overlap at 
the measured wavelengths (figure 11) The small peak absorption at ^=646 nm can 
be completely attributed to assembled His-CP (see legend to figure 11).
Figure 10 Selective stabilization o f His-CP capsids. A) Schematic representation o f the 
experiment. Wt CP and His-CP were labeled with different dyes and the pH  was 
subsequently lowered, resulting in wt CP capsid labeled with DylightTM 647 and His-CP 
capsids labeled with Dylight™ 549. The capsids were then mixed and after stabilization o f 
the capsids with nickel ions, the pH  was increased back to pH  7.5. The resulting mixture was 
analyzed by FPLC. B) FPLC trace o f the mixture at pH  7.5 after the stabilization step. The 
thin black line represents the protein absorption at X=280 nm, the thick black line represents 
the absorption o f the labeled His-CP at X=562 nm and the grey line represents the 
absorption o f the labeled wt CP at 1=646 nm. The stabilized capsids elute at V=1.15 mL and 
the capsid protein dimers elute at V=1.8 mL. The FPLC system is equipped with a Superose 
6 column.
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Figure 11 UV-Vis traces o f His-CP labeled with Dylight™ 549 (black line) and wt CP 
labeled with Dylighi™ 647 (grey line). Labeled His-CP has a major absorption peak at X= 
562 nm, and also absorbs slightly at the wavelength o f the major absorption peak o f wt CP 
(X= 646 nm). The absorption o f labeled His-CP at X= 562 nm is 48 times larger than the 
absorption o f labeled His-CP at X= 646 nm. In the FPLC graph shown in figure 10b a small 
absorption at X= 646 nm is visible at V=1.15 mL. This absorption can be completely 
attributed to absorption o f His-CP at X= 646 nm. The area o f the V=1.15 mL peak at X= 562 
nm is 16.31, and the area o f the V=1.15 mL peak at X= 646 nm is 0.29. The expected area at 
X= 646 nm would be 16.31/48= 0.34. The expected and observed areas are very similar, and 
it is thus very likely that the small absorption at X= 646 nm at V=1.15 mL is indeed caused 
by the presence o f labeled His-CP and not due to assembled wt CP. The slight difference 
between the experimental value o f 0.29 and the theoretical value o f 0.34 can be attributed to 
inaccuracies in the measurement o f these small values.
The concentration of nickel ions bound to the capsid was determined by 
inductively coupled plasma-optical emission spectroscopy (ICP-OES). A sample of 
stabilized capsids was purified by FPLC and the concentration of sulfur and nickel 
in the fraction that eluted at V = ~1.15 mL was determined with ICP-OES (table 1). 
The concentration o f nickel was just above the detection limit o f ICP-OES and was 
therefore confirmed by inductively coupled plasma-mass spectrometry (ICP-MS), a 
more sensitive technique for the detection o f nickel. Sulfur cannot be analyzed by 
ICP-MS. The number of nickel atoms bound per protein monomer could be derived 
from the Ni/S ratio measured using ICP-OES, as the amount o f sulfur containing 
amino-acids in His-CP is known (two cysteines and three methionines, the starting 
methionine is removed by E.coli during expression), resulting in 0.7 nickel atoms 
per His-CP monomer. At pH 5.0, the theoretical number o f nitrogen atoms o f the 
imidazole side-chains that are non-protonated and thus able to coordinate to nickel 
atoms is 0.6 per His-tag. This number suggests that at pH 5.0 the available
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imidazole groups are bound to nickel in a one to one ratio. At pH 7.5 this ratio will 
be higher because of the larger number of available imidazole groups. This is 
expected to lead to cross-linking and stabilization of the subunits.
Table 1 Concentration o f  nickel and sulfur in stabilized T=3 particles at pH  7.5 determined 
by ICP-OES and ICP-MS
Concentration Ni (ppb) Concentration S (ppb)
ICP-OES 97.75 676.1
ICP-MS 94.78 -
Form ation of capsids containing wt C P’s and H is-C P’s a t pH  7.5
Both the presence of the His-tag in the His-CP as the addition of nickel ions to the 
sample seem to be essential for the stabilization of the T=3 capsid at pH 7.5. It is, 
however, not known if all 180 His-tags present in the capsid are needed for capsid 
stabilization at pH 7.5, or if a small amount of capsid protein lacking the His-tag 
would be tolerated. To test this, the amount o f His-CP in the capsids was varied by 
mixing wt CP and His-CP in various ratios. Gillitzer et al.4 already showed that 
differently labeled dimers can be incorporated into the same CCMV capsid. Since 
the wt CP and His-CP dimers are structurally very similar, presumably they would 
also form mixed capsids at pH 5.0. To be able to differentiate between the wt CP 
and the His-CP they were labeled with different dyes. The labeled protein dimers 
were subsequently mixed in different ratios at pH 7.5 and the mixture was 
assembled at pH 5.0. NiCl2 was then added and the pH was increased to 7.5 (figure 
12 a).
The mixtures were analyzed by FPLC (figure 12b), and the amount of 
assembled capsid was derived from the ratio between the V=1.1 mL and V=1.8 mL 
peaks. For this the absorption at X=280 nm for the peak at V=1.1 mL was divided 
by the total absorption at X=280 nm, i.e. the amount of formed capsid was divided 
by the total amount of protein present in the sample, giving the percentage of 
assembled capsid. When more w t CP was present in the mixture, the amount of 
assembled capsid decreased (figure 13a). At low wt CP / total protein ratios the 
amount o f assembled capsid protein was higher than would be expected if  only the 
His-CPs would be able to assemble, indicating that at least part of the wt CP is also 
involved in the assembly.
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16.5.
Figure 12 Formation o f capsids at pH  7.5 containing wt C P’s and His-CP’s. A) Schematic 
representation o f the experiment. Wt CP was labeled with DylightTM 647 and His-CP was 
labeled with DylightTM 488. The capsid proteins were then mixed in different ratios and the 
p H  was lowered to induce capsid formation, resulting in capsids consisting o f wt CP and 
His-CP. Nickel chloride was added to the capsids and the p H  was increased to pH  7.5 and 
the resulting mixtures were analyzed by FPLC B) FPLC trace o f a mixture containing 30% 
wt CP. The thin black line represents the protein absorption at X=280 nm, the thick black 
line represents the absorption o f the labeled His-CP at X=493 nm and the grey line 
represents the absorption o f the labeled wt CP at 1=646 nm. The stabilized capsids elute at 
V=1.15 mL and the capsid protein dimers elute at V=1.8 mL. The FPLC system is equipped 
with a Superose 6 column. C) The percentages o f wt CP (grey diamonds) and His-CP (black 
triangles) in the capsids eluting at V=1.15 mL were calculated using the absorptions o f the 
DylightM labels measured on FPLC. The calculated percentages o f wt CP and His-CP 
present in the formed capsids were plotted against the initial fraction o f wt CP present in the 
samples. D) Silver stained SDS-Page gel o f FPLC fractions o f stabilized capsids at pH  7.5 
composed o f His-CP and wt CP. M  indicates the marker, molecular weights are given in kDa. 
Pure His-CP and wt CP are loaded on either side o f the gel.
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The fraction o f wt CP in the assembled capsids could be calculated using the 
different absorbances of the labeled wt CP and His-CP. Since the labeling 
efficiency was not the same for the wt CP and the His-CP, a correction factor had to 
be introduced in order to compare the absorption values o f the two dyes (see 
experimental section fo r  calculation details).
Figure 13 Formation o f capsids at pH  7.5 containing wt CPs and His-CPs. A) The amount o f  
assembled capsid in the sample was calculated using the capsid peak and dimer peak areas 
o f the FPLC graphs. The black squares show the percentage o f capsid protein that was 
assembled as a function o f the fraction o f wt CP present in the sample. The solid line 
indicates the fraction o f His-CP present in the samples. B) The elution volumes o f the 
assembled capsids vary as a function o f the fraction o f wt CP present in the sample. Open 
black squares represent the elution volumes o f the capsid proteins as monitored by the 
absorption at X=280 nm, grey diamonds represent the elution volumes o f the His-CP as 
monitored by the absorption at X=493 nm, and black triangles represent the elution volumes 
o f the wt CP as monitored by the absorption at 1=646 nm.
The fraction of wt CP in the assembled capsids increases with increasing 
amounts o f wt CP present in the mixture (figure 12c). However, the fraction of wt 
CP in the capsids was smaller than the fraction wt CP in the total mixture. This 
would suggest that more wt CP was in its dimeric form than His-CP. From the 
FPLC graphs it can clearly be seen that this is the case. The dimer peaks are almost 
solely composed o f wt CP.
With increasing wt CP:total protein ratios, the capsid peak showed a shift to 
higher elution volumes. At low ratios the elution volume was V=1.14 mL which 
corresponds to a T=3 capsid, but at higher wt CP:total protein ratios, the elution 
volume shifted to V=1.30 mL, which is indicative o f a smaller capsid (figure 13b). 
TEM micrographs confirmed this decrease in size (figure 14).
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Figure 14 Size distribution o f mixed His-CP wt CP capsids stabilized with NiCl2 at pH  7.5, 
based on TEM micrographs. A) Fraction o f wt CP was 0.2. B) Fraction o f wt CP was 0.4. C) 
Fraction o f wt CP was 0.6. D) Fraction o f wt CP was 0.8.
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Encapsulation of EG FP using coiled-coils in nickel stabilized capsids a t pH  7.5
In a first step towards a multi-enzyme virus-based nanoreactor12 we were able to 
encapsulate multiple EGFP proteins into the capsid by attaching EGFP to the capsid 
protein prior to pH induced assembly as described in chapter 6 . The capsid protein 
and EGFP were genetically modified to contain a coiled-coil amino acid sequence. 
The coiled-coils bind non-covalently to each other, and thus the capsid protein 
could be attached to EGFP by mixing the proteins. Since this complex was too 
bulky to form capsids, the complex was mixed with non-functionalized w t CP 
before induction of assembly by decreasing the pH. Multiple EGFP proteins could 
be encapsulated this way. One major drawback of a nanoreactor formed is this way, 
however, is the low pH which is required to form and stabilize the capsids. 
Stabilization at pH 7.5 might be accomplished by combining the method to stabilize 
capsids using nickel, with the encapsulation strategy described in chapter 6.12
As a small amount of wt CP does not seem to destabilize the nickel-stabilized 
capsid, a small amount of EGFP-capsid protein complex might also be tolerated. So 
for this experiment, wt CP was replaced by the EGFP-capsid protein complex. 10% 
of EGFP-capsid protein complex was mixed with 90% His-CP at pH 7.5, and the 
assembly was induced by lowering the pH to 5.0 (figure 15a). The capsid was then 
separated from non-encapsulated EGFP and dimers by FPLC. Using the absorption 
of EGFP at X=395 nm and the protein absorption at X=280 nm, it could be 
determined that six EGFP proteins had been encapsulated per capsid (see  
experimental section fo r  calculation details). This procedure was repeated and the 
purified fractions containing the highest concentration of capsid were combined. 
Nickel was then added to these purified capsids and the pH was increased to 7.5. 
The procedure to encapsulate EGFP at pH 7.5 was also repeated without 
purification of the capsids containing EGFP at pH 5.0 before addition of nickel. 
This resulted in samples containing a larger amount of large aggregates (figure 15d) 
than when the capsids were pre-purified at pH 5.0.
Analysis by FPLC showed that the capsids were still largely intact and still 
contained 6 EGFP proteins per capsid (figure 15c and d). The capsid fraction at 
V=1.15 mL was analyzed by SDS-PAGE gel, and the proteins were detected by 
silver staining (figure 15e). This confirmed the presence of EGFP in the capsid 
fraction of the FPLC. Capsids containing EGFP at pH 5.0 and pH 7.5 were also 
analyzed by fluorescence spectroscopy. Since EGFP is pH sensitive, its quantum 
yield is very low at pH 5.0 and no fluorescence signal could be detected. The
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capsids containing EGFP at pH 7.5, however, did give a clear fluorescence signal, 
clearly pointing to the presence of intact EGFP at pH 7.5 in the samples (figure 15f).
Figure 15 Encapsulation o f EGFP using coiled-coils in nickel stabilized capsids at pH  7.5. 
A) Schematic representation o f the experiment. Capsid protein with K-coil is added to EGFP 
with E-coil to form the EGFP-capsidprotein complex. This complex is then mixed with His- 
CP at pH  7.5 and subsequently dialyzed to pH  5.0 to induce capsid formation. The capsids 
are then either first purified on FPLC before addition o f NiCl2 or directly stabilized without 
additional purification. The pH  is subsequently increased to 7.5 and the resulting mixture is 
analyzed by FPLC. B) FPLC trace o f capsid with EGFP encapsulated at pH  5.0. The thick 
black line represents the protein absorption at X=280 nm, the thin black line represents the 
EGFP specific absorption at X=395 nm. The stabilized capsids elute at V=1.15 mL and the 
capsid protein dimers elute at V=1.8 mL. The FPLC system is equipped with a Superose 6 
column. C) After addition o f NiCl2 to the FPLC purified capsids shown in graph B, the pH  
was increased to 7.5 and the capsids were reinjected on the FPLC column. The thick black 
line represents the protein absorption at X=280 nm. The thin black line represents the EGFP
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specific absorption at 1=490 nm. D) FPLC trace o f  stabilized capsids with EGFP at pH  7.5, 
which were not purified prior to addition o f NiCl2. E) Silver stained SDS-Page gel o f  FPLC 
fractions o f  stabilized capsids containing EGFP at pH  7.5. M  indicates the marker, 
molecular weights are given in kDa. Lane 1: His-CP. Lane 2: Capsids containing EGFP 
purified at pH  5.0 prior to stabilization (from graph 15C), due to the low concentration o f  
this sample the EGFP is barely visible. Lane 3: Capsids containing EGFP not purified at pH  
5.0 prior to purification (from graph 15D). Lane 4: GE-CK complex F) Fluorescence 
spectrum o f EGFP containing capsids at pH  7.5. The sample was excited at 1=490 nm. The 
black line represents the capsids with EGFP at pH  7.5; the grey line represents the capsids 
with EGFP at pH  5.0.
Concluding remarks
The CCMV capsid protein is a versatile nano-building block, o f which the self­
assembly behavior can be tuned by changing the solvent parameters or by the 
addition of polyelectrolytes to form a range of different structures.
To further extend and employ the capsid proteins they were heterologously 
expressed in E.coli bacteria to allow for their genetic modification. The capsid 
protein produced by E.coli is identical to the wt CP, except for the N-terminal 
domain where a thrombin cleavage site and a His-tag were added. Upon lowering 
the pH to 5.0 the His-CP assembles into a 28 nm sized capsid, hence the addition of 
a His-tag does not seem to hamper the pH induced assembly. It does however 
expand the possibilities for assembly of the capsid protein. The His-tag is able to 
bind to a range of metal ions, and when these metal ions are added to a solution of 
His-CP at pH 7.5, a portion of the proteins assembles into particles of 
approximately 22 nm in size. Furthermore, when nickel ions are added to assembled 
His-CP capsids at pH 5.0, the interaction between the nickel and the His-tags 
seemingly stabilizes the capsid, such that it also remains stable when the pH is 
afterwards increased to 7.5. In contrast to what happens when nickel ions are added 
to the capsid proteins at pH 7.5, the nickel His-tag interaction at pH 5.0 presumably 
does not induce the assembly of the capsid, but only stabilizes the already formed 
capsid. The His-tags of the capsid proteins are closely located to each other at the 
centers o f the hexamers and perhaps also at the centers of the pentamers. It is 
conceivable therefore that a nickel ion is coordinated to several his-tags, connecting 
the capsid proteins to each other. This might stabilize the hexamers, which in  turn 
leads to stabilization of the entire capsid, as all hexamers are interconnected through 
dimer contacts of the C subunits.
144
Chapter 8
Stabilization of the capsid at pH 7.5 could prove to be very useful in, for 
example, the construction of an enzyme containing nanoreactor. Enzymes are often 
studied in solution, while in  living organisms, they reside in the closely confined 
and highly structured environment of cell organelles. Studying enzymes in the 
confined space of a nanometer-sized reaction vessel such as the CCMV capsid, 
mimicks the cellular environment and thus may provide fundamental insights into 
the way living cells work and process molecules.13
In chapter 612 it was shown that it is possible to encapsulate multiple proteins 
in the capsid interior, which is a first step in the development of such a nano-reactor. 
A major disadvantage of this system however is the low pH required to keep the 
capsid intact, since many enzymes do not function well at low pH. Therefore, the 
ability to stabilize the capsid at pH 7.5 is an important step in the realization of a 
multi-enzyme nanoreactor. Another important step is the ability to combine the 
system described in chapter 6 to encapsulate multiple proteins within the CCMV 
capsid, with the method described in this chapter to stabilize the capsids at pH 7.5, 
in order to encapsulate multiple enzymes in the nickel stabilized capsids at pH 7.5. 
Since proteins were non-covalently attached to the capsid proteins in order to be 
able to encapsulate them, a portion of the capsid needs to consist of this protein- 
capsid protein complex. To test whether the nickel stabilized His-CP capsid would 
still be stable if a portion of the capsid proteins would not contain His-tags, capsids 
were assembled that contained both wt CP and His-CP. This showed that a small 
portion of capsid proteins lacking a His-tag could be incorporated into the capsid, 
without significantly affecting the stability.
To create nickel stabilized capsids at pH 7.5 containing EGFP as a model 
protein, a small amount of EGFP-capsid protein complex was mixed with His-CP to 
create EGFP containing capsids at pH 5.0. After addition of nickel, these capsids 
were stable at pH 7.5, while still containing approximately the same amount of 
EGFP. Further tools for the creation of a multiple enzyme nanoreactor have now 
been developed using a genetically modified version of the capsid protein, which 
contains a metal binding N-terminal His-tag sequence. This sequence expands the 
assembly properties of the CCMV capsid protein. By the addition of nickel ions, 
both empty capsids and capsids which contain multiple encapsulated proteins can 
now be stabilized at a physiologically relevant pH. In the future, this technique 
could be used to study the effect of close confinement on enzymes at a 
physiologically relevant pH.
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Experimental section 
Materials
Protein concentrations were determined using a Cary 50 Conc (Varian, Middelburg) UV-VIS 
spectrophotometer using a quartz cuvette with a path length of 3 mm. FPLC measurements 
were performed using a Superose 6 PC 3.2/30 analytical column from GE lifesciences, on an 
Amersham Ettan LC system, fitted with a fractionating device. Buffers for FPLC were 
filtered with a Millipore 0.2 ^M filter before use. TEM grids (Formvar-Carbon) were 
exposed to an electron discharge treatment using a Cressington Carbon coater and power unit. 
The sample was applied to the grids by adding a 5 ^L drop of sample solution (~ 0.2 mg/mL) 
to the grid and carefully removing it after 1 minute immersion using a filter paper. The grid 
was allowed to dry for at least 15 min. before applying 5 ^L of a 2% (w/v) uranyl acetate 
aqueous solution, which was removed after 15 s. The grid was again allowed to dry for at 
least 15 min. Samples were studied on a JEOL JEM-1010 TEM (Jeol, Japan). DLS 
measurements were performed on a Zetasizer Nano S (Malvern Instruments Ltd, England), 
samples were first purified by FPLC and subsequently measured. Fluorescence 
measurements were performed on a Perkin Elmer LS-55 fluorescence spectrometer and 
excited at 490 nm (slit width: 10 nm) and fluorescence emission was detected (slit width: 9 
nm) from 500 to 650 nm at 10 nm/s. After purification of the proteins two buffers were used; 
a buffer pH 7.5 (50 mM phosphate, 0.5 M NaCl) and buffer pH 5.0 (50 mM acetate, 0.5 M 
NaCl, 10 mM CaCl2), the pH of the buffers was set with HCl.
Creation of a heterologous expression system for the capsid protein in E. coli cells
This experiment was described in chapter 6.
Expression of His-CP
One colony of BL21(DE3)pLysS cells expressing His-CP was used to inoculate 100 mL of 
LB medium containing ampicillin (0.050 g/L) and chloramphenicol (0.025 g/L). After 
growth overnight at 30°C this culture was used to inoculate 900 mL of LB medium 
containing ampicillin (0.05 g/L) and chloramphenicol (0.025 g/L) and grown at 30°C. Protein 
expression was induced during logarithmic growth (0D600 =0.4-0.6) by addition of IPTG to 
a final concentration of 1 mmol/L.
Purification of His-CP
Cells were harvested after 7 hrs of expression by centrifugation at 4000 rpm for 15 min. at 
40C. The supernatant was discarded and the pelleted cells were stored at -200C. After thawing, 
the pelleted cells were resuspended in approximately 10 mL of lysis buffer (50 mM 
NaH2P 04, 10 mM imidazole and 1.5 M NaCl pH 8.0). Approximately 10 mg of lysozyme 
(EC 3.2.1.17 from Fluka) was added and the solution was incubated at 40C for 30 min. The 
solution was sonicated for 5 times 10 s with duty cycle 40 and output control 6 (Branson
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Sonifier 250, marius instruments Nieuwegein, the Netherlands). RNase (10 ug/mL) and 
DNase (5ug/mL) were added to the solution and the mixture was incubated at 40C for 15 min. 
The solution was centrifuged at 10,000 rpm for 20-30 min. to pellet the cellular debris. The 
supernatant was incubated with 1 mL of Ni-NTA agarose beads for 1 h at 40C. The flow 
through was collected and the column was washed with 40 mL of wash buffer (50 mM 
NaH2PO4, 25 mM imidazole and 1.5 M NaCl pH 8.0)). The capsid protein was then eluted 
from the column using approximately 10 mL of elution buffer (50 mM NaH2PO4, 250 mM 
imidazole and 1.5 M NaCl pH 8.0) and the protein was collected in small fractions. The 
fractions were dialyzed overnight to buffer pH 7.5, to remove the excess of imidazole. The 
protein purity was checked with SDS-Page gel electrophoresis.
Induction of capsid like structures at pH 7.5 by nickel ions
Ten equivalents of metal ion (i.e. 10 mol metal ion per one mol His-CP) were added to a 
solution of His-CP in phosphate buffer pH 7.5. The metal ion was dissolved in 5% of the 
protein solution volume of MQ. The mixture was stirred for 1 h at RT.
Stabilization of T=3 capsid structure at pH  7.5 by nickel ions
Ten equivalents of NiCl2 were added to a solution of His-CP in acetate buffer pH 5.0. The 
metal ion was dissolved in 5% of the protein solution volume of MQ. The mixture was 
stirred for 1 h at RT and the sample was subsequently dialyzed to a phosphate buffer pH 7.5 
for at least 3 hrs.
ICP-MS and ICP-OES
Nickel stabilized His-CP capsids were purified using FPLC to remove non-bound nickel and 
non-assembled proteins. FPLC fractions eluting at V=1.2 mL were dissolved in 1% (v/v) 
nitric acid in water. The concentrations of Ni and S were determined on a Thermo Fisher 
scientific IRIS Intrepid II XDL ICP-OES machine and the concentration of Ni was verified 
on a Thermo Fisher scientific X-series ICP-MS machine.
Protein labeling
A solution of capsid protein (500 ^L, ~ 3 mg/mL) in 0.1 M phosphate buffer pH 7.5, 0.15 M 
NaCl, was added to a vial containing 50 ^g DyLightTM NHS-ester (488 or 549 used for His- 
CP and 647 for wt CP) and stirred for 1 h at RT. The non-coupled dye was removed by 
dialysis to a buffer pH 7.5 or pH 5.0.
Mixed His-CP wt CP capsids
Dylight labeled His-CP and wt CP in phosphate buffer pH 7.5 were mixed in the desired ratio 
for 10 min. at 4oC, prior to dialysis to acetate buffer pH 5.0, to induce assembly.
147
Metal induced formation and stabilization o f the CCMV capsid
Encapsulation of EGFP using coiled-coils in nickel stabilized capsids at pH  7.5
Expression and purification of the EGFP-capsid protein complex was carried out according 
to a literature procedure.12
90% His-CP was mixed with 10% EGFP-capsid protein complex for 10 min. and capsid 
assembly was induced by dialysis to acetate buffer pH 5.0. The capsids were then either 
purified on FPLC equipped with a superose 6 column to remove all non-encapsulated 
proteins, or directly stabilized without purification. Capsids were stabilized by addition of 10 
equiv. of NiCl2. This mixture was stirred for 1 h at RT and the samples were subsequently 
dialyzed to a phosphate buffer pH 7.5 for at least 3 hrs.
Calculations
To determine the ratio of wt CP and His-CP in the mixed nickel stabilized capsids (figure 
12c), the different dye absorptions were used. Wt CP and His-CP were separately labeled 
with two different dyes. Wt CP was labeled with Dylight™ 647 and His-CP was labeled with 
Dylight™ 488. Since the proteins were not labeled with equal efficiency and the extinction 
coefficients of the dyes are different, the measured absorptions can not be compared directly. 
It is however possible to calculate a correction factor and using this correction factor the two 
absorptions can be compared directly, i.e. equal absorption then indicates the presence of 
equal amounts of protein.
Since the ratio between the His-CP and wt CP in the sample is known, the absorbance of all 
eluted peaks in the FPLC trace should reflect this ratio after using the correction factor. So if 
90% of the sample consists of His-CP, then the total absorption of all peaks at X=488 nm, 
should be 90% of the combined absorptions at X=650 nm and X=488 nm. The corrected 
absorption for wt CP would then be nine times less then this absorption, since the wt CP only 
constitutes 10% of the sample.
Error! Bookmark not defined. a — Ahis-cp fractionwtCP corrected r .. J 'uouu'‘wtCPf r actwnHÜ-CP
If we divide the real wt CP absorption by the correction factor, we should obtain the 
corrected absorption value.
AA — ______ ^ wtCP_____
wtCP corrected r ,correction _  fac to r  
So if we combine both formulas, we obtain the formula for the correction factor.
A
correction _ factor — - ""n°
jAh,s cp -fractionw
fraction His-CP
This correction factor can now be calculated for every sample, and the corrected absorption 
values can directly be used to calculate the percentage of wt CP or His-CP in the capsids, 
since the ratio between the absorptions of both dyes now directly reflects the ratios of the 
proteins.
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Catalytic capsids: the effect o f confinement*
Introduction
To better understand the complex workings of the cell, it is important to appreciate 
the interplay between the enzyme and its environment. In the cell, enzymes are 
invariably spatially confined in crowded and tightly controlled cellular organelles. 
Even in bacteria, which do not have organelles, enzyme loaded MCPs have been 
recently discovered, which have a similar function. It is therefore important to study 
enzymes in an environment which mimics these confined conditions where normal 
solution reaction kinetics is no longer valid. It is, however, challenging to find 
suitable biomimetic containers and to entrap enzymes within these artificial systems 
in a controlled way. Polymeric vesicles,1,2 mimicking lipid vesicles, are a 
commonly employed system for the encapsulation of enzymes as these are robust 
and easy to use. Despite their potential, their relatively large size (diameter (D) = ~ 
100 nm) combined with usually a high polydispersity results in non-uniform 
reaction conditions in each vesicle hindering kinetic analysis.
In contrast, protein cages, like virus capsids, can have diameters of only tens of 
nanometers and are exceptionally monodisperse. Viruses are the most abundant 
biological entities on earth,3 and are mostly known for their infectious properties. 
They often consist of only one or a few different protein components and nucleic 
acids, presented by Nature in numerous variations. Their simple composition makes 
them very useful as versatile nanobuilding blocks, e. g. for the creation of 
conductive nanowires,4 MRI contrast agents5 and drug delivery systems.6
One example of a frequently used virus is CCMV. Its unique assembly 
properties have been used to encapsulate inorganic materials,5,7 negatively charged
* This work was published: Chem. Sci., 2010, DOI: 10.1039/C0SC00407C
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polymers,8,9 or even enzymes10 by adding these molecules during the assembly 
process.
The encapsulation o f single enzyme molecules inside the CCMV capsid by a 
statistical procedure has already been demonstrated.10 Following up on this work, 
we have described a method using coiled-coils to encapsulate multiple proteins in 
the confined space o f the CCMV capsid (see chapter 6).11 This method significantly 
increases the encapsulation efficiency and, most importantly, provides control over 
the average number of encapsulated proteins. This directed assembly process 
closely matches the strategy used by Nature to pack enzymes into MCPs via short 
N-terminal peptide sequences.12 In this chapter, we aim to use this method to 
encapsulate the enzyme Pseudozyma (formerly Candida) antarctica lipase B (PalB) 
and to investigate the overall reaction rate as a function o f the number of 
encapsulated PalB molecules. In addition we co-encapsulated EGFP as a non- 
catalytic protein to investigate the reaction rate as a function o f the total protein 
concentration inside the capsid.
Results and Discussion
pH 7.5 pH 7.5 PH 5.0
Capsid-K-coil PalB-E-coil PalB-E-coil + Capsid-K-coil Capsid
and His-tag labeled with dye with PalB
Figure 1 Schematic representation o f PalB encapsulation. Capsid with K-coil and His-tag 
will be referred to as capsid protein in the text, PalB with E-coil will be referred to as PalB 
in the text. The PalB-capsid protein complex is mixed with wild-type capsid at pH  7.5 and 
subsequently dialyzed to pH  5.0 to induce capsid formation.
PalB (EC 3.1.1.3), a widely used biocatalyst, was chosen as the model enzyme 
since it retains most o f its activity at pH 5.0.13 PalB was genetically modified with 
the E-coil monomer of the heterodimeric coiled coil, while the capsid protein was 
modified with the complementary K-coil (see chapter 6). To enable the 
encapsulation efficiency to be determined, PalB was labeled with the fluorescent 
dye Alexa Fluor 568. Coiled-coil formation was achieved by simply mixing capsid
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protein with PalB. The resulting complex was purified by size exclusion 
chromatography and subsequently mixed with wildtype capsid protein in various 
ratios to form capsids with different amounts o f encapsulated PalB. This capsid 
assembly was induced by lowering the pH to 5.0 (figure 1). Following assembly, 
the capsids were purified and analyzed by size exclusion chromatograpy using a 
Superose 6 column (figure 2) and TEM (figure 3). The UV-Vis absorption o f the 
protein and the dye was monitored during the run and the ratio between the dye- 
specific and protein-specific absorption of the non-encapsulated CalB was used to 
determine the amount o f CalB encapsulated per capsid (see experimental section). 
Four different batches of capsid were made, with on average 1.3, 2.0, 3.5 and 4.0 
CalB enzymes per capsid.
Figure 2 Analysis o f proteins and capsids. A) Silver stained SDS-PAGE gel o f proteins and 
protein complexes used in the experiments. M  indicates the marker, molecular weights are 
given in kDa. Lane 1: wt CP. Lane 2: Capsid protein with K-coil. Lane 3: PalB-capsid 
protein complex after purification on FPLC. Lane 4: PalB with E-coil. Lane 5: GE-CK 
complex. B) Immuno blots. Lane 1: wt CP. Lane 2: Capsid protein with K-coil. Lane 3: 
Capsid protein with K-coil and PalB with E-coil. Left blot was probed with anti-CCMV 
antibody, right blot was probed with anti-PalB antibody.
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C) FPLC trace o f a mixture o f PalB-capsid protein complex with wt CP at pH  5.0. The FPLC 
system is equipped with a Superose 6 column. The thick black line represents the protein 
absorption at 1=280 nm, and the thin black line the absorption o f the dye with which PalB is 
labeled at 1=586 nm. The capsid with encapsulated PalB elutes at V=1.1 mL, and the 
unassembled capsid dimers and o f PalB-capsid protein complex elute at V ~1.8 mL.
Figure S TEM micrographs o f uranyl acetate stained samples. A) Empty wild-type capsids. 
B) Capsids filled with 1 PalB per capsid C) Capsids filled with 4 PalB per capsid. D) 
Capsids filled with 1 PalB and 7 EGFP per capsid.
In steady-state enzyme kinetic measurements, when the concentration o f the 
substrate is well above KM, the enzyme functions at its maximum rate (kcat). The 
reaction rate is then directly proportional to the enzyme concentration in solution. 
To test if  this is also true for our confined system, the four samples containing 
different amounts o f encapsulated PalB and a sample with non-encapsulated PalB 
were diluted such that the concentration of PalB was the same for all samples 
(figure 5a). To determine the overall reaction rate o f these different samples, the 
pro-fluorescent substrate 6,8-difluoro-4-methylumbelliferyl octanoate (DiFMU- 
octanoate) was added to give a final concentration o f 40 ^M, which is well above 
the Km values o f 8.8 ^M  determined in this study (see figure 4a and experimental
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section) and 2.6 reported for PalB and DiFMU octanoate in the literature.14,15 
The initial reaction rates were calculated and normalized with respect to the sample 
with the lowest encapsulated enzyme concentration (see figure 5b and experimental 
section). Since the overall enzyme concentration is the same in all five samples, the 
reaction rates should also be the same, if  these were to follow standard Michaelis­
Menten reaction kinetics. We observed, however, that the reaction rate is inversely 
proportional to the number of encapsulated enzymes (figure 5c) and the 
encapsulated enzymes appeared to outperform the non-encapsulated PalB.
0 20 40 60 80 100
time/ min
Figure 4 A) Michaelis-Menten saturation curve o f the normalized initial reaction rate versus 
the DiFMU concentration. The KM value calculated from this data is 8.8 ^M. B) Plot o f the 
normalized initial rate versus PalB concentration. DiMFU concentration was 40 juM. C) 
DiFMU substrate conversion curves. The concentration o f PalB was the same in all samples. 
Grey line depicts buffer with DiFMU, thin dotted line depicts the control sample with non­
encapsulated PalB, solid thin line depicts sample with 4 PalB/capsid, thin line with crosses 
depicts sample with 3.5 PalB/capsid, thin line with squares line depicts sample with 2 
PalB/capsid, and thick black line depicts sample with 1.3 PalB/capsid.
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4 PalB /capsidl PalB /capsid 4 PalB free
* .
A *
a ♦
1 2  3 4
number of PalB enzymes per capsid
Figure 5 Kinetics o f encapsulated PalB. The concentration o f PalB is the same in all 
samples. A) Schematic representation o f experimental setup. B) Initial rates normalized with 
respect to 1.3 PalB/capsid. Black bars represent initial rates o f samples with encapsulated 
PalB. White bars indicate normalized initial velocity o f non-encapsulated PalB (one 
experiment was plotted four times for clarity.) Error bars indicate SD o f triplicate 
experiments. C) Normalized initial rates plotted against the number o f encapsulated PalB 
enzymes per capsid. Filled diamonts represent capsid with encapsulated PalB; open 
triangles represent capsids with the indicated number o f PalB and 7 EGFP proteins. Error 
bars indicate SD o f triplicate experiments. The dashed line indicates the initial velocity o f 
non-encapsulated PalB.
1.3 2.0 3.5 4.0
number of PalB enzymes per capsid
It should be noted that the overall amount o f capsids is higher in the samples 
with less PalB per capsid. In order to eliminate any effect o f the capsid on the 
catalytic reaction, four samples containing different amounts o f PalB were diluted 
such that all samples contained the same amount o f capsids. Since the concentration 
of PalB is now different for each sample, four different control experiments were 
performed, in which the concentration o f non-encapsulated PalB was the same as 
for the corresponding encapsulated PalB samples (figure 6a). As expected, the 
initial reaction rates o f non-encapsulated PalB increase with increasing enzyme 
concentrations (figure 6b). The initial reaction rates of the encapsulated PalB 
samples, however, are relatively constant within experimental error.
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1 PalB /capsid 1 PalB free 4 PalB /capsid 4 PalB free
1.3 2.0 3.5 4.0 1-3 2.0 3.5 4.0
number of PalB enzymes per capsid number of PalB enzymes per capsid
Figure 6 Kinetics o f encapsulated PalB. The concentration o f capsid is the same in all 
samples. A) Schematic representation o f the experimental setup. B) Initial rates normalized 
with respect to 1.3 PalB/capsid experiment reported in figure 5b. The reduced normalized 
rate with respect to figure 5b is a result o f the absolute dilution in order to obtain the same 
concentration o f capsid in all samples. Black bars represent initial rates o f samples with 
encapsulated PalB. White bars indicate the normalized initial rate o f non-encapsulated PalB. 
Error bars indicate standard deviation o f triplicate experiments. C) Normalized initial rates 
per PalB and per capsid; values are obtained by dividing the values o f the initial rates o f 
graph B by the number o f PalB enzymes per capsid.
Dividing the activity of the non-encapsulated PalB by its concentration (figure 
4c), the calculated activity should be the same for the four different samples. Within 
experimental margins this is the case. The calculated activity of the encapsulated 
PalB, however, appears to be the largest when only one or two PalB molecules are 
encapsulated per capsid, suggesting that an increase in the protein concentration 
inside the capsid might have a negative effect on the reaction rates due to some 
form of crowding effect.
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In summary, these results show two remarkable effects of the encapsulation of 
PalB in the very confined space of the CCMV capsid, i.e. (i) encapsulated PalB 
seems to outperform the non-encapsulated PalB, and (ii) the presence of more 
PalBs per capsid does not lead to an increase in the overall reaction rate. The former 
of the two effects could be the result o f a change in kcat upon encapsulation inside 
the virus. It is known that PalB is more active when immobilized, and one could 
argue that the enzyme is immobilized within the capsids. Furthermore, Chen et al.16 
have shown that in vesicle systems the turnover number (kcat) of entrapped enzymes 
increases when the vesicle size becomes smaller. They observed a 2-fold increase in 
turnover number going from non-encapsulated enzymes to enzymes spatially 
confined within vesicles with an internal volume of 5 atto liter (5*10-18 L), and an 
additional 2 -fold increase going from these vesicles to vesicles with an internal 
volume of 0.05 atto liter. In contrast, the second effect (ii) could be explained by a 
crowding effect inside the virus. This potential contribution of crowding will be 
discussed in more detail below.
Both effects together can be readily explained by a change in the effective 
molarity of the enzyme in the confined space of the capsid, which we define as 
confinement molarity Mconf. The internal volume of the CCMV capsid is 
approximately 5 zepto liter (5*10-21 L), a factor 10 smaller than the smallest 
vesicles tested in the paper by Chen et al. In this small volume Mconf for the 
encapsulated enzyme is ~1mM, which is a factor 104 higher than the bulk enzyme 
concentration (30-100 nM). Assuming that the rate of diffusion through the capsid 
pores is significantly larger than the rate of catalysis and that the concentration of 
substrate inside the capsid and outside the capsid is equal (steady state situation) we 
can calculate that the enzyme concentration inside the capsid is approximately 25 
times higher than the substrate concentration of 40 ^M. Considering that KM is not 
altered as a result of the encapsulation, the high Mconf can therefore be expected to 
shift the equilibrium towards the formation of the enzyme-substrate complex 
thereby increasing the reaction rate. The observed results clearly highlight that the 
advantage of confinement is the shifting of the enzyme-substrate equilibrium 
completely in the direction of the enzyme-substrate complex. Faster formation of 
the enzyme substrate complex might be further assisted by an increased number of 
collisions between the enzyme and the substrate resulting from the confinement as 
has been shown by Chen et al. 16
Having explained the overall increase in reaction rate, we can now look at the 
number of molecules inside the capsid in more detail to explain why the reaction
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rate does not increase with an increasing number of enzymes in the capsid. Using a 
Poisson distribution the chance that two or more substrates are present in the capsid 
at the same time can be calculated. This chance is 0.64%, which is negligible low. 
In fact, only ~10% of the capsids do contain a substrate molecule at all. It therefore 
makes no difference whether a capsid contains one or more enzymes, as there is 
maximally only one substrate molecule present. In other words, a consequence of 
the high Mconf is that upon going from 1 to 4 enzymes in the capsid the change in 
Mconf is so small that it has a minimal effect on the overall reaction rate. It should be 
noted that in solution the substrate concentration is in excess whereas in the capsid 
the enzyme concentration is in excess.
A possible effect of crowding within the capsid upon increasing in the number 
of enzymes cannot be fully discarded. To investigate a potential crowding effect, 
EGFP was co-encapsulated with PalB, which was labeled with a fluorescent dye. 
This protein does not contribute to product conversion. Two samples were prepared, 
one containing 1 PalB and 7 EGFP per capsid and the other containing 3 PalB and 7 
EGFP per capsid. Co-encapsulation of the enzyme and the protein was 
demonstrated by Dual-Color Fluorescence Cross-Correlation Spectroscopy (FCCS). 
Control experiments o f capsid containing exclusively PalB or EGFP showed only 
auto-correlation in the appropriate channel and little cross-correlation, while 
analysis o f the samples containing both proteins clearly showed cross-correlation 
(figure 7) proving that indeed both biomacromolecules are present in the same 
capsid. From the FCCS data a typical dwell time of 2 ms was calculated. Assuming 
a 250 nm wide focal volume of the microscope, a diffusion constant of 7.4 ^m2/s 
can be calculated for the CCMV capsid. This corresponds with a Stokes-Einstein 
radius of 29 nm, which is in reasonable agreement with the capsid size known from 
TEM images.
Co-encapsulation of EGFP did indeed result in a small decrease in the 
reaction rate (figure 5c), but since the total protein concentration was approximately 
two times higher than the highest amount of PalB encapsulated, the effect should 
have been more pronounced if  crowding due to the high local enzyme concentration 
would really have been the only cause for the decrease in activity. Instead the 
observed lower reaction rate in figure 5c might be attributed to a decreased 
diffusion speed of the substrate and product molecules over the capsid shell. The 
EGFP and PalB molecules are attached to the N-termini of the capsid proteins and 
thus located in the vicinity of the pores in the capsid shell.
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Figure 7 Dual color FCCS correlation curves o f CCMV capsids containing EGFP (grey 
circles), PalB (black circles) or both. When EGFP is encapsulated, there is correlation in the 
green channel B, while when PalB is encapsulated there is correlation in the red channel A. 
but only when both compounds are present in the same capsid the cross-correlation arises. 
The EGFP fluorescence extends to the red wavelengths, so some of the emission of EGFP is 
also recorded in the red channel, thereby causing some red channel auto-correlation even 
when the red dye Alexa Fluor 568 is absent.
There are 20 pores o f D = 2 nm in the capsid shell, together covering roughly 
1% of the solvent-exposed outer surface of the capsid. Therefore diffusion over the 
capsid wall is likely slower than diffusion in solution.8 If  diffusion over the capsid 
wall would be slower than the substrate conversion, diffusion could be the rate- 
limiting step. This is unlikely however, since substrate conversion of native PalB is 
about nine orders o f magnitudes slower than unhindered diffusion of a substrate 
molecule over the capsid wall. This diffusion rate however could be affected by an 
increasing number o f proteins close to the pores, which will then result in a reduced 
overall reaction rate, as is observed (figure 5 c).
160
Chapter 9
Conclusion
We have studied the effects o f encapsulation o f multiple PalB enzymes in the 
spatial confinement of the CCMV capsid. The spatially confined PalB seems to 
have a higher activity than non-encapsulated PalB (figure 8). Although this might 
be caused by the immobilization o f PalB in the capsid viz. a chance in kcat, there is 
no evidence for this. It is more likely that the observed effect is caused by the high 
effective concentration o f the enzyme combined with an increased chance of 
collisions due to the spatial confinement. Since a capsid rarely contains more than 
one substrate molecule, one enzyme is sufficient to convert the substrate, and the 
presence o f additional enzymes has only a minimal effect on the reaction rate. 
Further research will be needed to confirm this theory by varying the substrate 
concentration, which in the described system however is hindered by the limited 
solubility of the DiFMU.
Increased activity
Figure 8 Scheme representing the main findings o f this chapter.
We have shown in this chapter that it is indeed possible to encapsulate two 
different proteins inside the CCMV capsid, i.e. EGFP and PalB. In the future 
multiple different enzymes, capable of performing cascade reactions might be 
incorporated in the CCMV capsid using this method. When multiple different 
enzymes are encapsulated in the CCMV capsid it can readily be predicted that due 
to Mconf the reaction rate o f the cascade reactions will be considerably enhanced. 
The converted substrate o f one encapsulated enzyme would more likely collide and 
bind with another enzyme in the capsid than diffuse through the capsid wall. Thus 
the converted substrate would react with a different enzyme present in the same 
capsid at a much faster rate than if  the enzymes were not encapsulated. The study of 
cascade reactions in confinement could not only potentially provide insight into the 
mechanisms of enzymatic cascade reactions inside cellular organelles, but also lead 
to the creation of a highly efficient nano-sized reaction vessels with potential 
industrial applications.
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Materials
Protein concentrations were determined using a Cary 50 Conc (Varian, Middelburg) UV-VIS 
spectrophotometer using a quartz cuvet with a path length of 3 mm.
FPLC measurements were performed using either a Superose 6 PC 3.2/30 analytical column 
or a Superdex 200 PC 3.2/30 analytical column from GE lifesciences, on an Amersham Ettan 
LC system, fitted with a fractionating device. Buffers for FPLC were filtered with a 
Millipore 0.2 ^M filter before use. TEM grids (Formvar-Carbon) were exposed to an electron 
discharge treatment using a Cressington Carbon coater and power unit. The sample was 
applied to the grids by adding a 5 ^L drop of sample solution (~ 0.2 mg/mL) to the grid and 
carefully removing it after 1 minute immersion using a filter paper. The grid was allowed to 
dry for at least 15 min. before applying 5 ^L of a 2% (w/v) uranyl acetate aqueous solution, 
which was removed after 15 s. The grid was again allowed to dry for at least 15 min. 
Samples were studied on a JEOL JEM-1010 TEM (Jeol, Japan).
DLS measurements were performed on a Zetasizer Nano S (Malvern Instruments Ltd, 
England),
Restriction enzymes and Antartic Phosphatase were obtained from New England Biolabs. 
DNA containing the coiled-coil sequences was obtained from Biolegio (Nijmegen, The 
Netherlands).
Fluorescence for enzyme kinetics was measured in 96-well flat-bottom microplates on a 
Wallac Victor 1420 multilabel counter.
Two buffers were used, a buffer pH 7.5 (0.5 M NaCl, 0.05 M Tris-HCl, 0.01 M MgCl2 and 
0.001 M EDTA) and buffer pH 5.0 (0.5 M NaCl, 0.05 M NaCH3COO, 0.01 M MgCl2 and
0.001 M EDTA), the pH of the buffers was set with HCl.
Capsid protein with K-coil and His-tag construction in vector pET-15b
The insert containing the K-coil DNA sequence was designed to have a 5’ NdeI and a 3’ 
NdeI restriction site overhang after annealing of the strands (table 1). The pET-15b vector 
containing the capsid protein sequence was digested sequentially with NdeI, 
dephosphorylated with Antartic Phosphatase, and purified by agarose gel elecrophoresis. The 
vector was mixed with the annealed insert and ligated with T4 DNA ligase. The resulting 
plasmids were redigested with NdeI. The insert was designed such that after ligation the 
plasmid would not contain NdeI restriction sites anymore. Thus ensuring that only plasmids 
with the insert would not be liniarized by the digestion. The plasmids were then transformed 
into E. coli XL1-Blue cells, the DNA was extracted and the sequence of the capsid protein 
with K-coil and his-tag was confirmed by DNA sequencing. The plasmids were then 
transformed into E. coli BL21(DE3)pLysS cells, which were used for production of the 
capsid protein with the K-coil and His-tag.
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Table 1 DNA and amino acid sequences. DNA sequences fo r  the inserts used fo r  the creation 
o f the His-CK and PalBE proteins. Overhangs are complementary with the overhangs in the 
vector sequences, created with restriction enzymes. Amino acid sequences fo r  wt CP, His-CK 
and PalBE protein. K-coil and E-coil amino acid sequences are printed in bold lettering.
First line: K-coil forward (5 ’^ 3 ’). second line: K-coil reverse (3 ’^ 5 ’)
TAGCAAAATTGCCGCGCTGAAAGAAAAAATTGCGGCCCTGAAAGAAAAAATCGCGGCGCTGAAAGAAGG
C G T T T T A A C G G C G C G A C TTTC TTTTTTA A C G C C G G G A C TTTC TTTTTTA G C G C C G C G A C TTTC TTC C A T
First line: E-coil forward (5 ’^ 3 ’). second line: E-coil reverse (3 ’^ 5 ’)
TCGACGAAATTGCGGCGCTGGAAAAAGAAATTGCGGCGCTGGAAAAAGAAATTGCGGCGCTGGAAAAACTGGTGCCGCGCGGCAGCG
G CTTTA A CG CCG CG A CCTTTTTCTTTA A CG CCG CG A CCTTTTTC TTTA A C G C C G C G A C C TTTTTG A C C A C G G C G C G C C G TC G C A G C T
W t CP amino acid sequence
MSTVGTGKLTRAQRRAAARKNKRNTRVVQPVIVEPIASGQGKAIKAWTGYSVSKWTASCAAAEAKVTSAITISLPNELSSERNKQ
LKVGRVLLWLGLLPSVSGTVKSCVTETQTTAAASFQVALAVADNSKDVVAAMYPEAFKGITLEQLAADLTIYLYSSAALTEGDVI
VHLEVEHVRPTFDDSFTPVY
Capsid with His-tag and K-coil amino acid sequence
MGSSHHHHHHSSGLVPRGSHSKIAALKEKIAALKEKIAALKEGMMSTVGTGKLTRAQRRAAARKNKRNTRVVQPVIVEPIASGQG
KAIKAWTGYSVSKWTASCAAAEAKVTSAITISLPNELSSERNKQLKVGRVLLWLGLLPSVSGTVKSCVTETQTTAAASFQVALAV
ADNSKDVVAAMYPEAFKGITLEQLAADLTIYLYSSAALAEGDVIVHLEVEHVRPTFDDSFTPVY
PalB with E-coil amino acid sequence
MKYLLPTAAAGLLLLAAQPAMAMGLPSGSDPAFSQPKSVLDAGLTCQGASPSSVSKPILLVPGTGTTGPQSFDSNWIPLSAQLGY
TPCWISPPPFMLNDTQVNTEYMVNAITTLYAGSGNNKLPVLTWSQGGLVAQWGLTFFPSIRSKVDRLMAFAPDYKGTVLAGPLDA
LAVSAPSVWQQTTGSALTTALRNAGGLTQIVPTTNLYSATDEIVQPQVSNSPLDSSYLFNGKNVQAQAVCGPLFVIDHAGSLTSQ
FSYVVGRSALRSTTGQARSADYGITDCNPLPANDLTPEQKVAAAALLAPAAAAIVAGPKQNCEPDLMPYARPFAVGKRTCSGIVT
PLDEIAALEKEIAALEKEIAALEKLVPRGSVEHHHHHH
PalB with E-coil construction in vector pET-22b
The insert containing the E-coil DNA sequence was designed to have a 5’ XhoI and a 3’ 
XhoI restriction site overhang after annealing of the strands (table 1).
The pET-22b vector containing the PalB protein sequence was digested with XhoI, 
dephosphorylated with Antartic Phosphatase, and purified by agarose gel elecrophoresis. The 
vector was mixed with the annealed insert and ligated with T4 DNA ligase. The resulting 
plasmids were redigested with XhoI. The insert was designed such that after ligation the 
plasmid would not contain XhoI restriction sites anymore. Thus ensuring that only plasmids 
with the insert would not be liniarized by the digestion.
The resulting plasmids were transformed into E. coli XL1-Blue cells, the DNA was extracted 
and the sequence of the PalB with E-coil was confirmed by DNA sequencing. The plasmids 
were then transformed into E. coli BL21(DE3)pLysS cells, which were used for production 
of the PalB enzyme with the E-coil.
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Expression of capsid protein with K-coil and His-tag
One colony of BL21(DE3)pLysS cells expressing His-CK was used to inoculate 100 mL of 
LB medium containing ampicilin (0.050 g/L) and chloramphenicol (0.025 g/L). After growth 
overnight at 30°C this culture was used to inoculate 900 mL of LB medium containing 
ampicilin (0.05 g/L) and chloramphenicol (0.025 g/L) and grown at 30°C. Protein expression 
was induced during logarithmic growth (OD600 =0.4-0.6) by addition of IPTG to a final 
concentration of 1 mmol/L. After induction the culture was grown at 30°C for 5 hrs.
Expression of PalB with E-coil
One colony of BLR (DE3) pLysS cells expressing PalB with E-coil was used to inoculate 
100 mL of 2xTY medium containing ampicilin (0.05 g/L) and tetracycline (0.0125 g/L). 
After growth overnight at 30°C this culture was used to inoculate 100 mL of 2xTY medium 
containing ampicilin (0.05 g/L) and tetracycline (0.0125 g/L) and grown at 30°C. Protein 
expression was induced during logarithmic growth (OD600 =0.4-0.6) by addition of IPTG to a 
final concentration of 1 mmol/L. After induction the culture was grown at 25°C for 20 hrs.
Purification of capsid protein with K-coil and His-tag
E. coli cells containing the capsid protein with K-coil and His-tag were harvested by 
centrifugation at 4000 g for 15 min. at 4°C. The supernatant was discarded and the pelletted 
cells were stored at -20°C. After thawing, the pelletted cells were resuspended in 
approximately 10 mL lysis buffer (50 mM NaH2PO4, 10 mM imidazole and 2000 mM NaCl 
pH 8.0). Approximately 10 mg of lysosyme (EC 3.2.1.17 from Fluka) was added and the 
solution was incubated at 4°C for 30 min. The solution was sonicated for 5 times 10 s with 
duty cycle 40 and output control 6 (Branson Sonifier 250, marius instruments Nieuwegein, 
the Netherlands). RNase (10 ^g/mL) and DNase (5 ^g/mL) was added and the mixture was 
incubated at 4°C for 15 min. The solution was centrifuged at 10,000 rpm for 20-30 min. to 
pellet the cellular debris. The supernatant of was incubated with 0.5 mL of Ni-NTA agarose 
beads for 1 h at 4°C. The flow-through was collected and the column was washed with 20 
mL of wash buffer (50 mM NaH2PO4, 25 mM imidazole and 2000 mM NaCl pH 8.0). The 
capsid protein was eluted from the column using approximately 10 mL of elution buffer (50 
mM NaH2PO4, 250 mM imidazole and 2000 mM NaCl pH 8.0) and the protein was collected. 
The capsid protein was dialyzed overnight to buffer pH 7.5, to remove the excess of 
imidazole. The protein purity was checked with SDS-PAGE (figure 2).
Purification of PalB with E-coil
E. coli cells containing the PalB with E-coil enzymes were harvested by centrifugation at 
4000 g for 15 min. at 4°C. The supernatant was discarded and the pelletted cells were stored 
at -20°C. After thawing, the pelletted cells were resuspended in approximately 10 mL 
lysisbuffer (50 mM NaH2PO4, 10 mM imidazole and 300 mM NaCl pH 8.). Approximately 
10 mg of lysosyme (EC 3.2.1.17 from Fluka) was added and the solution was incubated at
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4°C for SÖ min. The solution was sonicated for S times 1Ö s with duty cycle 4Ö and output 
control 6 (Branson Sonifier 2SÖ, marius instruments Nieuwegein, the Netherlands). The 
solution was centrifuged at 1ö,ööö rpm for 2Ö-SÖ min. to pellet the cellular debris. The 
supernatant of was incubated with Ö.S mL of Ni-NTA agarose beads for 1 h at 4°C. The 
flow-through was collected and the column was washed with 2ö mL of wash buffer (Sö mM 
NaH2PO4, 2Ö mM imidazole and SÖÖ mM NaCl pH S.Ö). PalB was eluted from the column 
using approximately 1Ö mL of elution buffer (SÖ mM NaH2PO4, 2SÖ mM imidazole and SÖÖ 
mM NaCl pH S.Ö) and the protein was collected. PalB was dialyzed overnight to phosphate 
buffer pH 8^  (1ÖÖ mM phosphate, 1SÖ mM NaCl), to remove the excess of imidazole. The 
protein purity was checked with SDS-PAGE (figure 2).
Production and purification of wt CP
The purification of the CCMV virus and the removal of its RNA were carried out according 
to literature procedures17,18.
Formation and purification of PalB-capsid protein complex
PalB with E-coil was labeled with Alexa Fluor® S68. Excess dye was removed by dialyses to 
buffer pH 7. S. Approximately 1/S of the obtained labeled PalB with E-coil was further 
purified by FPLC equipped with a Superdex 2ÖÖ column. The rest of the labeled PalB with 
E-coil was added to an two times excess of His-CK and stirred for at least 16 h at 40C to 
form the PalB-capsid protein complex. The PalB-capsid protein complex was further purified 
by FPLC equipped with a Superdex 2ÖÖ column to remove any non-complexed PalB, capsid 
protein or other proteins. Pure PalB with E-coil eluted at V=1.6 mL as detected at X=28ö and 
S86 nm or, whereas the PalB-capsid protein complex eluted between V=1.S-1.S mL.
PalB with E-coil encapsulation
PalB-capsid protein complex in buffer pH 7^ (SÖ mM Tris-HCl, SÖÖ mM NaCl, 1Ö mM 
MgCl2, 1 mM EDTA pH 7^) was added in different ratios to wild type capsid protein in the 
same buffer. For the co-encapsulation of EGFP and PalB, GE-CK complex11 was also added 
to the mixture. The proteins were allowed to mix for S min., before dialysis of the mixture 
overnight to buffer pH S.Ö. The mixtures and non-encapsulated PalBE were then purified and 
analyzed on an FPLC system equipped with a Superose 6 column.
Sample preparation
Fusion proteins consisting of monomers of the coiled coil motif and PalB (E-coil), EGFP (E- 
coil) or the capsid protein (K-coil) were expressed in E. coli and purified by Ni2+-NTA 
chromatography using standard protocols. The PalB fusion protein was fluorescently labeled 
with NHS-Alexa Fluor S68. Prior to capsid assembly, coiled coil complexes were formed 
between PalB and capsid protein as well as between EGFP and capsid protein. Complexes 
were mixed with wildtype capsid protein in the desired ratios in pH 7^ buffer. Lowering the
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pH to 5.0 by dialysis induced capsid assembly. Characterization of the coiled coil complexes 
as well as of the assembled capsids were performed using size exclusion chromatography. 
The absorption at 280 nm or 586 nm was used to determine the concentration of capsid 
protein or labeled PalB, respectively, neglecting the small contribution of PalB to the 
absorption at 280 nm.
Calculations o f PalB encapsulation
The number of PalB enzymes in a capsid can be calculated similarly to the number of EGFP 
molecules in a capsid (chapter 6)11, by using the absorption ratios of the protein absorption 
(X=280 nm) and the dye absorption (X=586 nm) at the capsid peak (V=1.1 mL) from the 
FPLC data.
Enzyme activity measurements
For the enzyme activity measurements with 6,8-difluoro-4-methylumbelliferyl octanoate 
(DiFMU-octanoate) either the concentration of PalB or the concentration of capsid was kept 
constant for all measured samples. Reactions were performed in triplicate using a microplate 
reader (Xex = 355 nm and Xem=460 nm). The reaction was started with the addition of 
DiFMU-octanoate. The initial reaction rates were calculated from the obtained data by 
determining the slope of the initial part of the curves. These values were then normalized by 
dividing all initial slopes by the same value (i.e. the obtained initial velocity for 1.3 
PalB/capsid were the concentration of PalB was kept constant throughout the experiment).
Dual-color fluorescence cross-correlation spectroscopy (FCCS)
This work will be described in detail elsewhere: V.I.Claessen, Thesis, Radboud University 
Nijmegen.19 Laser light of 488 nm (Spectra-Physics 2080 argon ion laser) and 568 nm 
(Coherent CR-599 dye laser, pumped by 532 nm Spectra-Physics Millennia Nd:YAG laser) 
was coupled into a single-mode optical fiber, reflected by a dichroic beam splitter (Chroma 
z488/568rpc) and focused onto the sample by an oil immersion 100x objective (Carl Zeiss, 
NA = 1.30), which was mounted on a Carl Zeiss Axiovert 200 inverted microscope. 
Fluorescent light coming from the focal volume was collected by the same objective, passed 
through the dichroic beamsplitter, focused through a 100 ^m pinhole, split by a second 
dichroic mirror (Chroma 560dcxr), filtered by either a ‘red’ (Chroma D630/60m) or ‘green’ 
filter (Chroma HQ525/50m) and focused onto avalanche photodiodes (PerkinElmer SPCM- 
AQR-14). The photon count signals were recorded using a Picoquant PicoHarp 300E TCSPC 
module.The focal volume was positioned in a solution of CCMV capsids containing EGFP, 
PalB or both. EGFP is autofluorescent and is excited at 488 nm, the PalB was labeled with an 
Alexa568 dye which is excited at 568 nm. Emission of both fluorophores was filtered and 
recorded by separate photodetectors. The photon correlation functions were calculated using 
matlab scripts developed in-house. Curves were normalized on the G(0) parameter and then 
multiplied by the r-square of the fit for clarity.
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Summary
Viruses are increasingly utilized as nano building blocks. Their unparalleled 
ability to self-assemble into precisely defined nano-sized structures makes them 
uniquely suitable as nano-reactors or drug-delivery systems, and as novel materials. 
Nature has provided us with a multitude of virus types to choose from, each bearing 
their own distinct characteristics.
In our group, we are working with the cowpea chlorotic mottle virus (CCMV), 
an icosahedral RNA-containing plant virus with interesting assembly properties. It 
is possible to remove the RNA to obtain an empty virus shell, called capsid. The 
proteins forming the virus shell, i.e. capsid proteins, can be assembled and 
disassembled reversibly by adjusting the pH. Without the stabilizing interactions of 
the negatively charged RNA, the capsid disassembles at pH 7.5 into 90 capsid 
protein dimers. At pH 5.0, the capsid protein dimers re-assemble into the native 28 
nm capsid.
Natural negatively charged polyelectrolytes like RNA are not the only 
compounds capable of templating the formation of capsids at high pH. It was 
previously shown by our group that polystyrene sulfonate (PSS), which is a 
negatively charged polymer, can also induce the formation of a capsid at pH 7.5. 
The obtained assembly, however, is smaller than that formed in the presence of 
RNA as a template at pH 5.0. In chapter 3, we describe studies aimed at obtaining 
more insight into the role of the polyelectrolyte in stabilizing the capsid, namely by 
the encapsulation of a negatively charged redox active polyelectrolyte, 
polyferrocenylsilane (PFS). This polyelectrolyte can be oxidized electrochemically, 
resulting in a polymer with a net neutral charge. Since the capsid is thought to be 
stabilized by the presence of negative charges, oxidation of the polyelectrolyte 
could remove these interactions, which might result in destabilization of the capsid. 
Although the results were inconclusive, it was shown that PFS can also induce the 
formation of a small 18 nm capsid.
In chapter 4, it is demonstrated that capsid-like structures not only assemble 
around linear polyelectrolytes at pH 7.5, but also around micelles formed by DNA 
amphiphiles. This provides a general method to load small molecules into the 
capsid either by hybridization to the DNA or by loading into the hydrophobic core
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of the DNA particles. This could potentially have applications for the development 
of a drug delivery system.
To further explore and expand the properties of the CCMV capsid protein, it 
was heterologeously expressed in E.coli with the objective to perform genetic 
modifications. The production and purification of these genetically modified capsid 
proteins is discussed in chapter 5. They proved to be more resistant to degradation 
than the wild-type protein. The effect of the length of the N-terminus on the PSS- 
induced capsid formation is also described.
Previous studies conducted in our group by Dr. M. Comellas on the 
encapsulation of single enzymes inside the capsid had already provided new 
insights into the way enzymes function. The study of multiple enzymes in the 
confined space of the CCMV capsid was expected to provide greater understanding 
of the effect of confinement and local high concentration on enzyme activity. 
Confinement of enzymes is of interest since it mimics the natural cellular 
environment of enzymes, but the encapsulation of multiple enzymes is very difficult 
to achieve by statistical encapsulation. In chapter 6 , the development of a new 
method, which increases the encapsulation efficiency and also allows control over 
the number of encapsulated enzyme is described s. To this end, an amino-acid motif 
called coiled-coil was attached to the capsid proteins, which could serve as a handle 
to attach proteins of interest. As a first test, enhanced green fluorescent protein 
(EGFP) was attached to the modified capsid proteins, and mixed with wild-type 
capsid protein prior to induction of capsid assembly. The number of encapsulated 
proteins was controlled by varying the ratio between the wild-type capsid protein 
and the capsid protein-EGFP complex. The assembly mechanism of this system 
appeared more complicated than expected and was analyzed in detail. These results 
are described in chapter 7.
Using the method described in chapter 6 , multiple copies o f a functional 
enzyme, Pseudozyma (formerly Candida) antarctica lipase B (PalB), were 
encapsulated inside the capsid. The effect of varying the amount of encapsulated 
PalB on the rate of substrate conversion was studied. The encapsulated PalB 
appeared to convert the substrate faster than the non-encapsulated PalB. 
Furthermore, the amount of encapsulated enzymes seemed to have little effect on 
the efficiency of the reaction. The reaction rates thus appear to be markedly 
influenced by the confinement and the resulting high local concentration of enzyme. 
These studies are described in chapter 9. The encapsulation of multiple different 
enzymes is important for the study of cascade reactions in the confined space of the
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capsid. The method developed in chapter 6 also proved suitable to achieve co­
encapsulation of EGFP and PalB, as reported in chapter 9.
The study of cascade reactions at pH 5.0 is challenging since most enzymes 
are not stable at low pH. This is a major drawback of the use of the CCMV capsid 
as a nanoreactor. Therefore, a new method was developed to stabilize the capsids at 
physiological pH. The N-terminus of the capsid protein was genetically modified 
with a histidine-tag, which is able to bind nickel ions. Capsids were stabilized at 
pH 7.5 by adding nickel ions to assembled capsids at pH 5.0, then increasing the pH 
to 7.5. By mixing EGFP-capsid protein complexes with the capsid proteins bearing 
a histidine tag, we successfully achieved encapsulation of EGFP at pH 7.5.
With the methods described in chapter 6 , 8 and 9, it is now possible to 
encapsulate multiple different proteins and enzymes into the capsid in a controlled 
way, and to stabilize the capsid at physiological pH. It should now be possible to 
study cascade reactions inside the CCMV capsid. This might lead to exciting new 
insights and to the development of efficient nano-reactors.
In order to fully realize the potential of CCMV as nano-building block, it is 
essential to have a thorough understanding of the assembly properties of wild-type 
and modified capsid proteins, and to develop ways to manipulate and control their 
assembly. The studies described in chapters 3, 4, 5, 7 and 8 have contributed to this. 
Further development of the system proposed at the end of chapter 3 may elucidate 
the necessity of the negatively charged polymer for the stability of the capsid after 
assembly, by demolishing this polymer after it has induced the formation of the 
capsid.
The focus of this thesis is on the decoration of the capsid interior. This is only 
one of the three exploitable surfaces that CCMV has to offer. The exterior and 
interface of the capsid provide very different challenges and opportunities. The use 
of CCMV as a versatile nano-building block has just started. The present work 
provides several new methods that aid the utilization of CCMV as a biohybrid 
building block in nanotechnology.
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Samenvatting
Virussen worden in toenemende mate gebruikt als bouwstenen voor de constructie 
van moleculaire systemen van nanometer afmeting. Ze zijn ongeëvenaard met 
betrekking tot het vermogen zichzelf spontaan te assembleren uit kleinere 
componenten, hetgeen ze erg geschikt maakt om gebruikt te worden in nano- 
reactoren, als medicijn-afgiftesystemen en als nieuwe materialen. De natuur heeft 
ons een grote diversiteit aan virussen geboden om mee te werken, elk met hun eigen 
karakteristieke eigenschappen.
In onze groep werken we met het cowpea chlorotic mottle virus (CCMV). Dit 
is een icosaedrisch plantenvirus, dat RNA bevat als genetisch materiaal, en 
interessant assembleergedrag vertoont. Het is mogelijk om het RNA te verwijderen, 
zodat een leeg omhulsel verkregen wordt, de eiwitmantel, die geassembleerd kan 
worden en weer uiteen kan vallen door de pH te veranderen. Zonder de 
stabiliserende interacties van het negatief geladen RNA, valt de mantel bij pH 7,5 
uiteen in 180 manteleiwitten. Een verlaging van de pH naar 5,0 resulteert in het 
omgekeerde gedrag: 180 manteleiwitten vormen weer spontaan de eiwitmantel van 
28 nm in doorsnede.
Negatief geladen polelektrolyten die voorkomen in de natuur, zoals RNA zijn 
niet de enige verbindingen die in staat zijn om als mal te dienen voor de formatie 
van de eiwitmantel bij hogere pH. In onze groep is eerder aangetoond dat een 
negatief geladen polymeer, polystyreensulfonaat (PSS), ook de vorming van de 
mantel kan induceren bij pH 7,5. De op deze manier verkregen structuur is echter 
kleiner dan wanneer de mantel zich vormt in het bijzijn van RNA als mal. In 
hoofdstuk 3 beschrijven we onderzoek dat gericht is op het verkrijgen van meer 
inzicht in de rol van het polymeer in de stabilisatie van de mantel, en wel door de 
insluiting van een negatief geladen redox-actief polyelektrolyt, polyferrocenylsilaan 
(PFS). Dit polyelektrolyt kan chemisch geoxideerd worden, hetgeen resulteert in 
een polymeer zonder lading. Omdat de mantel waarschijnlijk gestabiliseerd wordt 
door de aanwezigheid van negatieve ladingen, zou de interactie tussen het 
manteleiwit en het PFS dus kunnen verdwijnen door oxidatie van het polyelektrolyt, 
hetgeen mogelijk zou leiden tot destabilisatie van de mantel. Hoewel de resultaten
173
Samenvatting
geen duidelijk uitsluitsel hierover gaven, werd wel aangetoond dat PFS ook de 
formatie van een klein 18 nm virusdeeltje kan induceren.
In hoofdstuk 4 wordt beschreven dat de manteleiwitten bij pH 7,5 niet alleen 
kunnen assembleren rondom lineaire polelektrolyten, maar ook rond micellen, die 
bestaan uit DNA-amphiphilen. Kleine moleculen kunnen aan de micellen bevestigd 
worden door middel van hybridisatie aan het DNA of door ze onder te brengen in 
de hydrofobe binnenkant van de micellen. Dus levert dit een algemene methode op 
om de binnenkant van de mantel te beladen met kleine moleculen. Dit zou mogelijk 
toepassingen kunnen hebben in de ontwikkeling van medicijn-afgiftesystemen.
Om de eigenschappen van de CCMV manteleiwitten verder te onderzoeken en 
uit te breiden, werden deze eiwitten tot expressie gebracht in E.coli-bacteriën om zo 
genetische modificaties aan te kunnen brengen. De productie en zuivering van deze 
genetisch gemodificeerde manteleiwitten wordt besproken in hoofdstuk 5. Ze 
bleken tevens beter bestand te zijn tegen degradatie dan het wild-type eiwit. Het 
effect van de lengte van de N-terminus op de door PSS geïnduceerde formatie van 
de mantel wordt ook in dit hoofdstuk beschreven.
Dr. M. Comellas heeft in onze groep onderzoek gedaan naar de insluiting van 
enkelvoudige enzymen in de virus mantel. Dit heeft nieuwe inzichten opgeleverd 
over de werking van enzymen. De verwachting was daarom dat de studie van 
meerdere enzymen in de beperkte ruimte van de CCMV mantel tot een beter begrip 
zou kunnen leiden van de effecten van een beperkte ruimte in combinatie met een 
hoge lokale enzym-concentratie op de activiteit van de enzymen. Insluiting van 
enzymen in kleine ruimtes is van belang omdat dit het gedrag in cellen nabootst, die 
de natuurlijke omgeving zijn van enzymen. De insluiting van meerdere enzymen in 
de CCMV mantel is echter erg moeilijk te realiseren met de statistische 
insluitingsmethode, die gebruikt is door Dr. M. Comellas. In hoofdstuk 6 wordt 
daarom de ontwikkeling van een nieuwe methode beschreven die de 
insluitingsefficiëntie verhoogt en die ook de mogelijkheid biedt om te regelen 
hoeveel enzymen er ingesloten worden. Om dit te bereiken werden de 
manteleiwitten genetisch gemodificeerd zodat ze een aminozuur-sequentie genaamd 
coiled-coil bevatten. Deze coiled-coil kon worden gebruikt als een soort klittenband 
om er andere eiwitten, uitgerust met de complementaire coiled-coil, aan te 
bevestigen. Als een eerste test werd een fluorescent eiwit, het “enhanced green 
fluorescent protein” (EGFP), bevestigd aan de gemodificeerde manteleiwitten, en 
vervolgens gemengd met wild-type manteleiwit, waarna de vorming van de mantel 
geïnduceerd werd door verlaging van de pH. Het aantal ingesloten eiwitten kon
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gestuurd worden door de verhouding tussen het wild-type manteleiwit en het 
manteleiwit-EGFP complex te variëren. Het vormingsmechanisme van dit systeem 
bleek complexer te zijn dan gedacht en werd in detail geanalyseerd. De resultaten 
hiervan zijn beschreven in hoofdstuk 7.
Door de in hoofdstuk 6 ontwikkelde methode te gebruiken konden meerdere 
kopieën van een functioneel enzym, Pseudozyme (voorheen Candida) antarctica 
lipase B (PalB) ingesloten worden in de mantel van CCMV. Het effect van het 
variëren van het aantal ingesloten enzymen op de reactiesnelheid werd bestudeerd. 
Het bleek dat ingesloten PalB het substraat sneller omzette dan niet ingesloten PalB. 
Ook had de hoeveelheid ingesloten PalB enzymen weinig invloed op de efficiëntie 
van de reactie. De kleine ruimte en resulterende hoge concentratie van het enzym in 
deze ruimte bleek een grote invloed te hebben op de reactiesnelheid. Dit is 
beschreven in hoofdstuk 9. De insluiting van meerdere verschillende enzymen is 
belangrijk voor de studie van cascadereacties in de begrensde ruimte van de 
CCMV-mantel. De methode die beschreven staat in hoofdstuk 6 bleek geschikt te 
zijn om zowel PalB als EGFP aan de binnenkant van de eiwitmantel samen te 
brengen. Ook dit resultaat staat beschreven in hoofdstuk 9.
De studie van cascadereacties bij pH 5,0 is lastig omdat de meeste enzymen 
niet actief zijn bij lage pH. Dit is een groot nadeel van het gebruik van de CCMV 
eiwitmantel als nanoreactor. Een nieuwe methode werd daarom ontwikkeld om de 
mantel bij fysiologische pH te stabiliseren. De N-termini van de manteleiwitten 
werden door genetische modificatie voorzien van een histidine-tag, die in staat is 
om nikkelionen te binden. De mantel werd gestabiliseerd bij pH 7,5 door 
nikkelionen aan de mantel toe te voegen bij pH 5,0 en vervolgens de pH te 
verhogen naar 7,5. Door EGFP-manteleiwit-complexen te mengen met de 
manteleiwitten met een histidine-tag, kon EGFP ingesloten worden bij pH 7,5.
M et de methoden beschreven in hoofdstukken 6 , 8 en 9 is het nu mogelijk om 
meerdere typen eiwitten en enzymen op een gecontroleerde manier in te sluiten, en 
om de mantel van het CCMV te stabiliseren bij fysiologische pH. Het zou daarom 
nu mogelijk moeten zijn om cascadereacties te bestuderen binnenin de CCMV- 
mantel. Dit zou kunnen leiden tot interessante nieuwe inzichten en de ontwikkeling 
van efficiëntere nanoreactoren.
Om het volledige potentieel van CCMV als nanobouwsteen te kunnen 
verwezenlijken is het essentieel om een grondig begrip te hebben van de 
assemblage eigenschappen van het wild-type en de gemodificeerde manteleiwitten, 
en om methoden te ontwikkelen om de assemblage-eigenschappen te kunnen sturen.
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De studies beschreven in hoofdstuk 3, 4, 5, 7 en 8 hebben hieraan bijgedragen. 
Verdere ontwikkeling van een degradeerbaar polymeer template dat voorgesteld 
wordt aan het einde van hoofdstuk 3 zou licht kunnen werpen op de noodzaak van 
een negatief geladen polymeer voor de stabiliteit van de eiwitmantel nadat deze 
gevormd is. Dit zou bereikt kunnen worden door het polymeer te ontleden nadat het 
de vorming van de mantel geïnduceerd heeft.
Dit proefschrift heeft zich gericht op studies naar de modificatie van de 
binnenkant van de CCMV-eiwitmantel. Dit is echter maar één van de drie 
mogelijke oppervlaktes voor modificatie die CCMV te bieden heeft. De buitenkant 
en de tussenlaag van de eiwitmantel bieden weer hele andere uitdagingen en 
mogelijkheden. Het gebruik van CCMV als nanobouwsteen is pas net begonnen. In 
dit proefschrift werden verschillende nieuwe methoden beschreven die het 
toepassen van het CCMV als bouwsteen voor de constructie van biohybride 
systemen van nanometer-afmeting kunnen helpen.
176
List o f abbreviations
List of abbreviations
1,2-PD 1,2-propanediol
AgNP Silver nanoparticles
CalB Candida antarctica lipase B
CCMV Cowpea chlorotic mottle virus
cDNA Copy DNA
CK Capsid protein with K-coil
CMV Cowpea mosaic virus
CP Coat protein/capsid protein
C-terminus Carboxyl-terminus of a protein or peptide
CV Cyclic voltametry
DBCs DNA block copolymers
DiFMU-octanoate 6,8-difluoro-4-methylumbelliferyl octanoate
Dil 1,1’-dioctadecyl- 3,3,3’,3’-tetramethylindocarbocyanine 
perchlorate
DLS Dynamic light scattering
DMSO Dimethyl sulfoxide
DNA Deoxyribonucleic acid
Dsp Bacterial DNA binding proteins from starved cells
E1 Pyruvate decarboxylase component of PDH-complex
E2 Dihydrolipoyl acetyltransferase component of PDH-complex
E3 Dihydrolipoyl dehydrogenase component of PDH-complex
ECL Enhanced chemiluminescence
E-coil Negatively charged coiled-coil, amino acid sequence:
(EIAALEK3)
EDTA Ethylenediaminetetraacetic acid
EDX Energy dispersive X-ray
EGFP Enhanced green fluorescent protein
E.coli Escherichia coli
EM Electron microscopy
Eut Ethanolamine utilization
FCCS Dual-color fluorescence cross-correlation spectroscopy
FPLC Fast performance liquid chromatography
GE EGFP with E-coil
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GE-CK complex Two GE proteins bound to one CK dimer
GFP Green fluorescent protein
GST Glutathion S-transferase
His-CP Capsid protein with N-terminal His-tag
His-tag Histidine-tag, an amino-acid sequence of multiple sequential 
histidines, in this thesis a sequence of 6 histidines was used
HRP Horseradish peroxidase
HSFn Horse spleen apoferritin
Hsp60 Heat shock protein 60
ICP-MS Inductively coupled plasma-mass spectrometry
ICP-OES Inductively coupled plasma-optical emission spectroscopy
IPTG Isopropyl b-D-1-thiogalactopyranoside
K-coil Positively charged coiled-coil, amino acid sequence:
(KIAALKE3)
Kd Dissociation constant
LB Lysogeny broth
MBP Maltose binding protein
MCPs Proteinaceous microcompartments
MPV Murine polyoma virus
MVP Major vault protein
MQ Milli-Q water
MRI Magnetic resonance imaging
MW Molecular weight
MWCO Molecular weight cut-off
NA34 The N in this notation indicates that the amino acids are
missing from the N-terminus, A indicates missing amino acids, 
34 states the number of missing amino acids
NHS V-hydroxy succinimide
Ni-NTA Nickel-nitrilotriacetic acid
NP Nanoparticle
NTA Nitrilotriacetic acid
N-terminus Amino terminus of a protein or peptide
ODNs Oligonucleotides
P11 DBCs containing PPO blocks with a molecular weight of 6800
g/mol, attached to DNA ofll nucleotides in length
P22 DBCs containing PPO blocks with a molecular weight of 6800
g/mol, attached to DNA of 22 nucleotides in length
PalB Pseudozyma (formerly Candida) antarctica lipase B
PCB-1 Paramecium bursaria chlorella virus type I
PCR Polymerase chain reaction
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PDH
Pdu
PduP
PEG
PEI
PfFt
PFS
PPO
PSBD
PSS
PVX
RNA
ROX
RT
RuBisCO
SDS-PAGE
SFM
sHsp
STIV
STMV
SV40
SWNT
tcHis-CP
TEM
TEP1
TMV
Tris
UC
UU11
UV-Vis 
VLP 
VP1 
VPARP 
wt CP
wt CP NA34
yCD
Pyruvate dehydrogenase 
Propanediol utilization
CoA-dependent propionaldehyde dehydrogenase
Polyethylene glycol
Poly(ethylene)imine
Pyrococcus furiosus ferritin
Polyferrocenyl silane
Polypropylene oxide
Peripheral subunit-binding domain of the E2 component of the
PDH-complex
Polystyrene sulfonate
Potato virus X
Ribonucleic acid
6-carboxylic-X-rhodamine
Room temperature
Ribulose bis-phosphate carboxylase
Sodium dodecyl sulfate-poly acrylamide gel electroforese
Scanning force microscopy
Small heat shock protein
Sulfolobus turreted icosahedral virus
Satellite tobacco mosaic virus
Simian virus 40
Single-walled carbon nanotubes 
Thrombin cleaved His-CP 
Transmission electron microscopy 
Telomerase-associated protein 1 
Tobacco mosaic virus 
Tris(hydroxymethyl)aminomethane 
Unknown complex
Lipid-DNA 11-mer containing two 5-dodec-1-ynyluracil
nucleobases at the 5’- end followed by 9 naturally occuring
nucleobases
Ultraviolet-visual
Virus like particle
Virus protein 1
Vault poly(ADP ribose polymerase)
Wild-type capsid protein
Truncated capsid protein lacking the first 34 amino acids of the 
N-terminus
Yeast cytosine deaminase
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Dit dankwoord geeft me de kans om iedereen die op de een of andere manier aan dit 
proefschrift bijgedragen heeft te bedanken, en daar maak ik natuurlijk graag gebruik 
van. Waar we normaal gesproken in artikelen en presentaties alleen de namen 
noemen van degenen die een tastbare wetenschappelijke bijdrage hebben geleverd, 
krijg ik hier de gelegenheid om iedereen wat uitgebreider te bedanken, inclusief al 
degenen die op andere, maar minstens zo belangrijke manieren, hebben bijgedragen 
aan de totstandkoming van dit proefschrift.
Roeland en Jeroen, bedankt voor de grote vrijheid die ik gekregen heb bij het 
verkennen van het geweldige virus onderzoeksonderwerp. Jullie vertrouwen en 
vermogen om overal een positieve draai aan te geven, maakten dat ik na een 
gesprek met jullie altijd weer vol frisse moed buiten stond.
I would like express my gratitude to the manuscript committee, Jan van Hest, 
David Reinhoudt and Trevor Douglas, for reading and correcting my thesis.
Yujie, it was a great pleasure to work (and chat) with you. The research 
described in chapter 3 would not have been possible without you. It is funny how 
many times we kept bumping into each other after that.
Minseok, you were the driving force behind the research in chapter 4, you 
always wanted to go faster in your enthusiasm. The funny micelle puppets you 
designed were the direct inspiration for the carpenter on my cover.
Alan and Kerstin, without your enthusiasm and feisty discussions about the 
research in chapter 9, we might still not know how to interpret the results. Thank 
you for correcting the article so quickly and thoroughly.
Ik heb de afgelopen jaren meerdere malen gezien dat de confocale laser geen 
apparaat is waar je  ‘even’ wat metingen op doet. Jammer genoeg strooide de 
vulkaan in IJsland ook nog eens roet in het eten. Arend, bedankt dat je  geprobeerd 
hebt de metingen toch door te laten gaan. Victor, dank je  voor de inzet om direct na 
terugkomst uit Amerika achter de confocal te duiken. Het heeft de feitelijke 
onderbouwing geleverd enkele belangrijke aannames in hoofdstuk 9.
Naar huidige maatstaven heb ik geloof ik niet veel studenten gehad, maar 
liever kwaliteit dan kwantiteit, en dus heb ik absoluut niets te klagen. Koos, je  hield 
van discussiëren, en we hebben dan ook vele discussies gevoerd over jouw (en
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mijn) onderzoek, wat zich daar gelukkig ook uitstekend voor leende. Het heeft 
geresulteerd in een fantastisch stukje onderzoek, waar hoofdstuk 8  volledig aan 
gewijd is. Saskia, nadat Koos weg was, was jij er gelukkig nog wel, zodat ik ook 
tijdens het laatste halve jaar van mijn promotie iemand had om gezellig mee te 
kletsen. Je hebt veel synthese gedaan in je  project. De literatuur op dit gebied bleek 
helaas niet helemaal betrouwbaar, maar dankzij jou  doorzettingsvermogen en de 
input van Rene Aben en Hans Scheeren is het toch nog gelukt om het monomeer te 
maken. De scriptie die je  geschreven hebt, heeft als basis gediend voor mijn tweede 
hoofdstuk en een review artikel, en omdat je  dat zo’n geweldig goed werk af hebt 
geleverd, heb ik daar nauwelijks iets aan hoeven te veranderen.
When I started my research in the ‘virusgroup’ Marta, Friso and Linda had 
already laid de groundworks for my research. Marta and Friso, not only was your 
work the inspiration for a large part of this thesis, you also taught me a lot about the 
virus in general and how to extract it from the plants. Linda, jij hebt me niet alleen 
van het andere belangrijke basismateriaal voorzien; het plasmide wat codeert voor 
het bacteriële capsid eiwit, maar jij bent ook degene geweest die me in het begin 
wegwijs heeft gemaakt op het lab, en me zoveel verschillende technieken heeft 
geleerd. Ontzettend bedankt!
Guillaume, Andrès, Mauri and Christine, it was really nice having you here, 
growing plants in increasingly obscure corners of the university wouldn’t have been 
half as much fun without all of you.
All the other people of the Nolte group, thanks for the great time in and 
around the lab.
By the time this thesis is printed, the virus group in Nijmegen will have 
almost ceased to exist, but luckily a new and enthusiastic group of scientists are 
taking over the virus research in Jeroens new group in Twente. Rik, Melanie, Anne, 
Martijn, Oya and Yujie (again), I have enjoyed getting to know you and being able 
to help a little bit. It is nice to know that some of my projects are continued, and I ’m 
sure with you the research is in very capable hands.
Contrary to popular believe, I was never officially a part of the van Hest group 
(at least not during my PhD), but as the Nolte group was declining in size, they 
were kind enough to more or less adopt us, and I want to thank the entire van Hest 
group for the ‘gezelligheid’ during lunchtime, drinks, and other occasions. Hans, 
bedankt voor de hulp met peptide synthese en het delen van een schijnbaar 
onuitputtelijke hoeveelheid verhalen. Joris, het is moeilijk om jou  ergens specifiek 
voor te bedanken, want je  hielp, gevraagd of ongevraagd, altijd met alles.
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Linda, Sanne, Rosalie, Mark, Mark en Mark (tja, ik kan er ook niets aan doen, 
het is blijkbaar een populaire naam), het was fijn om een paar collega’s te hebben 
bij wie ik te rade kon gaan met moleculair biologische problemen. Bedankt ook 
voor alle gezelligheid aan de soms wat stille ‘overkant’.
Behalve op het NCMLS heb ik ook veel tijd besteed in het algemeen 
instrumentarium, waar Liesbeth, Jelle, Geert-Jan en Rien altijd klaar stonden om te 
helpen. Iedere keer dat de FPLC weer iets vreemds deed dacht ik weer ”de volgende 
keer heb ik Rien niet nodig, want nu heb ik toch wel alles gezien wat er mis kan 
zijn met dit apparaat”, en elke keer had ik het weer mis. Rien ontzettend bedankt 
voor al je  hulp!
Peter, ondanks de bestelsystemen heb ik dankzij jou  de chemicallieen vaak 
toch nog binnen een redelijke tijd gekregen, dank je  voor alle extra moeite. Desiree, 
zonder jou  zouden vele dingen minder soepel zijn verlopen. Dank je voor al je  hulp.
De afgelopen jaren ben ik twee keer naar het buitenland geweest voor een 
conferentie. Beide keren een fantastische ervaring, niet in het minst dankzij Sanne, 
Morten, Maaike, Stijn en Dennis, met wie ik Oxford verkend heb, en TuHa, Victor, 
Luiz en Loes, waarmee ik door de steile straten van San Francisco heb gewandeld.
Stijn en Loes, fijn dat twee vrienden die ik al ken vanaf de allereerste dag hier 
in Nijmegen mijn paranimfen willen zijn. Samen met Willem, Nearchos, Arjan, 
Vivike en Otmar, hebben we heel wat gezellige dagen en avonden doorgebracht, de 
afgelopen jaren zouden lang niet zo leuk geweest zijn zonder jullie.
En dan is er natuurlijk nog het thuisfront. Jan en Myriam, jullie hebben me 
van kinds af aan enthousiast gesteund in alles wat ik deed, en daar zijn jullie nooit 
mee opgehouden, dankzij jullie ben ik gezegend met een extra paar ‘grootouders’.
Peter, mijn ‘kleine’ broertje, je  hebt de afgelopen jaren enorme sprongen 
voorwaarts gemaakt, en me keer op keer versteld doen staan. Ik ben enorm trots op 
je.
Pap en mam, jullie hebben altijd iedere kans, die jullie zagen om me te helpen, 
aangegrepen, bedankt voor de onvoorwaardelijke steun tijdens mijn hele leven.
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